Abstract
Adipose tissue engineering holds promise for the development of therapeutic strategies for
subcutaneous adipose tissue regeneration to treat defects resulting from congenital birth
defects, invasive surgical procedures and traumatic injuries. Decellularized adipose tissue
(DAT) scaffolds represent a potential off-the-shelf tissue substitute for volume augmentation.
Seeding the DAT with adipose-derived stromal cells (ASCs) has been shown to enhance
adipose tissue regeneration in immunocompetent animals in vivo. Although promising, this
strategy is limited by low cell attachment on the DAT. As such, this thesis focused on the
development of bioreactor strategies to enhance the capacity of human ASCs to stimulate
angiogenesis and adipogenesis within the DAT.
Culturing human ASCs on the DAT scaffolds within a perfusion bioreactor under hypoxia
(2% O2) promoted ASC expansion, and altered cell phenotype, upregulating the expression
of hypoxia inducible factor 1-alpha (HIF-1), inducible nitric oxide synthase (iNOS) and
tumour necrosis factor-alpha (TNF-) in the ASCs in the peripheral regions of the DAT.
Further, bioreactor culture modulated the expression of pro-angiogenic and
immunomodulatory paracrine factors, suggesting that the capacity of the ASCs to stimulate
regeneration may have been altered by shear stress stimulation. In vivo testing in athymic
nude mice demonstrated that angiogenesis and adipogenesis within the DAT were markedly
enhanced when the ASCs were cultured for 14 days within the perfusion bioreactor under 2%
O2 prior to implantation as compared to bioreactor culture under 20% O 2, as well as staticcultured, freshly-seeded and unseeded controls. Analysis of host cell infiltration indicated
that there was increased CD31+ endothelial cell recruitment and potentially adipogenic
progenitor cell recruitment into the DAT implants, as well as a shift towards a more proregenerative macrophage response, in the 2% O2 bioreactor group relative to static cultured
controls.
Building from this work, a novel scalable rocking bioreactor platform was explored as an
expansion and preconditioning system for ASCs. Preliminary studies indicated that culturing
ASCs on DAT coatings within the rocking bioreactor enhanced the expression of the proangiogenic and immunomodulatory markers CD146 and iNOS. Collectively, this work
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supports that dynamic culture systems can be applied to enhance the pro-regenerative
potential of ASC-seeded DAT bioscaffolds.
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Summary for Lay Audience
The adipose (fat) tissue layer underneath the skin has limited ability for self-healing. Damage
or loss of these tissues resulting from conditions including trauma, cancer, burns, or
congenital birth defects can cause functional impairment and affect self-image, potentially
causing anxiety and post-traumatic stress disorder (PTSD). Current therapeutic strategies
have numerous limitations and there is a clear need for new approaches that promote the
stable regeneration of adipose tissue for volume augmentation applications in plastic and
reconstructive surgery.
To address this challenge, human adipose tissue discarded as surgical waste was processed to
extract cellular components that would cause an immune response and produce protein-based
decellularized adipose tissue (DAT) scaffolds. In combination with adipose-derived stromal
cells (ASCs), a population of regenerative cells found in fat, the DAT was previously shown
to promote the regeneration of fat tissues in pre-clinical models. Building from this work, the
current thesis primarily focused on investigating whether culturing the ASCs on the DAT
within a custom perfusion bioreactor system could enhance their capacity to stimulate blood
vessel formation and adipose tissue regeneration. Using this perfusion bioreactor system,
conditions were identified that promoted human ASC proliferation and infiltration on the
DAT. Further, in-depth biological characterization indicated that human ASC function was
altered by culturing within the bioreactor under low oxygen tension. More specifically, these
cells were shown to produce higher levels of a range of proteins that could stimulate tissue
regeneration. Testing in a pre-clinical mouse model demonstrated that culturing the ASCs on
the DAT scaffolds for 14 days using the established perfusion bioreactor strategy was
effective at promoting adipose tissue regeneration within the DAT. Characterization studies
suggested that these effects were mediated by enhancing the infiltration of cells from the host
tissues that contributed to the formation of new blood vessels and fat cells, as well as by
promoting a more pro-regenerative host immune response.
Although promising, it may be challenging to scale up the perfusion bioreactor for clinical
applications in humans where a large number of cells are needed, particularly in cases where
a large volume of fat tissue regeneration is required. As such, the development of a more
scalable rocking bioreactor was explored as an alternative to the perfusion bioreactor. Initial
iv

results showed that this system could also promote the expression of proteins that have been
identified as positive markers of the regenerative capacity of ASCs. Overall, the work in this
thesis represents an advancement towards a clinically translatable strategy to support the
stable and predictable regeneration of the fat tissue layer below the skin.
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Chapter 1

1

Literature review

1.1 Overview of the integumentary system
The integumentary system, comprised of the skin and its appendage structures, along
with the subcutaneous adipose tissue layer, is one of the largest organ systems in the body
(Figure 1.1)1. The skin consists of two distinct layers, termed the epidermis and dermis.
The epidermis is composed of a thin layer of keratinized squamous epithelium, which is
largely made up of keratinocytes, but also contains melanocytes, Langerhans cells and
Merkel cells2. The epidermis is avascular and dependent on the dermal layer for
oxygenation and nutrients2. The epidermal layer is organized into several sub-layers,
from the deep stratum basale, also referred to as the stratum germinativum, to the apical
stratum corneum.
The dermal layer is located between the epidermis and the subcutaneous tissues. The
dermis is enriched in lymphatic vessels, blood vessels, and nerve endings necessary for
the physiological function of the skin3. Further, the dermis also contains hair follicles, as
well as apocrine, sebaceous and eccrine glands4. In addition, the dermal layer contains a
high density of collagen and elastin, which are essential for maintaining the structural
integrity and elasticity of the skin. Notably, collagen accounts for approximately 70% of
the dry mass of the skin2.
The hypodermis, also known as subcutaneous tissue, is a part of the integumentary
system that is located below the dermis4. The subcutaneous tissue layer is predominantly
composed of adipose tissue that can be anatomically divided into two layers: the
superficial adipose tissue layer and the deep adipose tissue layer 5. While the superficial
layer can be variable in depth depending on the fat depot, it averages around 1 cm in
thickness6. In addition to being rich in adipocytes, this layer contains a dense network of
blood and lymphatic vessels. Adipose tissue in this layer is organized into lobules that are
separated by connective tissue6. The deep adipose tissue layer is separated from its
superficial counterpart by a thin layer of highly fibrous fascia, known as the fascia
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superficialis5. While the superficial fat layer is relatively resistant to hypertrophic and
hyperplastic expansion in adult humans, the deep fat layer accounts for the majority of
overall adipose tissue growth in instances of increased fat accumulation 6. Additionally,
fat tissue in this layer is also more sensitive to glucose, which could explain its
susceptibility for expansion compared to the superficial adipose tissue depots 6.
Functionally, the subcutaneous adipose tissue layer is an important endocrine organ, and
has been shown to regulate metabolism7–10. Additionally, subcutaneous adipose tissue is
involved in thermoregulation, and also provides structural support to the dermis and
epidermis4.

Figure 1.1 Overview of the structure of the integumentary system showing the
anatomy of the epidermis, dermis and hypodermis (subcutaneous tissue). Image reprinted with permission from publisher1.

1.2 Clinical need for soft tissue augmentation strategies
Subcutaneous adipose tissue damage or loss are prevalent issues that can be caused by
trauma, birth defects, aging and surgical procedures, such as oncologic resection
surgeries11. It was estimated that over 5.8 million reconstructive procedures were
performed in the U.S. in 2018 alone to address these issues, including more than 480,000
scar, burn or laceration repairs, 101,000 breast reconstructions, and 4.4 million tumour
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removals12. Existing clinical interventions and therapeutic strategies generally aim to
augment the volume of the damaged or missing tissues.
The current gold standard to correct large-volume defects is the transfer of vascularized
flaps of skin, fat and muscle from a distant depot on the patient’s body 12. For example,
deep inferior epigastric perforator flaps are common procedures where subcutaneous
tissues and a small portion of the muscle tissue from the abdominal region of the patient
are directly grafted to augment the breast13. However, these types of surgical
interventions are associated with serious complications including tissue necrosis,
weakening of the abdominal wall, and abdominal hernia14–16.
Common clinical interventions for medium-volume defects (50 – 150 cc) include
autologous fat grafting, where subcutaneous adipose tissue from a distal fat depot is
extracted, processed and injected into the target site17,18. This strategy requires a high
degree of surgical precision, and the grafted tissue may be quickly resorbed following
implantation due to a lack of supporting vascularization19. In addition, poorly
vascularized fat grafts can lead to complications such as the formation of oil cysts and
calcification13.
For small-volume augmentations, such as the treatment of wrinkles, dermal fillers are the
primary treatment strategies. These dermal fillers are typically composed of injectable
hyaluronic acid (HA) formulations20–22. However, the augmentation effects of these
fillers are transient, typically lasting 3-6 months19. Inappropriate techniques can lead to
swelling, pain, infections and tissue necrosis19. Additionally, these materials do not
support the natural regeneration of host adipose tissue 23.
While existing clinical interventions can address soft tissue damage or loss to varying
degrees, these treatment strategies are associated with risks and complications as outlined
above. In addition, these strategies have not demonstrated the capacity to support tissue
regeneration, which often leads to transient and/or unpredictable augmentation22. The
lack of intervention strategies to address soft tissue damage that are effective in the longterm can lead to anxiety and depression24. For patients with injuries caused by trauma or
cancer, an inability to address these issues can also precipitate post-traumatic stress
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disorder (PTSD)25. As such, there is a critical need for alternative clinical treatment
strategies that can provide long-term augmentation and support the stable and predictable
regeneration of damaged or deficient subcutaneous adipose tissue.

1.3 Adipose tissue engineering
Adipose tissue engineering has generated promising advances toward strategies that can
promote subcutaneous adipose regeneration. A common approach involves a combination
of pro-regenerative cell populations and biocompatible scaffolds26–28. The scaffolds can
provide immediate volume augmentation and serve as a delivery vehicle for the
regenerative cell populations. In addition, depending on the properties of the
biomaterials, they can also provide the necessary biomechanical and biochemical support
to promote host-derived regenerative processes29–31. Existing biomaterials that have been
investigated for adipose tissue engineering applications can be categorized as either
synthetic polymers, such as poly(lactic-co-glycolic) acid (PLGA), polyglycolic acid
(PGA) and polyethylene glycol (PEG)32–34, or naturally-derived biomaterials, which
include extracellular matrix (ECM) components such as collagen, HA, or decellularized
ECM bioscaffolds35–37. Key studies involving a variety of scaffolds will be described in
more detail in Section 1.6.
Pro-regenerative cell populations are often delivered within the bioscaffolds to help
stimulate regeneration. To date, the majority of studies have incorporated either mature
adipocytes38 or adult mesenchymal stromal cell (MSC) populations39–41. The specifics of
these cell populations will be discussed in detail in the next section.

1.4 Cell sources for adipose tissue engineering
To develop a therapeutic strategy for adipose tissue regeneration, potential cell sources
should be readily available and accessible, and ideally provide a high density of proregenerative cells to support clinical translation in humans 42. A range of cell sources
such as adipocytes, embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
and MSC populations, such as bone marrow-derived MSCs and adipose-derived stromal
cells (ASCs) have been examined for this application43–46. This section will discuss the
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specifics of these cell populations and how they can contribute to the processes involved
in adipose tissue regeneration, with a particular focus on MSCs as the most predominant
cell source studied to date.
Among cell types investigated for adipose tissue regeneration, mature adipocytes have
been used to provide immediate tissue augmentation to the target site, similar to
autologous fat grafting47. While studies have demonstrated that this cell population could
be promising, it is unclear if adipocytes can survive long-term and maintain volume over
time. A recent study by Eto et al. demonstrated that human adipocytes that were
delivered in vivo into mice did not survive under hypoxia48. In particular, the lack of
vascularization near the newly grafted tissue led to the loss of ~80% of the delivered
adipocytes within 3 days48. Additionally, mature adipocytes can be fragile to handle,
which could add further challenges for clinical translation 49,50. In light of these findings,
studies have largely shifted away from delivering mature adipocytes.
In addition to mature adipocytes, ESCs, a population of pluripotent cells derived from the
inner cell mass of blastocysts51, have also been studied as a potential cell source for
adipose tissue engineering52. This cell population has the capacity to differentiate into
mature cells derived from the endoderm53,54, mesoderm55,56 and ectoderm57,58 layers,
which makes them promising for a wide range of therapeutic applications. However,
grafting ESCs into patients had led to the formation of teratomas 59. This, in addition to
their embryonic sourcing, raises ethical concerns associated with their use 60. Similarly,
iPSCs generated from reprogrammed adult somatic cells have also been considered for
the regeneration of adipose tissue61. However, the process involved in reprogramming
has the potential to be tumorigenic and delivery of these cells into patients can also lead
to teratoma formation61. Overall, while ESCs and iPSCs have demonstrated promise for
adipose tissue regeneration, their associated safety and ethical concerns represent barriers
to clinical translation that currently limit their investigation for this application.

1.4.1

Mesenchymal stromal cells

MSCs are a heterogenous cell population that was first identified within the bone
marrow62. Since then, MSCs have also been isolated from numerous other sources
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including adipose tissue63, synovial fluid64, umbilical cords65 and peripheral blood66. To
address their diverse sourcing and heterogenous nature, MSCs were broadly defined as a
cell population that is adherent to tissue culture plastic, expresses the cell surface markers
CD73, CD90 and CD105, and lacks expression of CD14, CD31 and CD4567.
Additionally, MSCs also have the capacity to undergo adipogenic, chondrogenic and
osteogenic differentiation when cultured in vitro under inductive conditions67.

1.4.2

Adipose-derived stromal cells

The stromal vascular fraction (SVF) of adipose tissue contains fibroblasts, committed
adipogenic progenitors, endothelial cells, hematopoietic cell populations and a small
subpopulation of MSC-like cells called ASCs 68. The SVF can be isolated from adipose
tissue through enzymatic digestion with collagenase, followed by centrifugal separation
and filtration techniques69. The ASCs are broadly classified as the population within the
SVF that adheres to tissue culture polystyrene (TCPS)69. It is estimated that between 5 x
105 to 2 x 106 nucleated cells can be isolated per gram of fat, and ASCs account for 20%
of this population70,71. As such, ASCs are considerably more abundant than MSCs within
the bone marrow, which are estimated to represent only 0.04% of the nucleated cell
population71. Additionally, ASCs can be isolated from surgically discarded fat, which is a
highly abundant and readily available source material, making them a particularly
promising source of regenerative cells for adipose tissue engineering strategies.
In addition to being plastic-adherent, ASCs are also defined by the expression of selected
cell surface markers and their potential to undergo tri-lineage differentiation into
adipocytes, chondrocytes and osteoblasts when induced in culture72.
Immunophenotypically, ASCs are characterized by their positive expression of CD29,
CD44, CD73, CD90 and CD105 and their lack of expression of CD31 and CD45.
Additionally, ASCs may also have variable expression of CD26, CD34 and CD14670. A
comprehensive list of ASC surface markers and their associated functions is shown in
Table 1.1.
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Table 1.1 Key positive, negative and variable ASC surface markers.
Surface
Protein
Marker
CD29
Integrin β1
CD44
CD73
CD90
CD105

Homing cell
adhesion molecule
Ecto-5'nucleotidase
Thymocyte
differentiation
antigen 1
Endoglin

Positive Surface Markers
Function(s)
Component of cell surface integrins, which can
mediate cell adhesion and a diverse range of functions
including tissue regeneration and immunoregulation73
Cell surface glycoprotein, receptor for hyaluronic
acid74,75
Catalyzes the production of ECM adenosine,
modulates transforming growth factor beta 1
(TGF-β1) expression76
Maintenance of progenitor-like phenotype77
Surface glycoprotein, component of the TGF-β1
receptor complex78
Negative Surface Markers
Function(s)

Surface
Protein
Marker
CD31
Platelet endothelial Endothelial cell marker. Attenuates VEGFA-mediated
cell adhesion
angiogenesis79
molecule 1
CD45
Protein tyrosine
Hematopoietic marker. Membrane glycoprotein
phosphatase
involved in cell activation and differentiation80
receptor type C
Variable Surface Markers
Surface
Protein
Function(s)
Marker
CD26
Dipeptidyl
Modulates macrophage recruitment by degrading key
peptidase 4
cytokines and paracrine factors81,82

CD34
CD146

Transmembrane
glycoprotein
melanoma cell
adhesion molecule

Associated with a pro-fibrotic phenotype in dermal
fibroblast populations83
Associated with maintenance of clonogenicity84 and
pro-angiogenic functionality85.
Expressed in vascular endothelial cells, smooth
muscle cells and pericytes. Cell surface receptor for
laminin, mediates blood vessel maturation86,87

As mentioned, in addition to their characteristic cell surface marker expression profile,
ASCs also have the capacity to differentiate into adipocytes, chondrocytes and
osteoblasts in culture using differentiation media formulations incorporating lineagespecific supplements and factors88. For example, human ASCs can be induced to undergo
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adipogenic differentiation in culture by administering adipo-inductive hormones and
glucocorticoids, such as hydrocortisone, dexamethasone and insulin89. The sequential
addition of these factors can lead to growth arrest, and activation of the transcription
factors CCAAT/enhancer binding protein alpha (CEBP-α) and peroxisome proliferatoractivated receptor gamma (PPAR-γ)90,91. Activation of these two master regulators of
adipogenesis causes upregulation of a range of genes that are associated with intracellular
lipid accumulation and adipogenic differentiation92. Similarly, ASCs can be induced to
undergo chondrogenic differentiation by administering cytokines and growth factors such
as transforming growth factor-beta (TGF-β1) and bone morphogenetic protein-2 (BMP2), to cells cultured in 3-D aggregates89. These culture conditions induce the ASCs to
undergo cellular condensation and commit towards chondrogenic differentiation93. ASCs
can also be induced to undergo osteogenic differentiation using a combination of
dexamethasone, ascorbic acid and β-glycerophosphate94. These factors activate the
transcriptional factor, Runt-related transcription factor 2 (RUNX-2), which commits
ASCs towards the osteogenic lineage94.
ASC isolation protocols were initially developed using lipoaspirated fat from rats 95. Since
then, the isolation protocols have been adapted for numerous tissue sources including
human adipose tissue96. Advances in this field have led to an increasingly diverse range
of isolation methodologies69. One recent study compared several common isolation
protocols, including methods with collagenase digestion, trypsin digestion, red blood cell
lysis buffer solution-based isolation and a centrifugation-based protocol for lipoaspirated
human fat tissue97. This study demonstrated that while ASC yield was higher with the
collagenase digestion method, there was no difference in cell viability and key cell
surface marker expression between the protocols97. Recently, a study by Priya et al.
showed that outgrowth cultures from extracted adipose tissue could yield ASCs with
similar cell surface marker expression patterns and tri-lineage differentiation potential as
compared to cells extracted through traditional enzymatic isolation methods 98.
Additionally, magnetic bead purification methods have also been developed, where cells
with negative markers of ASCs, such as CD31 and CD45, were removed from the SVF
using antibodies conjugated to magnetic beads99,100. While this was effective at obtaining
a more homogenous starting cell population, it did not significantly impact the expression
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of positive ASC cell surface markers or the capacity of the cells for tri-lineage
differentiation.

1.5 Mechanisms of ASC-mediated tissue regeneration
While past studies have attempted to harness the differentiation potential of ASCs for
adipose tissue engineering, recent work has suggested that transplanted ASCs primarily
stimulate regeneration by remodeling the cellular microenvironment and secreting
paracrine factors that promote host-derived angiogenesis, macrophage recruitment and
adipogenesis101–103.
ASCs are highly metabolically active and secrete a range of ECM components, growth
factors and cytokines104–106. A recent study comparing the results from 5 independent
studies on the ASC secretome showed 68 proteins that were expressed in common 107.
Interestingly, ASCs were shown to secrete a range of ECM-associated proteins, most
notably, collagen I, II, III, IV, V, VI, XII, fibronectin, laminin, heparan sulfate (HS),
matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases-1
(TIMP-1)105, which suggests an active role in both the degradation and deposition of
ECM components. Their capacity for ECM remodeling is supported by a previous in
vitro study that demonstrated that ASCs seeded in a fibrin-based matrix could degrade
the hydrogel via matrix metalloproteinase 14 (MMP-14) activity and deposit collagen
type IV, which led to an increased invasion and tubule formation by seeded human
umbilical vein endothelial cells (HUVECs)108. In addition to supporting angiogenesis,
ASCs can also participate in remodeling the ECM to establish a more pro-adipogenic
microenvironment. Previously, ASCs were found to degrade a collagen-based matrix in
vitro and deposit collagen type IV109. In particular, the deposition of collagen VI has been
shown to play an important role in adipogenesis110. Collectively, ECM remodeling is a
mechanism for ASCs to mediate both angiogenesis and adipogenesis to support adipose
tissue regeneration.
ASCs are well recognized for their capacity to support regeneration through the secretion
of paracrine factors and cytokines that mediate angiogenesis and modulate the immune
response101,107,111. Previous studies have shown that ASCs can be stimulated to produce
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pro-angiogenic factors such as basic fibroblast growth factor (bFGF), hepatocyte growth
factor (HGF), TGF-β1, and vascular endothelial growth factor (VEGFA)112–115. For
example, a previous study showed that HGF can increase the diameter of endothelial
tubules in vitro, whereas VEGFA resulted in an increased branching of tubules115,
suggesting that these two pro-angiogenic factors that can be secreted by ASCs can play
distinct and complementary roles during neovascularization. Additional details of the
functions of key angiogenic factors secreted by ASCs are outlined in Table 1.2.
Table 1.2 Key pro-angiogenic factors secreted by human ASCs and their functions
Pro-angiogenic Factors
Basic fibroblast growth factor
(bFGF)

Function(s)
Promotes endothelial cell survival, proliferation,
migration and differentiation112

Granulocyte colony stimulating
factor (G-CSF)

Binds and activates fibroblast growth factor
receptor 1 on endothelial cells, and activates MAPK
to promote angiogenesis116
Stimulates the proliferation, survival and
recruitment of innate immune cells113

Chemoattractant for endothelial progenitor cells;
promotes the differentiation of endothelial cells117
Hepatocyte growth factor (HGF) Promotes endothelial cell survival, proliferation and
mobilization114
Creates an autocrine loop that drives
angiogenesis118

Vascular endothelial growth
factor A (VEGFA)
Platelet-derived growth factor
(PDGF-B)
Angiopoietin 1 (Ang-1)

Works synergistically with VEGFA to increase
vessel diameter115
Potent driver of vessel sprouting and
neovascularization115
Promotes endothelial cell proliferation119
Chemoattractant for pericytes and promotes blood
vessel stabilization120,121
Promotes endothelial cell survival, proliferation and
motility122
Supports blood vessel maturation and
stabilization122
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In addition to angiogenesis, ASCs can promote tissue regeneration by mediating both
pro-inflammatory and anti-inflammatory immune responses123,124. ASCs can be induced
towards a pro-inflammatory phenotype by treatment with lipopolysaccharide (LPS) 125,126.
Upon induction, ASCs can produce an array of pro-inflammatory cytokines, including
tumor necrosis factor alpha (TNF-α)127. At the molecular level, TNF-α can not only lead
to an increased expression of pro-inflammatory cytokines by effector cells, such as
monocytes, it can also act in an autocrine loop on ASCs, which leads to the increased
expression of additional pro-inflammatory mediators, such as interleukin 6 (IL-6),
interleukin 8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and interferon gamma
(IFN-γ)128,129. Interestingly, TNF-α also plays an important role in angiogenesis130,131. An
in vitro study by Yuan et al. demonstrated that TNF-α can increase the expression of
VEGFA and promote tube formation in human omental tissue microvascular endothelial
cells127.
While the transient exposure of MSCs to these factors could be pro-angiogenic, chronic
exposure to TNF-α and the pro-inflammatory mediator interferon gamma (IFN-γ) have
been shown to impair the proliferation and differentiation capacity of MSCs in vitro and
in athymic nude mice in vivo129. IFN-γ can also increase the expression of inducible nitric
oxide synthase (iNOS) and the production of nitric oxide (NO)132. In an inflamed
microenvironment, NO can mediate tissue regeneration and inhibit fibrotic pathways 133.
Moreover, interferon gamma (IFN-γ), along with prostaglandin E2 (PGE-2) can also
promote the expression of the anti-inflammatory cytokine interleukin-10 (IL-10), which
subsequently downregulates the expression of pro-inflammatory cytokines in ASCs as
well as immune cell populations134,135. Additionally, IL-10 can promote the polarization
of macrophages towards a more pro-regenerative phenotype136. A detailed discussion of
the roles of IL-10 and pro-regenerative macrophage populations in tissue regeneration is
provided in Section 1.9.2. A list of key immunomodulatory cytokines secreted by ASCs
is summarized in Table 1.3.
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Table 1.3 Key pro- and anti-inflammatory cytokines expressed by ASCs.
Cytokines
Tumor necrosis factoralpha (TNF-α)

Function(s)
Binds to surface receptors on monocytes, T cells,
endothelial cells and fibroblasts, activates IKK/NFκB
signaling cascade137 to modulate cell survival138 and
mobilization139

Interleukin-6 (IL-6)

Promotes the release of pro-inflammatory mediators140,
such as IL-6141 and IFN-γ142
Binds to surface receptors on monocytes and endothelial
cells, leading to survival, proliferation and differentiation
of monocytes143,144

Interleukin-10 (IL-10)

Expression in ASCs induced by IFN-γ and PGE-2145
Downregulates the expression of pro-inflammatory
factors (e.g. TNF-α)146

Interferon gamma (IFN-γ)

Nitric oxide (NO)

Promotes the polarization of monocytes towards a
pro-regenerative phenotype and inhibits the maturation
of dendritic and pro-inflammatory macrophages147
Activates pro-inflammatory immune cells such as T
cells, natural killer cells148
Upregulates iNOS expression in ASCs132
Inhibits fibrotic pathways by inhibiting the TGF-β1
signaling pathway133
Inhibits T-cell activation by inhibiting STAT5 and the
expression of pro-inflammatory cytokines149

1.6 Biomaterials for adipose tissue engineering
Both synthetic and naturally-derived biomaterials have been explored for adipose tissue
engineering. Scaffolds that are fabricated from synthetic materials can offer advantages in
terms of their tunability, as they typically have more highly adjustable mechanical and
chemical properties150. Biodegradable polymers such as poly-lactic acid (PLA) and PGA
have been investigated for adipose tissue engineering44,151–153. For example, PLA-based
scaffolds, when seeded with human ASCs and implanted into the muscularis layer of the

13

subcutaneous tissue of nude rats, promoted adipose tissue formation after 4 weeks 44.
Furthermore, this study demonstrated that seeding the PLA scaffold with the ASCs
promoted the degradation of the polymer and supported adipogenesis in vivo44. Similarly,
Weiser et al. investigated the adipogenic and angiogenic potential of PGA-based
scaffolds151. When these scaffolds were seeded with 3T3-L1 preadipocytes exposed to
adipogenic induction media and implanted subcutaneously into athymic nude mice, blood
vessels and adipose tissue were observed within the scaffolds at 12 weeks 151.
PLGA, a co-polymer of PLA and PGA, has also been investigated for adipose tissue
engineering, and has been shown to support adipogenesis in animal models with
moderate success154–157. For example, Patrick et al. demonstrated that PLGA, when
seeded with rat ASCs, can support the formation of adipocytes at 2 weeks following
implantation in an immunocompetent rat model158. Similarly, when PLGA spheres were
seeded with rabbit bone marrow-derived MSCs that were transfected to express green
fluorescence protein (GFP), exposed to a short-period of adipogenic induction, and
implanted in nude mice for 2 weeks, GFP+ cells with lipid accumulation were observed in
the implanted scaffold159. Moreover, a study by Cho et al. showed that PLGA scaffolds
seeded with human ASCs and loaded with bFGF can also support adipose tissue
formation in nude mice at 6 weeks157.
Overall, while biodegradable synthetic materials have shown promise in supporting
adipose tissue formation in rodent models, these effects are largely transient, and the
scaffolds are unable to maintain long-term volumetric augmentation following
degradation of the polymer44. Further, while providing a supporting structure, synthetic
polymers typically lack the innate bioactivity of naturally-derived biomaterials, which
have greater potential to have intrinsic pro-angiogenic and/or pro-adipogenic properties
that may be favorable for adipose tissue regeneration 160–162.

1.6.1

Naturally-derived biomaterials

In addition to synthetic polymers, naturally-derived biomaterials have also been
investigated for adipose tissue engineering. Broadly, these biomaterials can be
categorized based on their compositional complexity. For example, purified structural
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components of the ECM, such as HA and collagen, have been fabricated into bioscaffolds
for adipose tissue engineering163–165. In addition, more highly complex biomaterials
derived from decellularized tissues have also been explored, which contain a diverse
range of ECM components166–170.
HA is a naturally-derived biomaterial found within the ECM of connective, epithelial and
neural tissues171. HA is a non-sulfated glycosaminoglycan (GAG) that plays an important
role in tissue hydration, nutrient diffusion and proteoglycan organization172–174. HA has
been studied for adipose tissue regeneration because its mechanical properties can mimic
native soft tissues, and it has the potential to be fabricated into an injectable material163.
In addition, studies have shown that HA scaffolds can support the attachment,
proliferation and adipogenic differentiation of seeded ASCs in culture 175. The adipose
tissue regenerative effects of HA have also been examined in animal models.
Borzacchiello et al. designed HA-based scaffolds that maintained mechanical and
viscoelastic properties similar to that of adipose tissue when implanted into rats for up to
12 weeks164. When seeded with human ASCs and implanted into athymic nude mice for
3, 5 and 8 weeks, HA-based scaffolds demonstrated increased cell infiltration and blood
vessel formation compared to unseeded control scaffolds, as well as hydrogels without
HA176. Moreover, ASC-seeded HA-based scaffolds were shown to support blood vessel
and adipose tissue formation when delivered into the subcutaneous tissue of pigs for 6
weeks, although the implants were highly degraded at this timepoint 36. Collectively, these
studies demonstrated that HA-based scaffolds have the potential to support adipose tissue
regeneration, but have been unable to maintain long-term volume augmentation when
tested in animal models due to rapid scaffold degradation.
HA-based composite materials have also been explored with the goal of improving
handleability, as well as enhancing the stability and tuning the mechanical properties of
the scaffolds177–181. For example, composite HA-g-poly(N-isopropylacrylamide) scaffolds
have been developed, which can function as thermo-responsive injectable biomaterials177.
Furthermore, these composite hydrogels could be crosslinked in situ, supported cell
infiltration and were stable when delivered subcutaneously in athymic nude mice over 5
days177. In another study, HA was incorporated with gelatin to form naturally-derived
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composite hydrogels165. This study showed that porcine ASCs encapsulated in the HAgelatin composites could survive and undergo adipogenic differentiation in vitro, as well
as promote adipose tissue remodeling in vivo when implanted in athymic nude mice and
pigs for 8 weeks165.
In addition to GAGs such as HA, collagen has also been used to fabricate bioscaffolds for
adipose tissue engineering160–162,182–185. Collagen is a highly abundant and essential
structural component of the ECM that is highly conserved between species 186–188. Culture
studies have confirmed that collagen-based scaffolds can support the attachment of
MSCs126 and ASCs138. Further, previous animal studies have demonstrated that collagen
scaffolds have the potential to both augment volume and act as a carrier for growth
factors and/or regenerative cell populations183,184,189. For example, increased blood vessel
formation and adipose tissue remodeling were observed at 6 weeks in collagen-based
microspheres loaded with bFGF that were implanted into C57BL/6 mice compared to
control scaffolds without bFGF190. This observation was further supported by a study by
Hiraoka et al., who demonstrated that composite collagen and gelatin bioscaffolds that
were loaded with bFGF could support angiogenesis and adipogenesis when delivered into
the inguinal tissues in Wistar rats at 6 weeks191. In addition, a study by von Heimberg et
al. demonstrated that seeding human ASCs on collagen sponge bioscaffolds better
supported angiogenesis than unseeded controls when implanted subcutaneously in
athymic nude mice for 12 weeks162. Collectively, these studies indicate that collagenbased bioscaffolds alone may not adequately support adipose tissue regeneration, and
often require additional cellular components or growth factors to enhance their proregenerative capacity.
Collagen scaffolds can also be combined with other naturally-derived or synthetic
materials to form composite scaffolds that may have enhanced properties for adipose
tissue engineering182,185,189,192,193. For example, composite chitosan/collagen scaffolds
seeded with rat ASCs were found to better support adipogenesis and angiogenesis as
compared to unseeded control scaffolds when implanted in Lewis rats as early as 14
days184. In another study, collagen scaffolds combined with alginate microspheres seeded
with both adipogenic-induced human ASCs and HUVECs were shown to better support
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adipogenesis and angiogenesis than acellular controls when implanted into athymic nude
mice at 12 weeks185. Additionally, this study also demonstrated that composite collagen
scaffolds with human ASCs and HUVEC showed greater volume retention than the
acellular controls at 12 weeks185. As another example, Zhang et al. demonstrated that
composite chitosan-collagen scaffolds incorporating PEG/PLGA microspheres loaded
with VEGFA and seeded with human ASCs showed enhanced adipose tissue remodeling,
as well as infiltration of CD31+ endothelial cells and CD163+ pro-regenerative
macrophages when compared to control scaffolds without PEG/PLGA microspheres or
human ASCs193.
Collectively, prior studies have demonstrated that naturally-derived bioscaffolds such as
HA and collagen can act as supportive cell and/or growth factor delivery platforms for
adipose tissue engineering. However, these materials often degrade rapidly and are
unable to provide long term volumetric augmentation required to be clinically
translatable.

1.6.2

Extracellular matrix-derived bioscaffolds

The ECM is the non-cellular structural and functional network of proteins, proteoglycans,
and glycoproteins that surrounds cells within tissues31,194,195. Together, these components
provide biochemical, structural and biomechanical cues that regulate cell
behaviour31,194,195. ECM proteins such as collagen, laminin and fibronectin not only
provide important structural support for cells, but they also contain binding sites for cell
surface receptors such as integrins, which can guide cell attachment and function 31,196–198.
Collagen is the most abundant structural protein in the ECM. To date, 29 types of
collagen have been identified, with collagen I, II, III, IV and V being the most abundant
within human tissues31. A characteristic feature of collagens is their triple helical
structure comprised of three alpha chains186. However, there can be interruptions within
the helical structures that enable interactions with other matrix proteins 31. Many types of
collagens can form fibrils, such as I, II, III, V, IX, XIV, XVII 186 . Collagen IV is a
network-type collagen that forms the structural meshwork of the basement membrane,
which is present in high abundance around adipocytes199. Collagens contain multiple
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receptor-binding sites that facilitate cell attachment. For example, a well-studied
specialized collagen binding site is the GFOGER motif that binds with α1β1 and α2β1
integrins with high affinity186,200 and also bind to integrins with a β2 component, such as
αmβ2 and αxβ2 integrins201.
In addition to collagen, fibronectin is also highly abundant in the adipose tissue ECM199.
This cell-adhesive glycoprotein associates with collagen and can also form fibrillar
structures. While fibronectin can exist in a soluble form in plasma, it is insoluble in the
ECM202,203. Functionally, fibronectin can bind with integrin receptors on the cell surface
and mediate cell adhesion. For example, one of the most well studied adhesion motifs is
the tripeptide Arg-Gly-Asp (RGD) sequence, which enables cell adhesion through
integrins such as α4β131, αvβ3 and α5β1204. In addition, fibronectin can also bind to
heparan sulfate, which acts as a reservoir for growth factors in the ECM 205,206. In adipose
tissue, fibronectin is associated with the pro-inflammatory cytokine, TNF-α, and the cell
surface receptor preadipocyte factor-1 (Pref-1), which play important roles in mediating
angiogenesis and adipogenesis, respectively207,208.
Laminin is another important structural and bioactive component of the adipose tissue
ECM. Laminins are a family of heterotrimeric glycoproteins that are composed of an α-,
β- and γ- chain and are a key component within all basement membranes209. Functionally,
laminin binds to cell surface integrins, as well as glycoproteins, dystroglycan and
syndecan within the ECM209,210. The interaction of laminin with these extracellular
components is crucial for cell adhesion, morphogenesis and differentiation, as well as
tissue integrity211–213.
Functioning in concert with the structural proteins within the ECM, proteoglycans can
influence the cellular response via biochemical cues214,215. Additionally, with their high
capacity to hold water, proteoglycans can also be important in maintaining the structural
integrity and mechanical properties of the ECM. Proteoglycans are composed of a core
protein and one or more GAG chains210. GAGs are linear polysaccharides that are
negatively charged, which enables them to sequester growth factors, cytokines and
chemokines214,216. As such, GAGs often serve as a reservoir for growth factors. One such
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GAG that is present in adipose tissue is HA217. As discussed in the previous section, HA
has been used as an injectable dermal filler due to its high abundance and compatibility
with adipose tissue. In addition to contributing to the structural integrity of the adipose
tissue ECM, HA has also been implicated in adipose tissue metabolism, as recent studies
have shown that it can mediate insulin sensitivity218,219 and lipid biogenesis220.
The combination of structural proteins and proteoglycans can guide cell behavior via
biomechanical and biochemical cues211. Cells can also remodel the ECM by degrading
existing components and depositing new matrices. The degradation of the existing ECM
is achieved via the secretion of extracellular proteases221. To date, over 569 matrixassociated proteases have been identified221. These proteins can be classified based on
their roles and properties in protein hydrolysis and can be categorized as MMPs, serine
proteases, cysteine proteases, aspartic acid proteases and threonine proteases 222.
By far the most well characterized ECM proteases are the MMPs, which are secreted by
the cells as inactive pro-enzymes, and can be converted into an active form by proprotein convertases194,223,224. Once activated, MMPs can degrade structural proteins in the
ECM. Moreover, the enzymatic activities of MMPs can be regulated by glycoproteins
such as TIMPs210. In addition, studies have shown that ECM-bound growth factors and
cytokines liberated through matrix degradation can act on cell surface receptors, such as
epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor (IGFR)
to downregulate the production of MMPs57.
Recognizing the innate capacity of the ECM to direct cell function, there has been
growing interest in the development of ECM-derived bioscaffolds for a broad range of
applications in tissue engineering37,166,169,226–232. One of the earliest forms of ECMderived biomaterials is Matrigel®, which is comprised of purified basement membrane
components secreted by Engelbreth-Holm-Swarm mouse sarcoma cells233. While the
precise composition of Matrigel® is not fully defined, it contains structural proteins, such
as collagen IV and laminin, as well as heparan sulfate233. In previous studies, Matrigel®
was shown to support angiogenesis and adipogenesis when injected with bFGF in
athymic nude mice for 6 weeks190. Furthermore, seeding the bFGF-loaded Matrigel® with
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human ASCs was shown to further promote host-derived angiogenesis and adipogenesis
in the same animal model for up to 9 weeks234. While Matrigel® has shown promise in
promoting tissue regeneration, its tumour cell origin represents a significant barrier to
clinical translation235.
Tissue decellularization is another approach that has been applied to generate a broad
range of tissue-specific ECM-derived bioscaffolds195,236,237. In general, the goal of
decellularization is to remove antigenic cellular components, including cellular proteins,
lipids and nucleic acids, while preserving the structure and composition of the native
ECM as much as possible228,236. Decellularization is typically accomplished by subjecting
tissues to a combination of mechanical, chemical and biological treatment steps that lyse
cells and extract cellular debris236. Mechanical and physical treatments are applied to
breakdown cellular structures and expose the intracellular antigens 236. These methods are
often supplemented with chemical treatments, such as acid, base and/or detergent
extractions, to degrade and extract cellular components 236. Furthermore, biological
treatments in the form of enzymes such as trypsin can further facilitate cell disruption,
and the addition of DNase and RNase can cleave residual nucleic acids236. It is inevitable
that the decellularization processes will alter the native ECM composition to some extent,
as well as causing some structural changes. However, the degree of disruption is highly
dependent on the nature of the tissues being processed and the protocols used for
decellularization. To date, several types of decellularized ECM scaffolds have been
investigated for applications in adipose tissue regeneration, as discussed below.
Decellularized placental matrix (DPM) has been studied for adipose tissue
engineering26,238,239. The placenta is rich in ECM and is composed of structural proteins
including collagen I, III, IV, V, VI and laminin, many of which are present in adipose
tissue238. In addition, it is a reservoir for growth factors and has a rich vascular network
that may provide structural cues that are conducive for angiogenesis 240. The DPM was
demonstrated to support the attachment and adipogenic differentiation of human ASCs 239.
In a subsequent study, the DPM was combined with crosslinkable HA hydrogels as a
possible strategy to enhance volume augmentation and modulate the cellular response to
promote adipose tissue regeneration239. Subsequently, ASCs were seeded in the DPM-HA
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composite scaffolds or DPM alone and implanted subcutaneously in athymic nude mice
for up to 8 weeks26. Results from this study showed that both types of scaffolds
macroscopically retained their volume and were able to promote blood vessel formation
and adipose tissue remodeling within the implants, with mouse-to-mouse variability
observed in the response26.
In addition to DPM, decellularized dermal matrix (DDM) has also been explored for
adipose tissue engineering241–243. Decellularized dermal tissue has been used clinically in
plastic surgery because of its low immunogenicity and robust mechanical properties242. In
a previous study, human ASCs were found to attach, survive, proliferate and remodel
DDM in vitro241. Subsequently, when the ASC-seeded DDM was implanted in vivo in
nude mice, angiogenesis was observed in the bioscaffolds as early as 2 weeks 243.
Collectively, ECM-derived bioscaffolds such as Matrigel®, DPM and DDM have shown
promise in supporting angiogenesis and to a certain degree, adipogenesis 238,243,244.
However, it is possible that the regenerative effects could be further enhanced by
applying a tissue-specific approach to designing ECM-derived bioscaffolds. For example,
adipose ECM-derived bioscaffolds can be fabricated to possess biomechanical properties
that closely mimic the native tissues, which could be favourable for adipose tissue
regeneration245–247. Additionally, the composition of the ECM is also tissue-specific,
containing a unique array of bioactive factors that can influence cell behaviour. Together,
this provides a strong rationale for exploring a tissue-specific approach to designing
ECM-derived bioscaffolds for adipose tissue regeneration.

1.6.3

Adipose tissue-derived bioscaffolds

Adipose tissue is important for maintaining energy homeostasis and also supports many
of the endocrine functions of the body248. This organ is composed largely of adipocytes,
with preadipocytes, endothelial cells, fibroblasts, immune cells and ASCs also found
within the SVF70. The mature adipocytes are encased in a meshwork of collagen type
IV187. Previous studies have demonstrated that the adipose tissue ECM plays a crucial
role in regulating the metabolic function of this organ199,249–252. For example, Khan et al.
demonstrated that an imbalance in collagen type IV and collagen type VI in the ECM of
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adipose tissue in collagen type VI knockout mice leads to uninhibited hypertrophic
expansion of adipocytes and decreased sensitivity to insulin 109. These findings support
that the composition of adipose tissue-derived bioscaffolds could be important for
promoting adipose tissue regeneration and function.
In the past, the Flynn lab group and others have made significant advances in developing
decellularized adipose tissue (DAT) as a bioscaffold to support adipose tissue
regeneration169,227,253–255. In the Flynn lab, DAT scaffolds are fabricated from surgically
discarded human fat by first lysing cells through repeated freeze-thaw cycles. Cell-cell
interactions are then disrupted via enzymatic digestion with trypsin, and the lipids are
extracted through repeated rinsing in isopropanol253. Finally, residual lipids and nucleic
acids are digested with a combination of lipase, DNase and RNase253. Notably, this
decellularization process is entirely detergent-free, which avoids potential cytotoxicity
concerns associated with residual detergents in the matrix199,249–252. Moreover, a
detergent-free process may also be favorable for preserving GAGs and sequestered
growth factors in the adipose tissue ECM253. DAT bioscaffolds processed using these
methods have been shown to retain similar structural ECM components and architecture
as the native adipose tissue ECM, including collagen IV, fibronectin, and laminin253.
Using high-throughput mass spectrometry techniques, over 1000 proteins were detected
in the DAT, including a diverse array of glycoproteins, proteoglycans, ECM-affiliated
proteins and secreted factors256. Additionally, the DAT bioscaffolds were also shown to
have similar viscoelastic properties as native adipose tissue 246,247, which may be favorable
for promoting adipogenic differentiation245.
Previously, culturing human ASCs on DAT scaffolds has been shown to upregulate genes
associated with adipogenesis, including the master regulators PPAR-γ and CEBP-α,
enhance activity of glycerol-3-phosphate dehydrogenase (GPDH), an enzyme associated
with lipid biosynthesis relative to TCPS controls, and induce low levels of intracellular
lipid accumulation, under proliferation conditions that would normally suppress
adipogenesis227,253–255. More recently, unseeded DAT scaffolds were demonstrated to
support adipose tissue and blood vessel formation in Wistar rats at 8 weeks 227. These
findings suggest that the DAT exhibits pro-adipogenic properties and may provide an
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inductive microenvironment for adipose tissue regeneration. In addition, when allogeneic
rat ASCs were seeded on the DAT bioscaffolds prior to subcutaneous implantation in the
Wistar rat model, significant increases in angiogenesis and adipogenesis were observed at
both 8 and 12 weeks169. In addition, the allogeneic ASCs were shown to promote a more
pro-regenerative macrophage response, which may have contributed to the enhanced
adipose tissue regeneration observed169. Together, these studies provide a strong case for
applying the DAT as a tissue-specific bioscaffold for adipose tissue regeneration.
The DAT can also be fabricated into other forms of bioscaffolds, such as microcarriers,
gels and composite hydrogels, which have also shown similar pro-adipogenic effects on
human ASCs in culture as the intact DAT scaffolds254,255. Microcarriers can be produced
by first digesting the DAT with enzymes to create an ECM suspension, which can be
electrosprayed into liquid nitrogen to form microcarriers 257. Previous in vitro studies have
shown that human ASCs expanded on these DAT microcarriers showed enhanced
adipogenic capacity relative to ASCs expanded on TCPS, with elevated adipogenic gene
expression and intracellular lipid accumulation after 2 weeks in culture in adipogenic
differentiation medium257.
In addition to microcarriers, adipose tissue can also be decellularized and fabricated into
injectable gels258,259. Previous work by Wang et al. demonstrated that the solubilized
human adipose tissue matrix stimulated host cell infiltration when injected
subcutaneously in Fischer rats for 30 days181. Additionally, when this scaffold was seeded
with human ASCs and injected into nude rats, blood vessel formation and adipose tissue
remodeling were observed in the scaffolds as early as 2 weeks and continued to be
present at 8 weeks258. In a similar study, adipose tissue matrix hydrogels fabricated from
lipoaspirates that were seeded with human ASCs and injected subcutaneously in nude
mice showed an increase in macrophage infiltration as early as 1 week and an increase in
blood vessel and adipose tissue formation at 4 weeks when compared to unseeded
hydrogels259.
DAT can also be fabricated into composite hydrogels for adipose tissue engineering
applications255. For example, previous work from the Flynn lab investigated DAT
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particles encapsulated with human ASCs within methacrylated chondroitin sulfate (MCS)
hydrogels255. Adipogenic differentiation in vitro was enhanced in the hydrogel
composites at 7 and 14 days relative to ASCs encapsulated in the MCS alone 260. In
addition, when similar composite hydrogels were delivered subcutaneously into Wistar
rats, blood vessel formation and adipose tissue remodeling were observed within the
implanted hydrogels at 12 weeks255.
Collectively, these studies demonstrate that DAT scaffolds hold promise as proadipogenic scaffolds for adipose tissue engineering, and that in vivo regeneration can be
enhanced by combining them with ASCs.

1.7 Cell preconditioning strategies
ASCs have shown promise for a broad range of cell therapy applications and there has
been emerging interest in the development of in vitro preconditioning strategies to
enhance their pro-regenerative functionality prior to in vivo delivery261–267. More
specifically, preconditioning strategies can involve culturing the cells within a controlled
environment that provides specific biochemical and/or biomechanical cues that can help
guide the cells to respond in a desired manner261. For example, preconditioning strategies
may involve treatment with specific factors to promote lineage-specific differentiation
towards the goal of replacing cell populations within damaged tissues268. Alternatively,
ASCs can also be preconditioned to enhance their expression of paracrine factors and
cytokines that can promote angiogenesis and modulate the immune response, to indirectly
support tissue regeneration269. Given that there is a growing body of evidence to support
that this is the primary mechanism for ASC-mediated regeneration, this section will focus
on preconditioning approaches that harness bioactive factors, oxygen tension and/or
mechanical stimulation to enhance the pro-regenerative paracrine functionality of ASCs.

1.7.1

Application of bioactive factors to precondition ASCs

Treatment with bioactive factors can be a powerful approach to stimulate MSC
populations including ASCs to express higher levels of various pro-regenerative growth
factors and cytokines261,262,268. For example, MSCs that were cultured in medium
supplemented with TGF-β1 for 24 h produced higher levels of VEGFA compared to
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controls and increased vessel formation when delivered into isolated rat cardiac tissue ex
vivo262. In another culture study, the pro-inflammatory cytokine TNF-α was used to
precondition ASCs for 3 days, which resulted in increased cell migration, proliferation
and expression of BMP-2268. A study by Baer et al. compared the paracrine effects of
preconditioning mouse ASCs in either TNF-α or epidermal growth factor (EGF) for 48 h
and demonstrated that each upregulated the secretion of different paracrine factors and
cytokines261. Preconditioning mouse ASCs with TNF-α upregulated the expression of IL10 and interleukin 11 (IL-11), whereas EGF preconditioning upregulated the expression
of HGF and bFGF261. While these approaches have shown promise, these bioactive
factors can be costly, which could limit the scalability of these strategies for clinical
applications.

1.7.2

Effects of hypoxic preconditioning on ASCs

Oxygen tension can also regulate the paracrine response of pro-regenerative cell
populations111,262,265,270,271. Cells that are grown in culture under atmospheric conditions
are generally exposed to a hyperoxic environment, as the oxygen tension in most tissues
in the human body is significantly lower than 21%272. Within adipose tissue, the normal
oxygen tension typically ranges between 7 – 9%, with an oxygen tension less than 5%
considered to be hypoxic273,274.
At the molecular level, the intracellular protein hypoxia inducible factor 1-alpha (HIF-1α)
is degraded following the hydroxylation of oxygen-dependent prolyl hydroxylase under
physiological normoxic states275–277 (Figure 1.2). Under hypoxia, this degradation
pathway is inhibited, leading to the stabilization of HIF-1α and the activation of the Akt
and P38 mitogen-activated protein kinase (MAPK) pathways that drive cell proliferation
and paracrine factor secretion278,279.
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Figure 1.2 Normoxic oxygen tension leads to the degradation of HIF-1α, whereas
hypoxia leads to the stabilization and nuclear translocation of this transcription
factor, leading to the expression of pro-angiogenic factors and immunomodulatory
cytokines.
In MSCs, hypoxia (1-3% O2) has been shown to increase cell proliferation263. More
specifically, a previous study demonstrated that when mouse bone marrow-derived MSCs
were cultured at 3% O2, they entered the exponential expansion phase earlier than
controls cultured under 21% O2280. Similarly, when human ASCs were cultured at 2% O2,
the cells exhibited greater gene expression of the stem cell markers REX14, SOX2, OCT4,
NANOG, and were more proliferative, with the effects mediated through HIF-1α
activation281. Moreover, the modulation of cell proliferation through HIF-1α-dependent
mechanisms was further supported by a study by Kakudo et al., who demonstrated that
HIF-1α expression led to increased bFGF expression in human ASCs, which accelerated
cell proliferation282.
In addition to proliferation, HIF-1α activation can also enhance the secretion of proangiogenic factors in cultured MSC populations263,283. For example, a study by Chen et
al. showed that culturing human bone marrow-derived MSCs at 2% O2 increased VEGFA
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secretion through a HIF-1α dependent mechanism283. Additionally, when human
placenta-derived MSCs were preconditioned under 2% O2 for 3 days, the conditioned
media from these cell cultures was found to contain elevated levels of TGF-β1, insulinlike growth factor 1 (IGF-1), HGF, VEGFA and bFGF269. This study also demonstrated
when these preconditioned cells were delivered into cutaneous wounds in Goto-Kakizaki
rats, the rate of wound closure was enhanced, with a 90% decrease in wound area as
compared to only 40% in the control group at 15 days269. In addition, studies have shown
that culturing rat bone marrow-derived MSCs at 5% O2 increased the expression of HGF,
bFGF and PDGF-B through a HIF-1α mediated mechanism also involving the activation
of Akt284,285.
In addition to pro-angiogenic growth factors, hypoxia can also upregulate
immunomodulatory cytokine expression in MSC populations including ASCs 261.
Previous studies have shown that when human bone marrow-derived MSCs were
cultured in 2% O2 for 3 days, the cells expressed higher levels of the pro-angiogenic
factors VEGFA and bFGF as well as the pro-inflammatory cytokines IL-6 and IL-8283.
Furthermore, studies have also shown that culturing fetal human astrocytes under 2% O 2
can increase the expression of pro-inflammatory cytokines such as IL-8 and MCP-1
through a HIF-1α-mediated mechanism286.
The increased secretion of pro-angiogenic factors and immunomodulatory cytokines as a
result of hypoxic preconditioning has been harnessed to promote adipose tissue
regeneration265,287. For example, a study by Hsiao et al. showed that the conditioned
media from human ASCs cultured under 0.1% O2 for 3 days had a greater effect on
stimulating angiogenesis at 2 weeks following subcutaneous delivery in C57BL/6 mice
relative to control media prepared with ASCs cultured under 21% O2111. In another study,
rat ASCs that were cultured under 0.5% O2 for 2 days were found to be better than
control cells cultured under 21% O2 at supporting the vascularization of fat flap grafts in
Lewis rats over 7 days288.
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1.7.3

ASC response to mechanical stimulation

Mechanical stimulation, including shearing forces from fluid flow, can provide important
biomechanical cues that guide the secretory behaviour of ASCs289–291. These cues can
activate mechanosignalling pathways through tensegrity, integrin-mediated
mechanotransduction and membrane fluidity292. Tensegrity-mediated mechanosensing
takes place when a mechanical force applied on the cell leads to changes in the
cytoskeleton, which transmits the signal to the nucleus293. Integrin-mediated signaling
generally involves the activation of the extracellular domains of integrins, which triggers
the phosphorylation and activation of focal adhesion kinase (FAK)-mediated intracellular
pathways294. Membrane fluidity is a mechanosensing mechanism by which shearing
forces can induce a change in membrane viscosity, which also leads to the activation of
mechanotransduction pathways294.
Mechanical stimulation often results in the activation of the MAPK and c-Jun N-terminal
kinase (JNK) pathways295,296, which can trigger a range of cellular responses including
migration, differentiation and paracrine factor secretion 138,297,298. A study from Yuan et
al. showed that inhibiting JNK and p38 inhibited the migration of human bone marrowderived MSCs that is typically induced by fluid flow296. In the context of biomaterials,
the application of shearing forces was shown to enhance the mobilization of human ASCs
on acellular blood vessel grafts299. More specifically, when the human ASCs were seeded
and perfused through the lumen of the vessel graft, migration was enhanced and the cells
aligned in the direction of the fluid flow299.
The application of shearing forces can also promote paracrine factor secretion in MSC
populations. A previous study demonstrated that when human bone marrow-derived
MSCs were cultured under fluid flow at 2 Pa, increased VEGFA expression was observed
relative to static culture controls290. Additionally, studies have shown that shearing forces
can stimulate the production of NO, which can act in an autocrine loop to increase the
expression of VEGFA289. A recent study by Becquart et al. further supported this
observation and showed that the NO production during shearing stress was mediated
through the extracellular signal-regulated kinase 1/2 (ERK1/2) intracellular signaling
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pathway291. Collectively, these studies support that shearing forces can be applied to
precondition ASCs to enhance their expression of pro-angiogenic factors.

1.8 3-D bioreactor systems for tissue engineering
Bioreactors are systems that allow for the close monitoring and control of biological
processes. Parameters that can be regulated within these systems include pH,
temperature, pressure and oxygenation, which generates a highly controlled environment
for cell growth300. A range of bioreactors have been explored for both MSC expansion
and tissue engineering applications including spinner flask systems, rotating wall
bioreactors, and perfusion bioreactor systems.

1.8.1

Spinner flask systems

Spinner flask systems allow for the culturing of cell-seeded bioscaffolds in suspension or
fixed within a holding device, with stirring of the culture media controlled through an
impellor (Figure 1.3A)300. Spinner flask bioreactors can increase the efficiency and
uniformity of cell seeding on scaffolds, which may be favorable for tissue
regeneration301–303. For example, previous studies have shown that the seeding efficiency
of chondrocytes on PGA scaffolds was 70% greater when a spinner flask system was
used as compared to static culturing304. Spinner flasks have also been successfully
applied for human bone marrow-derived MSC expansion on 3-D polymer microcarriers,
while maintaining their immunophenotype and capacity for tri-lineage differentiation
potential305. Additionally, previous work from the Flynn lab also showed that spinner
flask bioreactor systems could be used to culture and expand human ASCs on DAT
microcarriers, while maintaining their potential for adipogenic differentiation in vitro254.
More recently, the spinner flask system were also demonstrated to better support ASC
expansion on the DAT than commercially available Cultispher-S microcarriers following
28 days of culture257. Together, spinner flask bioreactors have been shown to be an
effective 3-D culture system for MSC expansion. However, studies to date have not yet
explored whether spinner flasks could also be applied as preconditioning systems to
increase the pro-regenerative functionality of cultured cell populations. One potential

29

limitation is that the stirring motion in spinner flask bioreactor systems can result in
heterogenous shear stresses being applied, which may lead to variable cell properties 306.

1.8.2

Rotating wall bioreactor systems

Rotating wall bioreactor systems can also be used to expand regenerative cell
populations. Within rotating wall vessels, the culture media, cells and scaffolds are
placed in between two concentric cylinders (Figure 1.3B)300. The vessel is then placed
horizontally, and the cells and scaffolds are maintained in a constant state of suspension
by the competing forces of gravity and the stirring caused by the rotation of the outer
cylindrical wall307. The rotation of the outer wall can generate a low amount of shear
forces, which can modulate cell functions including proliferation and differentiation 308.
For example, one previous study showed that epithelial cells cultured on synthetic ECMcoated beads in a rotating wall vessel proliferated well and formed multi-layer cell
aggregates307. Furthermore, cells cultured on these synthetic beads could be digested and
dynamically cultured under a bead-free environment within the rotating wall vessel307.
Rotating wall bioreactors have also been used to expand MSCs309. Nishi et al. showed
that rabbit bone marrow-derived MSCs seeded on a porous PLA bead scaffold cultured
within a rotating wall bioreactor proliferated and showed evidence of being primed for
osteogenic differentiation309. Moreover, a study by Chen et al. showed that human bone
marrow-derived MSCs cultured in a rotating wall vessel bioreactor expanded
significantly faster than statically cultured controls after 16 days in vitro306. Additionally,
a study by Ben-David et al. demonstrated that human bone marrow-derived MSCs could
be cultured on gelatin microspheres within a rotating wall bioreactor, and when
implanted subcutaneously in athymic nude mice could support in vivo osteogenesis at 8
weeks88. Overall, while rotating wall vessel bioreactors are a promising expansion
platform for pro-regenerative cell populations, to date these systems have been primarily
applied for bone tissue engineering applications.
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Figure 1.3 Schematic of A) spinner flask and B) rotating wall vessel bioreactor
systems. Image re-printed with permission from publisher300.

1.8.3

Perfusion bioreactor systems

Perfusion bioreactors are systems that circulate media via pumps through porous
scaffolds housed within customized chambers, with the goal of enhancing nutrient
delivery and waste removal throughout the 3-D constructs300. Relative to static cultures,
perfusion bioreactors can offer greater control over the media conditions and oxygen
tension experienced by cells within scaffolds300,310. Perfusion of the media also applies
shear stress, which can modulate cell function311–313.
Perfusion bioreactor systems have been investigated for a range of applications in tissue
engineering to support the proliferation of pro-regenerative cell populations within
scaffolds310,312,314–317. While media perfusion can potentially enhance proliferation, the
fluid flow rate must be carefully refined to prevent newly secreted factors and ECM
components from being rapidly removed310. In previous studies, perfusion bioreactors
have been shown to maintain a constant oxygen tension within the perfused regions of
scaffolds, and increase the uniformity of attached cells318. Another study using a twostage perfusion bioreactor optimized for nutrient delivery and waste removal showed that
human ESCs seeded on polyethylene-terephthalate (PET) scaffolds and cultured in this
system maintained their stem cell phenotype and also expanded significantly faster than
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cells grown in spinner flask systems314. Moreover, a recent study by Papadimitropoulos et
al. showed that human bone marrow-derived MSCs seeded on ceramic-based
bioscaffolds in an oscillating perfusion bioreactor system attached and proliferated under
perfusion, while maintaining their immunophenotype and trilineage differentiation
capacity312. Further, the cells that were cultured in the perfusion bioreactor were
demonstrated to express more immunomodulatory cytokines including IL-8, C-X-C motif
chemokine 5 (CXCL-5) and C-X-C motif chemokine 6 (CXCL-6) than 2-D and static
culture controls312.
Perfusion bioreactor systems have also been explored as a strategy to enhance the
differentiation of MSC populations313,319–323. More specifically, the shearing forces
applied to cells within these systems can potentially be harnessed to help direct MSCs
towards the osteogenic lineage319,323–325. A previous study demonstrated that when PLGA
scaffolds seeded with MSCs were perfused in an oscillating bioreactor for 21 days, the
cells exhibited greater mRNA expression of key osteogenic genes relative to static culture
controls326. This observation was supported by the work of Alvarez-Barreto et al., who
showed intracellular calcium accumulation in rat bone marrow-derived MSCs that were
seeded on an RGD-conjugated PLA scaffold and perfused in a bioreactor at a rate of 1
mL/min for 8 days313. Interestingly, a study conducted with a hollow-fibre bioreactor
showed that when ASCs were perfused within this system, they could be induced to
differentiate towards the adipogenic lineage over 3 weeks of culture 327.

1.9 In vivo adipose tissue regeneration
Adipose tissue regeneration within engineered bioscaffolds in vivo is a multistep process
that involves the interaction of diverse cell populations. One of the first key stages is an
angiogenic response that results in the development of a vascular network to support
seeded and infiltrating cell populations328. These newly-established vessels can facilitate
the recruitment of immune cells and other pro-regenerative cell populations that
contribute to scaffold remodeling and tissue regeneration 329. The next sections will
discuss current understanding of angiogenesis, macrophages and adipogenesis in the
context of adipose tissue regeneration.
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1.9.1

Angiogenesis in soft tissue regeneration

Angiogenesis is a key step in achieving soft tissue regeneration. The development of a
vascular network is required for the delivery of oxygen and nutrients, and enables the
recruitment of pro-regenerative host cell populations328,330. When tissue-engineered
implants remain poorly vascularized, it can lead to the death of delivered cell populations
and tissue necrosis, impeding regeneration48.
Broadly, sprouting angiogenesis is a multistep process that includes vessel sprouting,
lumen formation and finally anastomosis331. More specifically, vessel sprouting involves
outgrowth of endothelial cells from the existing vasculature in response to biochemical
cues within the local microenvironment332–334. Subsequently, lumen formation and
extension takes place, where endothelial cells proliferate and migrate as the length of the
newly-formed vessels increases335. These new extensions also form lumens that resemble
endothelial tubes. Finally, anastomosis leads to the fusion of existing sprouts, and allows
vascularization and blood flow to be fully established in these newly-built blood
vessels331.
Vessel sprouting typically begins with existing blood vessels within the target site.
Endothelial cells from these existing vessels send out extensions known as filopodia 336,
which are crucial in sensing and responding to biochemical cues within the
microenvironment332. The filopodia on these leading endothelial cells, termed tip cells,
can respond and extend to the presence of pro-angiogenic growth factors, such as bFGF
and VEGFA332,337, and can be repelled by angiogenic inhibitory proteins, such as
semaphorin338. The combination of these biochemical attractants and repellents guides
the direction of the sprouting. Endothelial cell proliferation occurs, with stalk cells
trailing the endothelial tip cell, resulting in extension of the sprouts and ultimately lumen
formation339.
As endothelial sprouts continue to extend, the stalk cells will begin the process of
forming a unicellular lumen339. These unicellular lumens will eventually become a
multicellular vessel, as the sprouts continue to extend in length. Although the precise
mechanisms of lumen formation have not been clearly delineated, it is possible that
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lumen formation can be achieved through an intracellular hollowing process, where
endothelial cells generate a hollow vacuole, and eventually fuse with the hollow vacuoles
in neighbouring endothelial cells to form an extended hollow lumen340.
Anastomosis is a multistep process where connections are built between the developing
vessels resulting in the formation of functional vasculature331. During anastomosis, the
filopodia from neighbouring tip cells interact to establish a stable connection via cell
junctions331. Once connected, these tip cells deposit basement membrane to support and
guide lumen connection341.
During soft tissue regeneration, newly-formed capillaries will continue to expand in
length and diameter. Stabilization is required for the long-term viability of these newlyformed and growing vessels333. Endothelial tube stabilization is achieved, primarily, by
pericytes. Pericytes are recruited to endothelial tubes by pro-angiogenic factors, such as
angiopoietin 1 (Ang-1), VEGFA and PDGF-BB342–345. Among these factors, PDGF-BB
can lead to an increased expression of stromal cell-derived factor 1 (SDF-1) from
endothelial cells, which is a potent chemoattractant for pericytes 344. Studies have shown
that when platelet-derived growth factor receptor beta (PDGFR-β) that is specific for
PDGF-BB is inhibited, vessel growth and stabilization are stalled 346. Moreover, when
both vascular endothelial growth factor receptor 1 (VEGFR-1) and PDGFR-β are
inhibited, the ability of pericytes to stabilize vessels is also blocked347. Collectively, this
supports the importance of VEGFA and PDGF-BB signaling in initiating and supporting
vessel stabilization. Once the connection between endothelial cells and pericytes is
established, remodeling of the basement membrane occurs through the action of secreted
MMPs and TIMPs to support the stabilized vessel348,349.
ASCs can play a critical role in mediating angiogenesis by secreting key paracrine
factors. As previously discussed in Section 1.4.2, ASCs can secrete HGF, VEGFA and
bFGF under hypoxia269,284,285, which can guide vessel sprouting and promote endothelial
tube extension. SDF-1 with Ang-1 and PDGF-B secreted from ASCs leads to the
recruitment of pericytes to stabilize the extending endothelial tubes 269,284,285 (Figure 1.4).
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Figure 1.4 Schematic showing the role of paracrine factors secreted by ASCs in
mediating endothelial tube elongation and the recruitment of supporting pericytes
to stabilize blood vessels. (1) ASCs initiate vessel sprouting by first secreting paracrine
factors such as VEGFA, HGF and bFGF, which drive endothelial cell proliferation and
tube elongation. (2) Endothelial cells can secrete SDF-1, in combination with PDGF and
Ang-1 from ASCs, to recruit pericytes to stabilize the newly formed endothelial tube.

1.9.2

Role of macrophages in mediating soft tissue regeneration

Although early work considered macrophages as a phagocytic cell population that was a
barrier to regeneration, recent studies have shown that this diverse cell population plays
essential roles in mediating soft tissue repair and regeneration350. In particular,
macrophages can modulate regenerative responses through the secretion of cytokines,
angiogenic growth factors and MMPs351. The macrophage secretion profile is highly
dependent on the stage of the inflammatory/regenerative response352.
Macrophages are highly plastic cells that historically have been classified as having the
capacity to be polarized towards either a pro-inflammatory M1-subtype or a proregenerative M2-subtype351. However, recent evidence supports that there are a wide
range of macrophage subpopulations that exist on a spectrum between these two
extremes, and can often exhibit characteristics of both the M1-subtype and
M2-subtype353,354. To better categorize the diversity of macrophages involved in tissue
regeneration, a new classification system has been proposed, which is based on the factor
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that activates the macrophages355. For example, M(IFN-γ) denotes pro-inflammatory
macrophages that are activated by IFN-γ. This macrophage population can also be
identified by the co-stimulatory molecule CD80356,357. M(IL-4) denotes pro-regenerative
macrophages activated by interleukin 4 (IL-4), and finally M(IL-10) denotes proregenerative macrophages that are activated by IL-10355. The M(IL-10) macrophage
population can be identified by the hemoglobin scavenger receptor CD163 358.
Monocytes and tissue-resident macrophages that are initially recruited to the target tissue
site are typically polarized towards a more pro-inflammatory macrophage phenotype359.
These populations are crucial in initiating tissue repair and regeneration359. For example,
previous studies suggest that depleting monocytes and dendritic cells immediately
following renal injury delays tissue regeneration360. These infiltrating monocytes are
activated by IFN-γ, which can be secreted by ASCs128,129 and innate immune cells, such
as natural killer cells361, to polarize toward a M(IFN-γ) phenotype355,362 (Figure 1.5).
These pro-inflammatory macrophages can subsequently release cytokines such as TNF-α,
interleukin 1 beta (IL-1β), IL-6 and interleukin-12 (IL-12), which promotes the
recruitment of further immune cells, such as neutrophils and eosinophils 363. Moreover,
these cytokines can act in an autocrine fashion to polarize more infiltrating monocytes
toward a pro-inflammatory phenotype364. A previous study in a hindlimb injury model in
rabbits suggested these pro-inflammatory macrophages are important in stimulating
vascularization, as the infiltrating macrophages were shown to express TNF-α and bFGF,
suggesting they were both pro-inflammatory and pro-angiogenic365.
Pro-inflammatory M(IFN-γ) macrophages can promote an increase in M(IL-4)
macrophages, as IL-6 secreted by M(IFN-γ) macrophages can upregulate the expression
of interleukin 4 receptor (IL-4R)366. These M(IL-4) macrophages can often exhibit both
pro-inflammatory and pro-regenerative characteristics and can mediate pro-regenerative
processes (Figure 1.5). More specifically, this macrophage subpopulation was shown to
secrete VEGFA and PDGF-B to support angiogenesis351. Further, these cells also secrete
TGF-β1, which can act on fibroblasts to stimulate matrix deposition367. In addition, these
M(IL-4) macrophages are also capable of remodeling the matrix through the secretion of
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MMP-2, matrix metalloproteinase 9 (MMP-9) and matrix metalloproteinase 13
(MMP-13)368.
Following the initial inflammatory response, macrophages can be polarized toward a
more pro-regenerative phenotype through the secretion of IL-10 by Th2 and Treg cells359.
Moreover, M(IL-10) macrophages can further secrete IL-10, which generates an
autocrine loop that further promotes a more anti-inflammatory response (Figure 1.5).
Overall, the increased expression of IL-10 contributes to the resolution of tissue
inflammation and establishes a microenvironment that is more conducive for tissue repair
and regeneration369.

Figure 1.5. Schematic highlighting the roles of pro-inflammatory and proregenerative macrophages in mediating tissue regeneration. Inflammatory mediators,
such as IFN-γ, present at the target site polarize infiltrating monocytes and tissue resident
macrophages towards a pro-inflammatory phenotype. These pro-inflammatory
macrophages secrete additional chemokines and cytokines to further increase the
accumulation of pro-inflammatory cells. The increase in pro-inflammatory mediators
promotes an increase in pro-regenerative macrophage populations that can secrete growth
factors and cytokines to increase angiogenesis and ECM remodeling. Once the early
inflammatory response subsides, IL-10 secreted from T cells mediates an antiinflammatory response from the macrophages. Image re-printed with permission from the
publisher362.
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1.9.3

Adipogenesis in soft tissue regeneration

Adipose tissue formation and expansion under physiological states can be achieved
through hyperplasia and hypertrophy370–372. Hyperplastic expansion involves increasing
the number of adipocytes in response to a need to store lipid, whereas hypertrophic
expansion refers to an increase in the size of existing adipocytes 373. It is important to note
that both mechanisms of adipose tissue expansion require existing adipocytes. In the
context of adipose tissue engineering, fat tissue formation is often required in target sites
without existing adipocytes. As such, different mechanisms of adipogenesis are involved
during adipose tissue remodeling and regeneration within engineered scaffolds, at least
during the early stages of the process.
As previously discussed, while delivering mature adipocytes and adipogenic-induced
ASCs have been investigated as a way to provide immediate adipocytes to the target
tissue, it is unclear if these exogenous cells are maintained or form stable adipocytes over
the long-term190,234,244. Alternatively, de novo adipose tissue formation in the context of
adipose tissue engineering has been speculated to be initiated by the recruitment of hostderived cells. One interesting study by Stillaert et al. delivered human fat grafts that were
embedded in Matrigel® into the groin of severe combined immunodeficient (SCID)
mice234. At 6 weeks post implantation, host-derived adipose tissue formation was
observed, whereas limited adipogenesis was observed in control implants without the
human fat graft. Moreover, host-derived blood vessels were observed in the SVF of the
implanted fat234. These observations support that cell populations in the SVF are
pro-angiogenic, and may be responsible for the recruitment of host cells that formed the
adipocytes. Interestingly, a study by Rodeheffer et al. showed that a CD29+CD34+ cell
population present in the SVF that were also stem cell antigen 1 (Sca-1)+ and CD24+
possesses the capacity to support adipogenesis in vivo, and therefore, could be an
adipocyte precursor population374. Additionally, Shook et al. demonstrated that this
adipocyte precursor population are also CD26+, and can be recruited to wounded dermal
tissue to facilitate tissue repair375. Given its proximity to dermal tissue, it is plausible that
this adipocyte precursor population could also play a role in subcutaneous adipose tissue
regeneration.
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Finally, there is some evidence that macrophages could also be a potential source of
adipocytes during tissue regeneration. Previous in vitro studies showed that when
macrophages were co-cultured with human adipocytes and ASCs, the macrophages
accumulated intracellular lipid droplets102. This study provided initial evidence that
macrophages could be directly involved in de novo adipogenesis. More recently, work
from the Flynn lab group showed that infiltrating CD163+ host macrophages expressed
the adipogenic markers perilipin and adiponectin in ASC-seeded DAT implants in an
immunocompetent rat model169. While these studies provide evidence for a possible
direct role of macrophages in adipose tissue formation, additional studies are required to
more fully understand the involvement of these cell populations in adipose tissue
regeneration.

1.10 Project overview
DAT is a promising adipo-inductive biomaterial for applications in adipose tissue
engineering that can support regenerative processes such as angiogenesis and
adipogenesis227. Further, previous studies indicate that combining DAT scaffolds with
allogeneic ASCs can augment adipose tissue regeneration in an immunocompetent Wistar
rat model by enhancing angiogenesis, adipogenesis, and modulating the host macrophage
response169,255.
While the delivery of ASCs on DAT bioscaffolds has shown potential for stimulating
tissue regeneration, limitations of previous work include the static seeding and culture
methods employed that result in a heterogenous distribution of ASCs predominantly on
the surface of the scaffolds. Perfusion bioreactor systems represent a promising approach
to promote cell expansion and infiltration on 3-D scaffolds. In the second chapter of this
doctoral thesis, a perfusion bioreactor strategy for culturing human ASCs on DAT
scaffolds was developed. Using this system, the effects of both shear stress stimulation
and hypoxic preconditioning were explored both in vitro and in vivo, with the goal of
enhancing angiogenesis and adipose tissue regeneration within the DAT. In the third
chapter, the effects of dynamic culturing of the human ASCs on the DAT scaffolds under
hypoxic conditions (2% O2) within the perfusion bioreactor system were assessed
through comparison to static culture controls. In particular, these studies focused on
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exploring the impact of shear stress stimulation induced by bioreactor culture on the ASC
phenotype and paracrine function through in vitro culture studies. Further, in vivo
characterization was performed to probe whether dynamic culture of the ASCs on the
DAT altered host cell recruitment into the implants, with a focus on angiogenesis and the
host macrophage response. Finally, in the fourth chapter, the development of an
alternative and more scalable rocking bioreactor platform was explored as a possible
strategy to precondition the ASCs to enhance their pro-regenerative paracrine
functionality. More specifically, the effects of dynamic culture on the rocking platform in
combination with DAT coatings on human ASC phenotype and pro-regenerative marker
expression were assessed as a first step to assess the potential of this new approach.

1.11 Hypothesis and specific aims
The underlying hypothesis for this work is that dynamic culture of human ASCs on DATbased biomaterials can enhance their capacity to stimulate regeneration by altering their
paracrine factor expression profile, which will contribute to enhanced host-derived
angiogenesis and adipogenesis within DAT implants.
To test this hypothesis, three specific aims have been formulated:
1. To apply dynamic culture of human ASCs on DAT bioscaffolds within a 3-D
perfusion bioreactor system to enhance ASC expansion in vitro and angiogenesis and
adipogenesis within DAT implants in vivo.
2. To characterize how dynamic culture of human ASCs on the DAT bioscaffolds within
the perfusion bioreactor system enhances the capacity of the ASCs to stimulate soft
tissue regeneration via paracrine-mediated mechanisms.
3. To develop a novel rocking bioreactor platform to dynamically culture ASCs on
DAT-based coatings to promote a more pro-regenerative ASC phenotype.
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Chapter 2

2

Perfusion bioreactor culture of adipose-derived stromal
cells on decellularized adipose tissue scaffolds
enhances in vivo regeneration

2.1 Abstract
Adipose tissue engineering holds promise to address the unmet need in plastic and
reconstructive surgery for strategies that promote the stable and predictable regeneration
of adipose tissue for volume augmentation applications. Previous studies have
demonstrated that decellularized adipose tissue (DAT) scaffolds can provide a proadipogenic microenvironment, and that seeding with adipose-derived stromal cells
(ASCs) can enhance in vivo angiogenesis and adipogenesis within DAT implants.
Recognizing that bioreactor systems can promote cell expansion and infiltration on
tissue-engineered scaffolds, this study evaluated the effects of culturing human ASCs on
DAT scaffolds within a perfusion bioreactor. Using this system, the impact of both shear
stress stimulation and hypoxic preconditioning were explored in vitro and in vivo. Initial
studies compared the effects of 14 days of culture within the perfusion bioreactor under
2% O2 or ~20% O2 on human ASC expansion and hypoxia inducible factor 1 alpha
(HIF-1α) expression in vitro relative to static cultured controls. The findings indicated
that culturing within the bioreactor under 2% O2 significantly increased ASC
proliferation on the DAT, with a higher cell density observed in the scaffold periphery.
HIF-1α expression was significantly higher when the scaffolds were cultured under 2%
O2. Subsequent characterization in a subcutaneous implant model in athymic nude mice
revealed that in vivo angiogenesis and adipogenesis were markedly enhanced when the
ASCs were cultured on the DAT within the perfusion bioreactor under 2% O 2 for 14 days
prior to implantation relative to the other culture conditions, as well as additional freshlyseeded and unseeded DAT control groups. Overall, culture within the perfusion
bioreactor system under hypoxia represents a promising approach for preconditioning
ASCs on DAT scaffolds to enhance their capacity to stimulate blood vessel formation
and infiltration, as well as host-derived adipose tissue regeneration.
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2.2 Introduction
The subcutaneous adipose tissue layer plays important structural and functional roles
within the integumentary system1. Due to the limited capacity of adipose tissue for selfrepair, damage or loss resulting from trauma, burns, tumour resections, disease or aging
can alter the normal body contours and result in scarring, deformities and loss of
function376. While reconstruction can have a major positive impact on self-image and
quality of life, there are numerous limitations to the existing clinical interventions that
rely on tissue transfer from other sites on the body or on current implants used for volume
augmentation18,377.
Adipose tissue engineering represents a promising approach to address the unmet clinical
need in plastic and reconstructive surgery for strategies that can promote the stable
regeneration of healthy host-derived soft tissues27,378. Towards this goal, our lab has
pioneered the development of off-the-shelf bioscaffolds derived from human
decellularized adipose tissue (DAT), demonstrating that they provide a pro-adipogenic
microenvironment both in vitro and in vivo227,253. DAT contains a diverse array of
extracellular matrix (ECM) components, including a variety of matricellular proteins,
small leucine-rich proteoglycans (SLRPs), growth factors and chemokines256 that may
have bioactive effects on seeded and infiltrating host cell populations. Moreover, the
DAT has similar biomechanical properties to native human fat 246,247, which may be
favorable for both implant integration and adipogenic differentiation245,253.
Previously, seeding the DAT with allogeneic adipose-derived stromal cells (ASCs)
enhanced angiogenesis and adipogenesis within the implants in an immunocompetent
Wistar rat model169. More specifically, our study suggested that the ASCs indirectly
contributed to host-derived adipose tissue regeneration through paracrine mechanisms,
rather than through long-term engraftment and differentiation. It is well-established that
ASCs secrete a variety of pro-regenerative growth factors and cytokines that can promote
the recruitment of host progenitor cells, stimulate angiogenesis, and modulate the
response of infiltrating immune cell populations, to help coordinate tissue
regeneration106,146,379.
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A key limitation to the previous approach was that the static seeding and culture methods
employed resulted in low cellular infiltration and a heterogeneous distribution of the
ASCs within the dense ECM of the DAT, which may have limited their long-term
survival and functionality following in vivo implantation. As such, the primary goal of
this study was to explore the potential of dynamic culture as a strategy to enhance human
ASC expansion, infiltration and pro-regenerative function on the DAT bioscaffolds. In
particular, perfusion bioreactors represent a promising approach for promoting cell
growth on 3-D bioscaffolds by enhancing nutrient delivery and waste removal 380,381.
Further, the shear forces applied by these systems can modulate cell phenotype and
function290,291,296,382, which may alter their capacity to stimulate regeneration.
In the current experimental design, human ASCs were pre-seeded on the DAT under
dynamic conditions on an orbital shaker and then transferred into a custom-designed
perfusion bioreactor system and cultured for 14 days. As oxygen tension has been shown
to modulate ASC survival287, proliferation282, differentiation271,281, and pro-angiogenic
factor production106,111,283 through the regulation of hypoxia inducible factor-1 alpha
(HIF-1α)282,284,285, the effects of culturing the cells under both normoxic (~20% O 2) and
hypoxic (2% O2) conditions were explored. The selection of 2% O2 was based on studies
showing enhanced ASC expansion in vitro at this level271,383. Initial studies focused on
characterizing human ASC distribution, proliferation, and HIF-1α expression in vitro
relative to control scaffold groups cultured under static conditions. Subsequently, in vivo
testing was performed to probe the effects of dynamic culture within the perfusion
bioreactor on human ASC retention, angiogenesis and adipogenesis within a
subcutaneous implant model in athymic nude (nu/nu) mice relative to static cultured,
freshly-seeded and unseeded DAT scaffold controls.
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2.3 Methods
2.3.1

Materials

Unless otherwise stated, all chemicals and reagents were purchased from Sigma Aldrich
Canada Ltd. (Oakville, Canada), and all antibodies were purchased from Abcam
(Cambridge, USA).

2.3.2

Adipose tissue processing

Subcutaneous adipose tissue was collected with informed consent from elective breast
reduction or abdominoplasty surgeries at the University Hospital and St. Joseph’s
Hospital in London, Canada. All studies were approved by the Human Research Ethics
Board at Western University (HREB# 105426). The tissues were transported on ice in
sterile phosphate buffered saline (PBS) with 2% bovine serum albumin (BSA) and
processed within 2 h of collection for ASC isolation238 or DAT scaffold fabrication253
using published protocols. Processed DAT was pooled from multiple tissue donors for all
subsequent experiments.
ASCs were cultured in proliferation medium comprised of DMEM:Ham’s F12
supplemented with 10% fetal bovine serum (FBS) (Wisent, St. Bruno, Canada) and 100
U/mL penicillin/0.1 mg/mL streptomycin (1% pen-strep) (ThermoFisher, Waltham,
USA) at 37°C with 5% CO2 and ~20% O2. Freshly isolated cells were passaged at 80%
confluence, and passage 3 (P3) cells were used in all studies.
Following decellularization, the DAT was lyophilized and cut into scaffolds with a mass
of 8 ± 1 mg. In preparation for seeding, the DAT scaffolds were rehydrated in deionized
water for 24 h and then decontaminated by repeated rinsing in 70% ethanol. Next, the
scaffolds were rinsed in sterile PBS and incubated in proliferation medium for 24 h.

2.3.3

Scaffold seeding and bioreactor setup

To seed the scaffolds, 1 x 106 P3 human ASCs were combined with individual DAT
scaffolds in 3 mL of proliferation medium within 15 mL vented cap conical tubes
(CellTreat Scientific Products, Pepperell, USA). The tubes were transferred into an
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incubator and agitated on an orbital shaker at a 15° incline and 100 RPM for 24 h (37°C,
5% CO2). Following seeding, the scaffolds were transferred into culture inserts that could
be positioned within the individual sample chambers of the customized perfusion
bioreactor system (Tissue Growth Technologies, Instron) (Appendix Figure A.1). The
cell-seeded scaffolds were cultured under a flow rate of 0.5 mL/min for 14 days in
proliferation medium under either normoxic (~20% O2: 5% CO2/95% air) or hypoxic
(5% CO2/93% N2/2% O2) conditions, controlled through the use of a tri-gas incubator
(ThermoFisher Forma Series II 3130), at 37°C. Static control scaffolds were included by
culturing within the inserts under static conditions within vented cap conical tubes.

2.3.4

Assessment of ASC density and distribution

After 14 days of culture, scaffold samples were collected (n=4 replicate scaffolds/trial,
N=3 trials with different ASC donors) for analysis of total cell density using the QuantiT® PicoGreen® dsDNA Assay Kit (ThermoFisher, Waltham, USA). For all trials, control
groups were included of freshly-seeded (collected after the 24 h dynamic seeding phase)
and unseeded DAT scaffolds. The scaffolds were finely minced with surgical scissors and
digested in 1 mL of 4 mg/mL collagenase (Worthington Type I) in Kreb’s Ringer Buffer
supplemented with 1% BSA, 2 mM glucose, and 25 mM HEPES under agitation at 100
RPM on an orbital shaker for 1 h at 37°C. The digested scaffolds were then centrifuged
for 10 min at 1200 xg at room temperature, resuspended in Tris-EDTA buffer (10 mM
Tris base, 1 mM EDTA, pH 8), and briefly sonicated using an ultrasonic dismembrator
(ThermoFisher Model 100). The samples were then centrifuged at 5000 xg for 10 min at
room temperature to remove debris, and the supernatant was analyzed using the
PicoGreen® Assay kit according to the manufacturer’s instructions using a CLARIOstar®
microplate reader (BMG Labtech, Guelph, Canada). All plates included a standard curve
generated with known numbers of ASCs to estimate the total number of ASCs per
scaffold.
To corroborate the PicoGreen® data, the density of ASCs on the scaffolds was also
assessed after 14 days of culture through quantification of DAPI staining (n=3, N=3).
Scaffold samples were fixed in 4% paraformaldehyde for 24 h at 4°C before being
embedded in paraffin and cut into 7 µm sections. Three non-adjacent cross-sections
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100 µm apart were stained with DAPI, mounted and imaged with an EVOS® FL Cell
Imaging System (ThermoFisher) under the 20X objective. DAPI + cells from 10 randomly
selected non-adjacent fields from each scaffold cross-section were quantified using
ImageJ software.
Hematoxylin & eosin (H&E) staining was also performed on scaffold cross-sections
following standard procedures to assess the cell distribution within the DAT scaffolds
after 14 days of culture. The samples were visualized using an EVOS® XL Cell Imaging
System (ThermoFisher).

2.3.5

Immunohistochemical analysis of Ki-67 and HIF-1α
expression

Immunohistochemical staining was performed on additional scaffold sections (3 nonadjacent sections at least 100 µm apart/scaffold; n=3, N=4) to examine the expression of
Ki-67 as a proliferation marker and HIF-1α to probe potential changes under hypoxia.
Heat-mediated antigen retrieval was performed in target antigen retrieval solution
(pH=6.0) (Agilent, Santa Clara, USA) for 25 min. The slides were allowed to cool for 25
min and then washed in PBS and blocked in PBS-T (0.1% Tween-20) supplemented with
10% goat serum for 1 h at room temperature. Sections were then incubated with rabbit
anti-Ki-67 antibody (1:100 dilution) or mouse anti-HIF-1α antibody (Novus Biologicals,
Oakville, Canada; 1:100 dilution) overnight at 4°C. Alexa Fluor® 594 conjugated goat
anti-rabbit (1:100 dilution) or Alexa Fluor® 680 conjugated goat anti-mouse (1:100
dilution) secondary antibody was subsequently applied for 1 h at room temperature and
the samples were mounted in Fluoroshield Mounting Medium with DAPI (Abcam,
Cambridge, USA). Mouse skin tissues and hypoxically cultured human ASCs were used
as positive controls for Ki-67 and HIF-1α, respectively, and no primary antibody controls
were included in all trials. Stained sections were visualized with the EVOS® FL Cell
Imaging System, and 10 randomly selected non-adjacent fields of view from both the
peripheral (< 200 µm from the scaffold edge) and central (>200 µm from the scaffold
edge) regions of the scaffolds were imaged under the 20X objective. The number of
Ki-67+DAPI+ cells and HIF-1α+DAPI+ within each region were quantified using ImageJ
Software.
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2.3.6

Subcutaneous implantation surgeries

Following the in vitro testing, studies were performed to assess the effects of bioreactor
culture on the capacity of the human ASCs to stimulate in vivo angiogenesis and
adipogenesis within the DAT scaffolds. More specifically, these studies compared 6
scaffold groups including the ASC-seeded scaffolds that had been cultured for 14 days
within the perfusion bioreactor or under static conditions at both 20% and 2% O 2 (i.e. (i)
20% O2 static, (ii) 20% O2 dynamic, (iii) 2% O2 static, (iv) 2% O2 dynamic) to (v)
freshly-seeded (after the 24 h seeding phase) and (vi) unseeded DAT scaffold controls.
For each scaffold group, duplicate samples were implanted for each trial and a total of 3
trials were performed using ASCs isolated from 3 different donors. All studies followed
the Canadian Council on Animal Care (CCAC) guidelines and the protocols were
approved by the Animal Care Committee at Western University (Protocol # 2015-049).
The scaffolds were implanted subcutaneously in female Nu-Foxn1nu mice (Charles River
Laboratories, Sherbrooke, Canada) that were 10-13 weeks of age for 4 and 8 weeks. A
total of 36 mice were used for this study (N=6 mice per scaffold group at each timepoint).
The mice were anaesthetized with isoflurane and given pre-operative analgesics via
subcutaneous injections of meloxicam (2 mg/kg loading dose; 1 mg/kg follow up dose at
24 h) and bupivacaine (2 mg/kg). Two small incisions (~7 mm) were made on the dorsa
of each mouse below each scapula, and pockets were created using blunt-ended forceps.
One scaffold was then carefully positioned within each pocket and the incisions were
closed with surgical staples. At each timepoint, the mice were euthanized by CO 2
overdose and the scaffolds were excised within their surrounding tissues. The samples
were fixed in 4% paraformaldehyde overnight at 4°C, prior to paraffin embedding and
sectioning (7 µm thick) in preparation for histological and immunohistochemical
analyses. For all staining analyses, 3 cross-sections per implant (N=6 per time point)
were analyzed that were a minimum of 100 µm apart.

2.3.7

Masson’s trichrome staining

Masson’s trichrome staining was performed using standard procedures to assess implant
integration and remodeling, as well as the density of erythrocyte-containing blood vessels
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within the scaffolds. The entire scaffold cross-section in each sample was imaged using
the EVOS® XL Cell Imaging System at 20X magnification and combined into a single
cross-sectional image using Adobe® Photoshop® CS6 Software. Within each complete
cross-section, the number of erythrocyte-containing blood vessels was quantified within
the DAT implant to determine the overall blood vessel density. Further, the distance to
the closest scaffold edge and diameter were measured for each vessel using ImageJ
Software. Vessel infiltration within 500 µm of the scaffold surface was analyzed using
frequency distribution graphs with a bin size of 25 µm.

2.3.8

Immunohistochemical analysis of perilipin expression

At both timepoints, immunohistochemical staining was performed to assess perilipin
expression as a marker of adipocyte formation within the DAT implants. The sections
were prepared as described in section 2.3.5 and incubated overnight in rabbit antiperilipin A antibody (1:200 dilution) at 4°C, followed by a goat anti-rabbit HRPconjugated secondary antibody (1:500 dilution) for 1 h at room temperature. The samples
were then processed with a DAB peroxidase (HRP) substrate kit (Vector Labs,
Burlington, Canada), followed by counterstaining with hematoxylin and mounting with
Permount® Mounting Medium (ThermoFisher, Waltham, USA). Mouse adipose tissues
were used as a positive control, and no primary antibody controls were included in all
trials. The entire scaffold region was imaged at 10X magnification and stitched into a
single cross-sectional image as previously described. Positive pixel counting was
performed to analyze the relative perilipin expression levels between the implant groups,
with the values normalized to the total scaffold area within each cross-section measured
using ImageJ Software.

2.3.9

Immunohistochemical analysis of human ASC engraftment
and differentiation

To detect the human ASCs within the DAT implants, cross-sections were stained for
human-specific Ku80384 using a rabbit anti-Ku80 antibody (Cedarlane, Burlington,
Canada; 1:100 dilution) followed by Alexa Fluor® 594 conjugated goat anti-rabbit (1:200
dilution) secondary antibody using methods described in section 2.3.5. Tissue positive

48

and no primary antibody controls were included in all trials. The stained cross-sections
were imaged using the EVOS® FL Cell Imaging System. Quantification of Ku80+DAPI+
cells was performed on 10 randomly selected non-overlapping fields of view taken at
20X magnification using ImageJ analysis software.
To probe whether the human ASCs were differentiating into adipocytes within the DAT
implant region, co-staining was performed using rabbit anti-perilipin A antibody as an
adipocyte marker in combination with a mouse anti-human mitochondria (hMito)
antibody conjugated with Cy3 (EMD Millipore, Burlington, USA; 1:100 dilution). hMito
was used as an alternative to Ku80 based on the availability of antibodies compatible for
co-staining. The samples were incubated overnight at 4°C and then incubated for 1 h at
room temperature with a goat anti-rabbit secondary antibody conjugated with Alexa
Fluor® 680 (1:100 dilution). The stained sections were visualized with the EVOS® FL
Cell Imaging System and imaged under 20X magnification.

2.3.10

Statistical analysis

All numerical values are represented as the mean ± standard deviation. Statistical
analyses were performed using GraphPad Prism® version 6 by one way or two-way
ANOVA and followed by a Tukey’s post-hoc test. Differences were considered
statistically significant at p<0.05.

2.4 Results
2.4.1

Dynamic culturing in the bioreactor under hypoxic conditions
for 14 days enhanced ASC density on the DAT bioscaffolds

To quantitatively assess cell density on the DAT, the scaffolds were digested and
analyzed with the PicoGreen® dsDNA Assay. Freshly-seeded scaffolds had an average of
1.49 ± 0.19 x 105 cells per scaffold following the 24 h seeding period. After 14 days of
culture, the total cell density was significantly higher in the 2% O 2 dynamic group as
compared to the freshly-seeded scaffolds and the 20% O2 static and 2% O2 static groups
(Figure 2.1A). DAPI staining showed similar patterns in terms of the ASC density on the
DAT scaffolds, corroborating the PicoGreen® results (Figure 2.1B).
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To complement the quantitative findings, H&E staining was performed to assess the ASC
distribution within the DAT scaffolds following the 14-day culture period. The ASCs
were predominantly localized to the surface of the DAT scaffolds in the samples that
were cultured under static conditions at both 20% and 2% O 2 (Figure 2.1C). A higher
density of ASCs was observed in the scaffolds cultured for 14 days within the bioreactor,
with a dense cell layer observed along the surface of the scaffolds. Consistent with the
PicoGreen® results, the 2% O2 dynamic group appeared to have a qualitatively higher
density of cells, with greater infiltration into the central scaffold regions.
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Figure 2.1 ASC density was enhanced on the DAT scaffolds following 14 days of
culture within the perfusion bioreactor under 2% O2. A) Average number of
ASCs/scaffold based on total dsDNA content following 14 days of culture. Dashed line
represents the average cell density in the freshly-seeded group. Error bars represent
standard deviation (n=4 replicate scaffolds, N=3 trials with different ASC donors). B)
The average number of ASCs per mm2 of the DAT bioscaffold as measured by DAPI
quantification following 14 days of culture. Error bars represent standard deviation (n=3
cross-sections/scaffold, N=3 trials with different ASC donors). * = 2% O2 dynamic is
significantly different than 20% O2 static and 2% O2 static group (p<0.05). C)
Representative H&E staining showing the distribution of ASCs on the DAT scaffolds
following 14 days of culture. Scale bars represent 100 µm.

51

2.4.2

Dynamic culturing in the bioreactor under hypoxic conditions
for 14 days enhanced Ki-67 expression in the scaffold
periphery

Immunostaining identified a low density of Ki-67+DAPI+ cells distributed throughout the
scaffolds at 14 days. Qualitatively, there appeared to be more Ki-67+DAPI+ cells in the
2% O2 dynamic group, with a higher density in the scaffold periphery (Figure 2.2A).
Representative images of the central scaffold regions are shown in Appendix Figure A.2.
These observations were confirmed by quantification of the number of Ki-67+DAPI+ cells
within the peripheral (< 200 µm from edge) and central (> 200 µm from edge) regions of
the scaffolds, which revealed that there was a significantly higher density of
Ki-67+DAPI+ cells in the periphery in the 2% O2 dynamic group as compared to both the
peripheral and central regions of all other culture conditions. Additionally, a greater
density of Ki-67+DAPI+ cells was measured in the central region of 2% O2 dynamic
group as compared to the central region of 2% O2 static group (Figure 2.2B).
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Figure 2.2 Ki-67 expression at 14 days was enhanced in the ASCs dynamically
cultured on the DAT scaffolds within the perfusion bioreactor under 2% O 2. A)
Representative images showing Ki-67+ cells (red) counterstained with DAPI (blue) in the
peripheral regions of the scaffolds after 14 days of culture. White arrowheads denote
positively labelled cells and dashed lines represents the edge of the bioscaffolds. Scale
bars represent 100 µm. B) The average number of Ki-67+DAPI+ cells in the peripheral
and central regions of the scaffolds at 14 days. Error bars represent standard deviation
(n=3 cross-sections/scaffold, N=4 trials with different ASC donors). * = significant
difference between 2% O2 dynamic group and all other groups, # = significant difference
between the central region of 2% O2 dynamic and 2% O2 static groups (p<0.05).
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2.4.3

Culturing under hypoxia increased the number of HIF-1α+
cells within the scaffolds at 14 days

Immunohistochemical staining revealed that there were very few HIF-1α+DAPI+ cells in
both the peripheral (< 200 µm from edge) and central (> 200 µm from edge) regions of
the scaffolds cultured either dynamically or statically for 14 days under 20% O 2 (Figure
2.3A). In contrast, HIF-1α expression was observed in the majority of the cells in the
2% O2 static and dynamic groups. Representative images of the central scaffold regions
are shown in Appendix Figure A.3. Quantification of the staining indicated that the
density of HIF-α+DAPI+ cells was significantly higher in the 2% O2 dynamic group as
compared to all other groups within both the peripheral and central scaffold regions
(Figure 2.3B). In addition, the density of HIF-1α+ DAPI+ cells was also significantly
greater in the 2% O2 static group as compared to the 20% O2 static and dynamic groups
within both the peripheral and central scaffold regions (Figure 2.3B).
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Figure 2.3 HIF-1α expression was enhanced at 14 days in the ASCs cultured on the
DAT scaffolds under 2% O2. A) Representative immunostaining showing HIF-1α+
ASCs (green) counterstained with DAPI (blue) in the peripheral (< 200 µm from the
edge) regions of the scaffolds following 14 days of culture. Scale bars represent 100 µm.
Dashed lines represent the border of the bioscaffolds. B) The average number of HIF1α+DAPI+ cells in the peripheral and central regions of the scaffolds at 14 days. Error
bars represent standard deviation (n=3 cross-sections/scaffold, N=4 trials with different
ASC donors). * = significant difference between the peripheral region of the 2% O2
dynamic group and both the central and peripheral regions of all other groups , # =
significant difference between the central region of the 2% O2 dynamic group and the
central region of all other conditions, Δ = significant difference between the 2% O2 static
group as compared to the 20% O2 static and 20% O2 dynamic groups in both regions
(p<0.05).
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2.4.4

DAT scaffolds cultured within the bioreactor for 14 days
under hypoxic conditions showed enhanced blood vessel
formation at 4 and 8 weeks following subcutaneous
implantation

In vivo studies were subsequently performed using a subcutaneous implantation model in
nu/nu mice to compare angiogenesis and adipogenesis in the scaffolds that had been
cultured for 14 days within the bioreactor or statically (20% O2 static, 20% O2 dynamic,
2% O2 static, 2% O2 dynamic) to freshly-seeded and unseeded controls. Masson’s
trichrome staining at 4 and 8 weeks revealed that the scaffolds were well integrated into
the host tissues and showed evidence of implant remodeling (Figure 2.4A). Small blood
vessels and adipocytes were observed in the peripheral regions of the DAT implants
starting at 4 weeks. At 8 weeks, more vessels were observed in the 2% O2 dynamic group
as compared to all other conditions, along with a greater number of adipocytes extending
into the more central scaffold regions (Figure 2.4A).
Quantification of the number of erythrocyte-containing blood vessels in the scaffolds
revealed that there was a significantly higher vessel density in the 2% O 2 dynamic group
as compared to all other conditions at 8 weeks (Figure 2.4B), with a significant difference
between the two timepoints for this group. The diameter of the erythrocyte-containing
blood vessels was also measured, with results indicating that there were no significant
differences in the average diameter between the groups at both 4 and 8 weeks, with an
average diameter in the range of ~25 - 35 µm (Appendix Figure A.4A).
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Figure 2.4 The density of erythrocyte-containing blood vessels was enhanced at 4
and 8 weeks in the DAT scaffolds that were cultured in the bioreactor under 2% O2
for 14 days prior to subcutaneous implantation in nu/nu mice. A) Representative
Masson’s trichrome staining of the DAT implants at 8 weeks, with black arrowheads
highlighting erythrocyte-containing blood vessels within the scaffolds. Scale bars
represent 100 µm. B) Density of erythrocyte-containing blood vessels within the
scaffolds at 4 and 8 weeks. Error bars represent standard deviation (n=3 crosssections/implant, N=6 implants/group). * = 2% O2 dynamic group at 8 weeks is
significantly different compared to all other groups at 8 weeks (p<0.05).
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Blood vessel infiltration was also probed by measuring the shortest distance from each
vessel to the scaffold periphery. No significant difference in the average distance of blood
vessel infiltration was measured between the groups at 4 weeks, with the average values
ranging from ~70 - 125 µm and a high degree of variability observed (Appendix Figure
A.4B). At 8 weeks, the average distance of vessel infiltration was significantly higher in
the 2% O2 dynamic group (198.8 ± 32.1 µm) as compared to all other groups with the
exception of the 20% O2 static (100.7 ± 38.3 µm) and 20% O2 dynamic (125.1 ± 46.6
µm) groups.
Vessel infiltration within 500 µm of the scaffold surface was further analyzed by
frequency distribution plots with pooled counts of the total number of vessels within
25 µm intervals for each of the scaffold groups (Figure 2.5). Based on this analysis, an
increase in the number of vessels within the first 100 µm of the scaffolds was observed in
the 2% O2 dynamic and static groups at 4 weeks, suggesting that hypoxic culture
promoted vessel formation in the scaffold periphery. At 8 weeks, a shift towards greater
infiltration (i.e. rightwards) was observed for both the 2% O2 dynamic and 20% O2
dynamic groups, suggesting that dynamic culture enhanced the number of vessels
infiltrating into the 100 – 200 µm depth range, with a higher number of vessels in the 2%
O2 dynamic group in this range, as well as farther into the scaffolds. Interestingly, the
distributions for the freshly-seeded and unseeded groups were similar at both timepoints,
indicating that the ASCs had little impact on vessel formation within the DAT under the
conditions in this study. While the distribution for the 20% O2 static group was similar to
these groups at 4 weeks, an increase in the number of vessels within the first 50 µm was
observed in this group at 8 weeks, suggesting that there was some benefit of culturing the
ASCs on the scaffolds prior to implantation in terms of vessel formation within the most
peripheral regions of the DAT scaffolds (Figure 2.5).
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8 Weeks

Frequency

4 Weeks

Figure 2.5 Frequency distribution plots showing the total number of erythrocytecontaining blood vessels at increasing depths from the scaffold periphery within the
DAT implants. Coloured lines represent non-linear Gaussian fits of the data sets. Pooled
data is shown representing the combined counts from 3 cross-sections at varying depths
from 6 implants per condition at both 4 and 8 weeks.

2.4.5

DAT scaffolds cultured within the bioreactor for 14 days
under hypoxic conditions showed enhanced adipose tissue
remodeling at 8 weeks following subcutaneous implantation

Immunohistochemical staining for perilipin was performed to identify adipocytes
containing intracellular lipid as a measure of adipose tissue formation within the
implanted scaffolds at 4 (Appendix Figure A.5) and 8 weeks (Figure 2.6A). At 4 weeks, a
small number of adipocytes were observed within the peripheral regions of the scaffolds
in all of the groups. At 8 weeks, there were qualitatively more adipocytes in the scaffolds
that incorporated ASCs as compared to the earlier timepoint, with more perilipin + cells
observed in the 2% O2 dynamic group as compared to all other conditions.
Semi-quantitative image analysis confirmed that the relative levels of perilipin expression
within the implant region were similar between the groups at 4 weeks (Figure 2.6B). In
contrast, at 8 weeks, the 2% O2 dynamic group showed significantly greater perilipin
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expression levels as compared to all other groups at both 4 and 8 weeks, with a
significant increase observed within this group from 4 to 8 weeks. Collectively, these
findings are indicative of enhanced remodeling of the DAT implant into adipose tissue in
the 2% O2 dynamic condition. (Figure 2.6B).
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Figure 2.6 Remodeling of the DAT into adipose tissue was enhanced in the 2% O2
dynamic group at 8 weeks following subcutaneous implantation in the nu/nu mouse
model. A) Representative immunostaining showing regions of perilipin + adipocytes
(brown) within the implanted scaffolds at 8 weeks. Scale bars represent 100 µm. B) The
expression of perilipin relative to the unseeded group at 4 weeks. Error bars represent
standard deviation (n=3 cross-sections/implant, N=6 implants/group). * = significant
difference between the 2% O2 dynamic group at 8 weeks and all other groups at both 4
and 8 weeks, as well as the 2% O2 dynamic group at 4 weeks (p<0.05).
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2.4.6

Human ASCs were detected in the DAT implants at similar
levels at both 4 and 8 weeks

Immunohistochemical staining was performed for human-specific Ku80 to identify
human ASCs within the DAT implants at both 4 (Appendix Figure A.6) and 8 weeks
(Figure 2.7A). Ku80+ cells were visualized throughout the seeded scaffolds at both
timepoints. Quantification of the number of Ku80+DAPI+ cells within the scaffold
regions revealed that there were no significant differences in the density of human ASCs
detected between the seeded implant groups at both 4 and 8 weeks (Figure 2.7B).
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Figure 2.7 Ku80+ cell density was similar between all seeded groups at both 4 and 8
weeks post-implantation. A) Representative immunostaining showing Ku80 labelled
cells (red) counterstained with DAPI (blue). Scale bars represent 100 µm. B) Bar graph
showing the density of Ku80+DAPI+ ASCs in the implants at 4 and 8 weeks. Data was
compiled from 6 implants per group (N=6), with 3 cross-sections per scaffold taken from
varying depths and 10 random fields analyzed per cross-section. Error bars represent
standard deviation.
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2.4.7

No evidence of human ASC differentiation into adipocytes in
vivo

Co-staining with a human anti-mitochondrial (hMito) antibody in combination with
perilipin was performed to probe human ASC differentiation into adipocytes within the
DAT implants. No perilipin+hMito+ cells were identified, indicating that the
newly-forming adipocytes within the DAT implants were predominantly host-derived
(Figure 2.8).

Figure 2.8 Staining patterns suggest that the human ASCs did not differentiate into
adipocytes within the DAT implants over 8 weeks. Representative image showing
distinct hMito+ (red) and perilipin+ (green) cell populations with DAPI (blue)
counterstaining. White arrowheads indicate human ASCs in close proximity to perilipin+
cells. Scale bars represent 50 µm.

2.5 Discussion
New strategies that can promote the regeneration of healthy host-derived adipose tissue
and enable stable and predictable volume augmentation would be of great value for a
broad range of applications in plastic and reconstructive surgery. With the long-term goal
of advancing towards clinical translation, the Flynn lab has been developing a broad
range of off-the-shelf bioscaffolds derived from the ECM of human adipose
tissue227,229,253,255,385. Previous in vivo study exploring DAT scaffolds in a subcutaneous
implant model in immunocompetent rats indicated that seeding the DAT with allogeneic
rat ASCs significantly enhanced blood vessel formation and remodeling of the DAT into
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host-derived adipose tissue169. In that study, the DAT scaffolds were seeded with the
ASCs within tissue culture inserts and then cultured statically for 72 h to promote cell
attachment. However, these static seeding and culture methods result in a heterogeneous
and sparse distribution of ASCs on the relatively dense intact DAT scaffolds, with limited
cell infiltration into the central scaffold regions. Therefore, a higher density and more
even distribution of cells throughout the scaffold may be favorable for enhancing the rate
and extent of adipose tissue regeneration within the DAT. Further, in the current study,
human ASCs were used as a more clinically relevant cell population.
Dynamic culture methods can enhance cell proliferation and infiltration into 3-D porous
scaffolds by promoting the exchange of nutrients and waste, as well as by providing
mechanical stimulation that can modulate cell function 300,386,387. Stirred culture systems,
such as spinner flasks, have been most extensively explored for the expansion of
mesenchymal stromal cell (MSC) populations including ASCs, incorporating a range of
microcarrier types to support cell attachment and growth257,301,388–392. Using an alternative
design, Papadimitropoulos et al. investigated the use of a ceramic scaffold-based
perfusion bioreactor for human bone marrow-derived MSC expansion312, and Kim and
Ma applied a perfusion bioreactor system for the expansion of human MSCs from bone
marrow on polyethylene terephthalate (PET) scaffolds319. In general, the overall goal in
these strategies was to harness the benefits of dynamic culture within a 3-D system to
better preserve MSC function in terms of their capacity to proliferate and differentiate
towards the adipogenic, osteogenic and/or chondrogenic lineages, as compared to the
progressive functional decline that is observed when the cells are expanded on 2-D tissue
culture polystyrene under static conditions257,393. The cells expanded within these systems
can typically be released, such as through enzymatic digestion, and subsequently
incorporated within a range of delivery platforms depending on the application of
interest303,394.
In the current study, an integrated approach was applied using a custom 3-D perfusion
bioreactor to expand the human ASCs on the same DAT scaffold on which they would be
delivered. While similar perfusion bioreactor strategies have been explored for bone
tissue engineering applications using biomaterials with properties that mimic bone 303,394,
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to the best of our knowledge this is the first study to investigate the use of a scaffoldbased perfusion bioreactor for adipose tissue regeneration. Culturing within the perfusion
bioreactor system was shown to enhance the cell density within the peripheral regions of
the DAT scaffolds, with a more marked effect in the samples that were cultured under 2%
O2. These findings supporting the benefits of perfusion culture are similar to a previous
study using a double chamber perfusion bioreactor that demonstrated that media
perfusion enhanced bone marrow-derived MSC homogeneity within decellularized
porcine tracheal scaffolds395. Additionally, a study by Sailon et al. showed that that the
density of MC3T3-E1 murine pre-osteoblastic cells was enhanced on porous
polyurethane scaffolds when cultured within a perfusion bioreactor system as compared
to static controls, with the cells typically localized in the more porous regions of the
scaffolds316. The enhanced cell density within the peripheral regions of the DAT suggests
that there may have been limited media perfusion into the central regions of the scaffolds
over time, which is a potential limitation. Regardless, the in vivo findings clearly support
that culturing the ASCs on the DAT within the perfusion bioreactor under 2% O 2
significantly augmented angiogenesis and adipogenesis within the implants, supporting
the benefits of the approach.
Based on the PicoGreen® and Ki-67 staining results, culturing under dynamic conditions
within the bioreactor stimulated ASC proliferation on the DAT. Interestingly, there was
no benefit of culturing the scaffolds under static conditions for 14 days in terms of the
total cell number per scaffold relative to the freshly-seeded group. In addition to
promoting ASC proliferation, bioreactor culture may have enhanced long-term cell
survival387,396, contributing to the higher cell density observed. Further, the media used in
this study contains both mitotic factors as well as potent chemotactic factors 397,398 that
may have promoted cell migration from the scaffold interior to the more highly perfused
periphery.
The ASCs cultured both statically and dynamically under 2% O2 were also shown to
express HIF-1α, consistent with hypoxia in adipose tissue being < 5% O2273,274. HIF-1α
activation is associated with MSC proliferation279,399, which may have contributed to the
enhanced Ki-67 expression in the hypoxic dynamic group. A previous study by Choi et
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al. demonstrated that culturing human ASCs under 2% O2 increased proliferation relative
to culture under ~21% O2 through HIF-1α-mediated mechanisms281. In a more recent
study, human ASCs were found to be more proliferative when cultured under 1% O2 as
compared to 2% O2 for 7 days282. Moreover, the increased proliferation was shown to be
mediated through the HIF-1α-dependent upregulation of bFGF282. In addition to
stimulating proliferation, HIF-1α is an important transcription factor that regulates the
expression of a range of angiogenic growth factors400. As such, it is possible that
culturing under 2% O2 may have modulated the paracrine factor secretion profile of the
ASCs within the DAT, which would be interesting to explore in future work.
Following in vitro characterization, in vivo testing was performed to assess the effects of
bioreactor culture on the capacity of the ASCs to promote angiogenesis and adipogenesis
within the DAT. Athymic nude mice, which have been used in a number of adipose tissue
engineering studies159,165,176,189,259,401–403, were applied to enable the investigation of
human ASCs. Angiogenesis was probed by quantifying the number of erythrocytecontaining blood vessels within the implants, indicative of functional vasculature.
Previously in the rat model, seeding the DAT with allogeneic rat ASCs resulted in an
increase in the number and diameter of erythrocyte-containing blood vessels within the
implants starting at 8 weeks169. In the current study, the vessel density was significantly
higher in the 2% O2 dynamic group at 8 weeks as compared to all other conditions. Since
the ASC density at 14 days was significantly higher in this group, it is possible that
enhanced cell delivery may have contributed to increased angiogenesis. A study by AlKhaldi et al. demonstrated there was a dose-dependent increase in in vivo blood vessel
formation at 28 days when varying densities of mouse MSCs (up to 2 x 10 6 cells/mL)
were delivered subcutaneously in Matrigel in C57BL/6 mice404. In addition to vessel
density, the increased blood vessel infiltration observed in the hypoxic bioreactor group
could be an indicator of an enhanced vessel sprouting effect. Previous studies have shown
that vascular endothelial growth factor A (VEGFA) and bFGF are key paracrine factors
that are crucial in driving vessel sprouting283, which are secreted by ASCs at enhanced
levels under hypoxia284,285. Moreover, there is also evidence to support that MSCs
subjected to shear stress induced by dynamic culturing systems can show enhanced
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VEGFA secretion290,296. As discussed, it would be worthwhile to explore the effects of
dynamic culture on the DAT on ASC phenotype and paracrine function in future studies.
In addition to enhanced angiogenesis, culturing the ASCs on the DAT within the
bioreactor under 2% O2 for 14 days prior to implantation resulted in a significant increase
in the number of perilipin+ adipocytes within the implants at 8 weeks as compared to all
other groups, consistent with enhanced remodeling of the DAT into adipose tissue.
Adipose tissue regeneration is typically a gradual process that is coupled with
angiogenesis, as a rich vascular supply is required to support mature adipocytes 405,406. In
previous rat study, seeding the DAT with allogeneic rat ASCs enhanced adipogenesis
within the implants at both 8 and 12 weeks169. However, the response at 8 weeks was
quite variable, with 20.1 ± 15.3% of the seeded DAT having remodeled into mature fat,
as compared to 3.9 ± 5.7% in the unseeded group, based on area analysis of Masson’s
trichrome stained cross-sections169. The lack of difference observed between the other
ASC-seeded groups in the current study relative to the unseeded controls may be related
to species variability in terms of both the ASC source and animal model employed, as
well as to differences in the ASC dose delivered. In addition, it is possible that further
differences would be observed between the groups at later timepoints. Regardless, the
present findings clearly demonstrate that dynamic culture of human ASCs on the DAT
within the perfusion bioreactor under 2% O2 significantly augmented both angiogenesis
and adipogenesis within the implants at 8 weeks, supporting the use of this new strategy
for adipose tissue regeneration.
While the density of ASCs was higher on the 2% O2 dynamic scaffolds at the time of
implantation, there were no significant differences between the groups in terms of the
number of human ASCs detected within the implants at both 4 and 8 weeks. It is possible
that the enhanced vascularization observed in the bioreactor-cultured samples may have
contributed to this decline by promoting the recruitment of immune cell populations such
as monocytes/macrophages that may recognize the human ASCs as being foreign. In
previous rat study, using fluorescence in situ hybridization (FISH) to track the allogeneic
ASCs sourced from male donors via the Y-chromosome, a progressive reduction in the
number of donor cells within the DAT implants was observed over time, with only a
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small number of donor ASCs visualized at 8 weeks and no positive cells detected at 12
weeks, indicating that the newly-formed adipose tissues were predominantly hostderived169. Similarly, Parisi-Amon et al. showed that mouse ASCs delivered
subcutaneously in nude mice within a peptide-based hydrogel showed an 80% reduction
in exogenous cells after 7 days in vivo based on bioluminescence imaging407.
Additionally, a more recent study using a poly(N-isopropylacrylamide)-polyethylene
glycol co-polymer to encapsulate human ASCs demonstrated ~13% retention at 14 days
following subcutaneous delivery in athymic nude mice408. The persistence of a relatively
high density of human ASCs in the current study at 8 weeks in all of the seeded groups
suggests that the DAT may provide a supportive platform for their delivery. The
functional role of these cells remains unclear, but the staining patterns suggest that there
was limited differentiation into adipocytes. It would be interesting to explore how long
these cells persist in future studies, as well as probing differences in possible paracrinemediated effects at later timepoints including host adipogenic progenitor cell recruitment.

2.6 Conclusions
The perfusion bioreactor system represents a novel and promising platform for the
dynamic expansion of pro-regenerative cell populations on 3-D bioscaffolds for adipose
tissue engineering, and also an advancement towards a clinically viable strategy to
support adipose tissue regeneration. The findings in this study demonstrated that the
perfusion bioreactor system is effective at increasing the density of ASCs on the DAT,
which suggests that it could address the previous limitations of the ASC-seeded DAT
bioscaffolds. Increasing the ASC density on the DAT bioscaffolds via culturing within
the perfusion bioreactor system under hypoxia subsequently translated into an enhanced
capacity to support blood vessel formation and adipose tissue remodeling in vivo.
Collectively, the body of work in the present study provided support for the use of a
perfusion bioreactor system to increase the pro-regenerative potential of the ASC-seeded
bioscaffolds. Moving forward, future studies should explore the mechanisms through
which the ASC-seeded DAT supports angiogenesis and adipogenesis in vivo as the next
step towards developing a clinically translatable subcutaneous adipose tissue regeneration
strategy.
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Chapter 3

3

Dynamic culture of human adipose-derived stromal
cells on decellularized adipose tissue scaffolds
modulates ASC paracrine factor expression and
promotes a robust pro-regenerative host response

3.1 Abstract
Adipose-derived stromal cells (ASCs) have shown great promise as a pro-regenerative
cell population that can be combined with decellularized adipose tissue (DAT) scaffolds
to promote adipose tissue regeneration. Previous studies have shown that culturing
human ASCs on DAT scaffolds within a perfusion bioreactor under 2% O2 can
significantly enhance in vivo angiogenesis and adipogenesis within the DAT. The focus
of the current study was on exploring how dynamic culture within the bioreactor over 14
days modulated the phenotype and paracrine function of the ASCs on the DAT relative to
controls cultured under static conditions. Multi-colour flow cytometry analysis of
enzymatically-digested scaffolds indicated that there were no significant differences in
the ASC immunophenotype between the groups. Immunohistochemical analyses
suggested that shear stress stimulation induced by dynamic culture modulated the ASC
response within the peripheral regions of the DAT, promoting the expression of inducible
nitric oxide synthase (iNOS) and tumour necrosis factor alpha (TNF-α). Moreover, a
greater fraction of the ASCs within this region co-expressed iNOS and arginase-1
(Arg-1), as well as TNF-α and interleukin 10 (IL-10). Gene and protein expression
analyses indicated that dynamic culturing modulated the expression of a range of proangiogenic and immunomodulatory factors in the ASCs on the DAT, suggesting that their
capacity to stimulate regeneration via paracrine mechanisms may be altered. In vivo
studies comparing the response of the two groups in a subcutaneous implant model in
athymic nude mice showed that culturing the ASCs on the DAT within the perfusion
bioreactor prior to implantation enhanced the infiltration of CD31 + endothelial cells and
CD26+ host cells into the DAT. While no significant difference was observed in total
macrophage recruitment between the groups, there was increased infiltration of CD163 +
macrophages in the dynamic group at 8 weeks, suggesting there was a shift towards a
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more pro-regenerative macrophage response. Overall, this work supports that dynamic
culturing of human ASCs on DAT scaffolds in the perfusion bioreactor can alter the ASC
phenotype in addition to promoting cell expansion, which may have contributed to the
enhanced host-derived adipose tissue regeneration observed in this group.

3.2 Introduction
Tissue engineering strategies represent a promising approach for the long-term
augmentation and regeneration of damaged or deficient subcutaneous adipose tissue for
applications in plastic and reconstructive surgery. Recent advances in the field have
focused on using a combined approach involving cell-seeded scaffolds as a means to
provide both immediate volumetric augmentation and promote the stable regeneration of
host-derived soft tissues27,150,409. In particular, decellularized adipose tissue (DAT) has
emerged as a promising pro-adipogenic platform for this application229,253. DAT scaffolds
can be fabricated from human adipose tissue that is abundantly discarded as surgical
waste, and have been shown to retain biochemical and biophysical properties that mimic
the native tissue source, which may be favorable for adipose tissue regeneration 246,256.
While applying DAT as an off-the-shelf scaffold is appealing, studies have suggested that
the rate and extent of adipose tissue regeneration can be enhanced by seeding the
scaffolds with regenerative cells169,255,258,259,410, which may be critical for larger volume
augmentation applications. In particular, previous work from our lab supports that
seeding the DAT with allogeneic adipose-derived stromal cells (ASCs) enhanced both
angiogenesis and adipogenesis within DAT implants in an immunocompetent rat
model169. ASCs are a logical cell source for this application given their relative
abundance and accessibility70,71, their high tolerance of ischemic conditions such as those
following implantation411, as well as their enhanced adipogenic potential compared to
other mesenchymal stromal cell (MSC) sources412.
In our previous work169, the static seeding methods used resulted in a sparse and
heterogeneous distribution of ASCs on the DAT scaffolds, which may have restricted
their capacity to stimulate regeneration. To address this limitation, we recently

71

investigated the effects of culturing human ASCs on the DAT within a scaffold-based
perfusion bioreactor413. Our findings demonstrated that dynamic culture under 2% O2
promoted human ASC expansion on the DAT. Further, culturing within the bioreactor
under 2% O2 for 14 days prior to implantation significantly augmented blood vessel
infiltration and adipose tissue formation within the DAT scaffolds in a subcutaneous
implant model in athymic nude (nu/nu) mice in comparison to scaffolds that had been
cultured within the bioreactor for 14 days under 20% O2, as well as scaffolds that had
been cultured statically, and freshly-seeded or unseeded controls413.
Although the delivery of a higher density of ASCs likely contributed to the enhanced
adipose tissue regeneration observed in the 2% O2 bioreactor group, the dynamic culture
conditions may have also primed the ASCs to have a more pro-regenerative phenotype. A
growing body of evidence supports that ASCs delivered within scaffolds primarily
stimulate regeneration through transient paracrine-mediated effects, rather than through
long-term engraftment and differentiation101–103. More specifically, ASCs can secrete a
diverse range of growth factors and cytokines that can promote the recruitment and/or
modulate the response of host cells, including immune cell populations, endothelial cells
and adipogenic progenitors that can contribute to implant remodeling, angiogenesis and
adipogenesis105–107,414. While the stimulatory effects of hypoxia on pro-angiogenic
factor106,111,263,288 and cytokine secretion283,286 are well documented, the effects of
dynamic culture on MSC paracrine factor expression remain largely unexplored, with
most bioreactor studies to date focused on characterizing the effects on proliferation
and/or differentiation305,313,314,316,325.
Recognizing that dynamic culture may enhance the pro-regenerative capacity of the
ASCs, the current study investigated how dynamic culture on the DAT scaffolds within
the bioreactor modulated human ASC phenotype and paracrine function. To assess the
effects of shear stress stimulation, the ASCs were cultured on the DAT scaffolds under
2% O2 either within the perfusion bioreactor or statically for 14 days. As discussed, our
previous studies clearly demonstrated that adipose tissue regeneration was markedly
enhanced in the DAT scaffolds in the 2% O2 dynamic group relative to all other groups,
including the 2% O2 static group, at 8 weeks post-implantation in the nu/nu mouse
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model413. In vitro analyses were first performed to assess the effects of dynamic culturing
on the DAT on ASC surface marker expression, phenotype and paracrine factor
expression. Subsequently, the impact of dynamic culture on the pro-regenerative
paracrine functionality of the human ASCs cultured and delivered on the DAT scaffolds
was explored by characterizing the effects on host cell recruitment at 1, 4 and 8 weeks
post-implantation in the nu/nu mouse model.

3.3 Methods
3.3.1

Materials

Unless otherwise stated, all reagents were purchased from Sigma Aldrich Canada Ltd.
and used as received (Oakville, Canada).

3.3.2

Human adipose tissue collection and processing

Surgically-discarded subcutaneous adipose tissue was collected with informed consent
from female donors undergoing elective lipo-reduction surgeries at the University
Hospital or St. Joseph’s Hospital in London, Canada. Human Research Ethics Board
approval for this study was obtained from Western University (HSREB# 105426). The
fresh tissues were transported to the lab in sterile phosphate buffered saline (PBS)
supplemented with 2% bovine serum albumin (BSA) on ice. Within 2 h of collection, the
adipose tissue was processed for either ASC isolation238 or decellularization253 following
established protocols. Processed DAT was pooled from multiple tissue donors for all
subsequent studies.
The human ASCs were cultured on T75 flasks (Corning, Fisher Scientific, Ottawa,
Canada) in proliferation medium (DMEM:Ham F12 (Wisent, St. Bruno, Canada)
supplemented with 10% fetal bovine serum (FBS) (Wisent, St. Bruno, Canada) and 100
U/mL penicillin and 0.1 mg/mL streptomycin ((1% pen-strep) (ThermoFisher, Waltham,
USA)).
To prepare the DAT scaffolds for cell culture, DAT samples were lyophilized and cut
into individual scaffolds having a mass of 8 ± 1 mg. The scaffolds were rehydrated in
deionized water, decontaminated through repeated rinsing in 70% ethanol, and finally
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washed in sterile PBS. Prior to seeding, the scaffolds were equilibrated in fresh
proliferation medium for 24 h.

3.3.3

Scaffold seeding and culture

ASCs were seeded at passage 3 at a density of 1 x 106 cells/scaffold by combining the
ASCs and individual DAT scaffolds in 3 mL of proliferation medium within a 15 mL
vented cap conical tube (CellTreat Scientific Products, Pepperell, USA). The samples
were cultured (37°C, 5% CO2) under agitation at 100 RPM for 24 h on an orbital shaker
at a 15° incline. Following seeding, the scaffolds were transferred into custom inserts 413
and cultured in proliferation medium for 14 days either statically in vented-cap conical
tubes or dynamically within a customized perfusion bioreactor system (Tissue Growth
Technologies, Instron) (Figure 2.1) under a flow rate of 0.5 mL/min. Hypoxic conditions
(2% O2/93% N2/5% CO2, 37°C) were maintained for all cultures using a tri-gas incubator
(ThermoFisher Forma Series II 3110).

3.3.4

ASC immunophenotype

After 14 days of dynamic or static culture on the DAT, multi-colour flow cytometry was
performed using a cell surface marker panel including CD90, CD29, CD26, CD34,
CD146, CD31 and CD45. To isolate the ASCs, 6 replicate scaffolds (n=6 pooled) from
each condition were pooled, finely minced and digested with Type IV collagenase (4
mg/mL, Gibco) diluted in sterile PBS at 37°C for 60 min. The scaffold digests were
filtered through a 40 µm nylon mesh filter and stained with calcein violet-AM
(BioLegend) for 25 min. The samples were then centrifuged at 500 xg for 7 min at 4°C
and stained with the antibody cocktail summarized in Table 3.1 (prepared in sterile PBS
supplemented with 5% FBS) for 30 min at 4°C. All antibodies were purchased from
BioLegend. Fluorescence minus one (FMO) controls for calcein violet-AM and all 7
antibodies were included for each cell donor prepared using ASCs cultured on tissue
culture polystyrene (TCPS). Single stain controls for all antibodies listed in Table 3.1
were included and performed with UltraComp eBeads (ThermoFisher).
The samples were analyzed with an LSR II Flow Cytometer (BD Biosciences) at the
London Regional Flow Cytometry Facility. A total of 1 x 105 events were collected per
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sample and a total of 3 trials were performed using ASCs from different donors (N=3).
Sample analysis and colour compensations were performed with FlowJo Software.
Gating was performed by first selecting single cells based on forward and side scatter.
Live cells were then selected based on calcein violet-AM staining using the 405 nm laser
with a 450/50 filter. Additionally, the CD31+ endothelial cell and CD45+ hematopoietic
cell populations were gated out using the 561 nm laser with the 780/60 filter. The CD31 CD45- population was then gated for both CD90 and CD29 using the 405 nm and 488 nm
lasers and the 610/20 and 530/30 filters, respectively. Finally, CD34 expression within
the CD90+CD29+ ASC population was analyzed with the 561 nm laser with the 610/20
filter, along with CD26 and CD146 expression using the 640 nm laser with the 670/30
and 780/60 filters, respectively.
Table 3.1 Antibody conjugations and dilutions used for the multi-colour flow
cytometry study.
Antigen Conjugation
Dilution Catalog Number
CD29
Alexa® Fluor 488
1:100
303015
CD90
Brilliant Violet 605 1:400
328128
CD31
PE-Cy7
1:200
303117
CD45
PE-Cy7
1:100
368531
CD26
APC
1:50
302709
CD34
PE-Dazzle 594
1:50
343533
CD146 APC-Fire750
1:50
361027

3.3.5

Immunohistochemical assessment of phenotypic markers in
ASCs cultured on DAT scaffolds in vitro

Immunohistochemical analysis was performed to assess the expression of inducible nitric
oxide synthase (iNOS), a marker associated with the immunomodulatory effects of
MSCs124,133,415, as well as arginase-1 (Arg-1) in the ASCs within the peripheral (< 200
µm from the scaffold edge) or central (> 200 µm from the scaffold edge) regions of the
DAT scaffolds cultured either dynamically or statically for 14 days. In addition, triple
staining was performed for Arg-1 with the pro-regenerative cytokine IL-10 and the proinflammatory cytokine tumour necrosis factor-α (TNFα). Primary and secondary
antibodies and dilutions used in these studies are summarized in Table 3.2.
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For both analyses, scaffolds (n=3) were fixed in 4% paraformaldehyde for 24 h at 4°C
before being embedded in paraffin and sectioned into 7 µm sections. The sections were
de-waxed in an ethanol series and heat-mediated antigen retrieval was performed with
Tris-EDTA buffer (10 mM tris base, 1 mM EDTA, 0.05% Tween-20, pH 9.0) for 25 min.
The sections were cooled for 25 min and then blocked with 5% BSA in PBS-T (0.1%
Tween 20) for 1 h at room temperature before being incubated with the primary
antibodies for (i) iNOS in combination with Arg-1 or (ii) Arg-1 in combination with
TNF-α and IL-10 at 4°C overnight. Next, the sections were washed three times for 5 min
with PBS, prior to being incubated with the appropriate secondary antibodies for 1 h at
room temperature. Mouse spleen and liver were used as tissue positive controls, and no
primary antibody controls were included in all trials.
Stained cross-sections were mounted in Fluoroshield Mounting Medium with DAPI
(Abcam, Cambridge, USA) and visualized with an EVOS® FL Cell Imaging System
(ThermoFisher). Positively-stained cells from 5 non-overlapping fields of view from both
the central and peripheral regions were quantified using ImageJ Software in 3 nonadjacent cross-sections taken at least 100 µm apart from each scaffold. A total of 3 trials
were performed with ASCs from different donors (N=3).
Table 3.2 Primary and secondary antibodies and dilutions used for immunostaining
in the in vitro studies.
Primary
Secondary
Primary antibody
Dilution
Secondary antibody
Dilution
Arg-1 (Millipore ABS535) 1:100
Goat anti-chicken Alexa® 488
1:200
(Abcam 150169)
iNOS (Abcam AB15323)
1:100
Goat anti-rabbit Alexa® 594
1:200
(Abcam 150080)
TNF-α (Abcam AB6671)
1:200
Goat anti-rabbit Alexa® 594
1:400
(Abcam 150080)
IL-10 (R&D AF519)
1:50
Donkey anti-goat Alexa® 680
1:100
(ThermoFisher 1871998)

3.3.6

Human Angiogenic Growth Factor RT2 Profiler PCR array

A Human Angiogenic Growth Factor RT2 PCR Profiler Array was performed to screen
for changes in gene expression of 84 different markers associated with angiogenesis
between the static and dynamic groups after 14 days of culture. A list of these genes can
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be found in Appendix Table A.1. For each trial, four replicate scaffolds seeded with
ASCs from the same donor were pooled, and a total of 4 trials were performed using
ASCs from different donors (n=4 scaffolds pooled/trial, N=4 trials with different ASC
donors). The scaffolds were frozen in liquid nitrogen, crushed with a mortar and pestle,
and resuspended in 1 mL of PureZol® (BioRad) and briefly sonicated 3 times in 4 second
bursts. mRNA was then isolated with the Aurum® Total RNA Mini kit (BioRad) and the
yield and purity were measured using a Nanodrop 1000 spectrophotometer
(ThermoFisher). cDNA was immediately synthesized with 400 ng of input RNA using an
RT2 First Strand Kit (Qiagen). The Human Angiogenic Growth Factor RT2 PCR Profiler
Array (Qiagen) was then prepared in accordance with the manufacturer’s protocols, with
all samples loaded in technical duplicates. Genes without consistent patterns of
amplification across the 4 ASC donors were excluded from further analysis. The
expression of the remaining genes of interest was normalized to a panel of housekeeping
genes (HGPRT, GAPDH, B2M). The 2-ΔCt values were expressed as a ratio
(dynamic/static) for each of the ASC donors, and the results were compared with a
multiple t-test, with a False Discovery Rate of 15%.

3.3.7

Human Magnetic Luminex® Assay

A Human Magnetic Luminex® Assay was performed to compare the protein expression
levels of TNF-α, IL-10, interleukin-6 (IL-6), hepatocyte growth factor (HGF), chemokine
C-X-C motif ligand 2 (CXCL-2) and chemokine C-X-C motif 10 (CXCL-10) between the
static and dynamic groups at 14 days, selected based on the PCR array data. For this
assay, 3 replicate scaffolds from each group (n=3) were analyzed with cells from a single
ASC donor, and a total of 5 trials were performed with different ASC donors (N=5). In
preparation for the Luminex® assay, the individual scaffolds were frozen in liquid
nitrogen, crushed with a mortar and pestle, and resuspended in a lysis buffer (50 mM
Tris-HCl, 100 mM NaCl, 10% glycerol, 1% Triton X-100, pH 7.4). The samples were
then briefly sonicated with ultrasonic dismembrator (ThermoFisher Model 100) and
centrifuged at 13,000 xg for 10 min at 4°C. The supernatant from each sample was then
analyzed with a Human Magnetic Luminex® Assay (R&D Systems), in accordance with
the manufacturer’s protocols. In brief, the protein samples were diluted 2-fold with the
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provided diluent solution (buffer RD6-52) before being loaded into a 96-well plate along
with the provided standards. Pre-mixed magnetic beads were then added and incubated
for 2 h at room temperature under constant agitation. The diluted biotin-antibody cocktail
was then added to each sample and incubated for 1 h at room temperature under constant
agitation before the Streptavidin-PE cocktail was added. The 96-well plate was then
assayed using a MAGPIX® System (Millipore). Protein concentrations were determined
based on comparison to the standard curves and normalized to the dsDNA content
measured in each sample using a PicoGreen® dsDNA Assay413, following the
manufacturer’s instructions.

3.3.8

Subcutaneous implantation surgeries

In vivo studies were performed to compare the effects of culturing the ASCs on the DAT
scaffolds for 14 days either statically or dynamically on the host cell response. All animal
studies followed Canadian Council on Animal Care (CCAC) guidelines and the protocols
were reviewed and approved by the Western University Animal Care Committee
(Protocol #2015-049). Female athymic nude mice (Nu-Foxn1nu) (Charles River
Laboratories, Sherbrooke, Canada) of 10 – 13 weeks of age were used for this study (N=6
mice per scaffold group/timepoint). Subcutaneous implantation surgeries were performed
in accordance with established protocols413. At 1, 4 and 8 weeks, the mice were sacrificed
by CO2 overdose and the scaffolds were excised within their surrounding tissues. The
samples were fixed in 4% paraformaldehyde at 4°C overnight before being embedded in
paraffin and sectioned (7 µm) for immunohistochemical analysis.

3.3.9

Immunohistochemical analysis of host cell recruitment

Immunostaining was performed to assess host cell infiltration into the scaffolds at 1, 4
and 8 weeks. More specifically, CD31 staining was performed to examine host
endothelial cell recruitment. In addition, co-staining was performed for CD26, a marker
that has been associated with highly proliferative multipotent progenitors that give rise to
preadipocytes in murine subcutaneous adipose tissue416, along with the human cell
marker Ku80384, to distinguish the host-derived CD26+ population. Finally, host immune
cell recruitment was characterized through triple staining for the pan-leukocyte marker
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CD45, the murine macrophage marker F4/80, and the phagocytic macrophage marker
CD68. The phenotype of the infiltrating macrophages was also probed by co-staining for
CD45 in combination with the pro-regenerative macrophage marker CD163358. Primary
and secondary antibodies and dilutions used in these studies are summarized in Table 3.3.
For each explanted scaffold, 3 non-adjacent cross-sections at least 100 µm apart were
analyzed.
Table 3.3 Primary and secondary antibodies and dilutions used for immunostaining
in the in vivo study.
Primary
Secondary
Primary antibody
Dilution Secondary antibody
Dilution
CD31 (Abcam ab28364)
1:100
Goat anti-rabbit Alexa® 594
1:200
(Abcam 150080)
Ku80 (Cell Signaling 2180)
1:200
Goat anti-rabbit Alexa® 594
1:400
(Abcam 150080)
CD26 (R&D AF954)
1:50
Donkey anti-goat Alexa® 680 1:100
(ThermoFisher 1871998)
CD45 (R&D AF114)
1:100
Donkey anti-goat Alexa® 680 1:200
(ThermoFisher 1871998)
CD68 (BioRad MCA1957)
1:100
Goat anti-rat Alexa® 488
1:200
(ThermoFisher A-11006)
F4/80 (Abcam 111101)
1:50
Goat anti-rabbit Alexa® 594
1:100
(Abcam 150080)
CD163 (Abcam ab182422)
1:200
Goat anti-rabbit Alexa® 594
1:400
(Abcam 150080)
For the staining, the cross-sections were dewaxed via ethanol series and subjected to
heat-mediated antigen retrieval in Tris-EDTA buffer for 25 min and cooled at room
temperature for 15 min. Sections were then washed and blocked in 5% BSA in PBS-T
(0.1% Tween-20) for 1 h at room temperature before being incubated in the appropriate
primary antibody cocktails (Table 3.3) diluted in the blocking solution at 4°C overnight.
Next, the sections were incubated with the corresponding secondary antibodies at room
temperature for 1 h before being mounted in Fluoroshield Mounting Medium with DAPI.
The stained sections were visualized with the EVOS® FL Cell Imaging System under
20X magnification. Quantification was performed within 10 randomly selected and nonoverlapping, non-adjacent fields of view in each section using ImageJ analysis software.
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3.3.10

Statistical analysis

All numerical values are represented as the mean ± standard deviation. Statistical
analyses were performed using GraphPad Prism® version 6 by paired t-test or two-way
ANOVA and followed with a Tukey’s post-hoc test. Differences were considered
statistically significant at p<0.05.

3.4 Results
3.4.1

Dynamic culturing did not affect the immunophenotype of the
ASCs on the DAT

Multi-colour flow cytometry was performed to compare the immunophenotype of the
ASCs that were cultured dynamically versus statically on the DAT scaffolds for 14 days.
Representative flow plots for a single donor are shown in Appendix Figure A.7. Flow
analysis of the cells that were enzymatically released from the scaffolds via collagenase
digestion indicated that there was no significant difference in the percentage of
CD90+CD29+ cells within the viable CD31-CD45- population between the static and
dynamic groups (Table 3.4). While donor-to-donor variability was observed, there were
no significant differences in the average expression levels of CD26, CD34 or CD146
within the CD90+ CD29+ population between the groups (Table 3.4). In general, these
findings suggest that dynamic culturing within the perfusion bioreactor did not
significantly alter the immunophenotype of the ASCs on the DAT.
Table 3.4 The percentage of live CD90+CD29+CD31-CD45- cells that were positive
for CD26+, CD34+ and CD146+ (n=6 scaffolds pooled, N=3 ASC donors).
CD90+CD29+CD31-CD45- (of viable cells)
CD90+CD29+CD31-CD45-CD26+
CD90+CD29+ CD31-CD45- CD34+
CD90+CD29+ CD31-CD45-CD146+

3.4.2

Static
Dynamic
77.2 ± 8.0 % 84.0 ± 1.4 %
76.9 ± 12.4 % 86.9 ± 1.7 %
37.4 ± 4.7 % 39.6 ± 9.8 %
27.8 ± 18.7 % 27.3 ± 13.9 %

Dynamic culturing of ASCs upregulated the expression of
iNOS in the peripheral regions of the DAT scaffolds

Immunostaining was performed to assess the expression of iNOS and Arg-1 in the ASCs
that were cultured statically or dynamically on the DAT scaffolds for 14 days. A high
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density of iNOS+ cells were visualized along the peripheral edges of the scaffolds in the
dynamic group (Figure 3.1A), with a smaller number throughout the central regions of
these scaffolds. In contrast, only low levels of iNOS+ cells were visualized in both
regions of the static culture group. Qualitative analysis of the Arg-1 staining patterns
showed that Arg-1+ cells were distributed throughout the central and peripheral regions of
the scaffolds in both the static and dynamic groups. Co-staining results suggested that
iNOS+Arg+ cells were present in both the static and dynamic groups (Figure 3.1A). While
relatively few iNOS+Arg+ cells were observed in the statically cultured scaffolds,
qualitatively more cells were visualized in the dynamic group, particularly along the
scaffold border (Figure 3.1A).
Quantification of the iNOS+Arg-1+DAPI+ cells in the central (> 200 µm from scaffold
edge) and peripheral (< 200 µm from scaffold edge) regions of the scaffolds was
performed. There was a significantly higher density of iNOS+Arg-1+DAPI+ cells in the
peripheral region of the dynamic scaffolds as compared to the central region in that
group, as well as both regions of the static group (Figure 3.1B). Analysis of the number
of iNOS+Arg-1+DAPI+ cells relative to the total DAPI+ cell population revealed that a
significantly higher percentage of the ASCs co-expressed iNOS and Arg-1 within the
peripheral region of the DAT scaffolds in the dynamic group (Figure 3.1C), suggesting
that culturing within the perfusion bioreactor altered the phenotype of the ASCs within
the scaffold periphery.
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Figure 3.1 Dynamic culture on the DAT for 14 days increased the co-expression of
iNOS and Arg-1 in the ASCs within the peripheral region of the scaffolds.
A) Representative immunostaining for Arg-1 (green) and iNOS (red) with DAPI (blue)
for the static and dynamic groups at 14 days. Dashed lines indicate the edge of the DAT
scaffolds. Scale bars represent 100 µm. B) The density of iNOS+Arg-1+DAPI+ cells and
C) the percentage of iNOS+Arg-1+DAPI+ cells relative to the total DAPI+ cell population
in the central and peripheral regions of the scaffolds cultured statically or dynamically.
Error bars represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with
different ASC donors). * = significant difference between the peripheral region of
dynamic group and all other groups (p<0.05).
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Further probing the expression levels of these functional markers, a significantly greater
density of iNOS+DAPI+ cells was present in the peripheral regions of the dynamic
scaffolds as compared to the central region in that group, as well as both the central and
peripheral regions of the static cultured scaffolds (Appendix Figure A.8A). When
assessed relative to the total DAPI+ cell population, the percentage of iNOS+DAPI+ cells
in the peripheral region of the dynamic group (33.2 ± 7.5%) was significantly different
than the central region of the static group (14.7 ± 7.3%) (Appendix Figure A.8B). Similar
to iNOS, a significantly greater density of Arg-1+DAPI+ cells was measured in the
peripheral regions of the dynamic scaffolds (Appendix Figure A.8C). In general, a high
percentage (>70%) of the ASCs within the DAT scaffolds expressed Arg-1 (Appendix
Figure A.8D).

3.4.3

Dynamic culture of ASCs on the DAT scaffolds in the
perfusion bioreactor altered angiogenic gene expression
patterns

To probe whether culturing within the perfusion bioreactor modulated angiogenic gene
expression in the ASCs cultured on the DAT scaffolds for 14 days, analysis with a
Human Angiogenic Growth Factor RT2 PCR Profiler Array was performed. Results
compiled from 4 ASC donors indicated that 33 of the 84 genes analyzed were
significantly different between the ASCs that were cultured dynamically versus statically
on the DAT, including a variety of pro-angiogenic cytokines and growth factors, several
ECM proteins, and a range of other signaling proteins implicated in angiogenesis (Figure
3.2). Of these genes, 24 were up-regulated and 9 were down-regulated in the dynamic
group as compared to the static group.
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Figure 3.2 Dynamic culture alters the angiogenic gene expression profile of ASCs
cultured on DAT scaffolds for 14 days. Fold regulation (Dynamic/Static) of the 33
genes on the PCR array that were significantly up- (green) or down- (red) regulated in the
ASCs cultured dynamically versus statically. Statistical significance was determined via a
multiple T-test (false discovery rate = 15%). Error bars represent standard deviation (N=4
trials with different ASC donors).
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3.4.4

Dynamic culture alters the paracrine factor expression profile
of the ASCs on the DAT scaffolds

To further probe whether dynamic culture altered the expression of a range of secreted
pro-angiogenic and immunomodulatory factors in the ASCs on the DAT scaffolds, a
custom Luminex® assay was performed to compare the protein expression levels of
IL-10, TNF-α, HGF, CXCL-10, IL-6 and CXCL-2 in cell lysates from the static and
dynamic groups after 14 days of culture. These factors were selected based on the PCR
array results, as well as their known biological functions that may be important in the
context of adipose tissue regeneration within the DAT. Consistent with the gene
expression results, the protein expression levels of IL-10, CXCL-10, and HGF were
significantly higher, and IL-6 expression was significantly lower, in the dynamic group as
compared to the static group (Figure 3.3A, C, D, F). In contrast to the PCR results, no
significant differences were observed in the protein expression levels of the
pro-inflammatory cytokine TNF- (Figure 3.3B) or the pro-inflammatory chemokine
CXCL-2 (Figure 3.3E) between the groups.

Figure 3.3 Dynamic culture within the perfusion bioreactor alters pro-angiogenic
and immunomodulatory protein expression in the human ASCs cultured on the
DAT scaffolds over 14 days. Expression of A) IL-10, B) TNF-α, C) CXCL-10, D) HGF,
E) CXCL-2 and F) IL-6 as measured by Human Magnetic Luminex® Assay normalized
to total dsDNA content. Error bars represent standard deviation (n=3 technical replicate
scaffolds/trial, N=5 trials with different ASC donors). * = significant difference between
static and dynamic groups (p<0.05; paired t-test).
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3.4.5

Dynamic culture increased the number of ASCs expressing
TNF-α and IL-10 in the DAT scaffolds at 14 days

Immunostaining was performed for Arg-1 in combination with TNF-α and IL-10 to
assess whether dynamic culture modulated the presence and distribution of ASCs
expressing these cytokines. A high density of Arg-1+, TNF-α+ and IL-10+ cells were
observed within the peripheral regions of the DAT scaffolds in the dynamic group
(Figure 3.4A). A qualitatively smaller number of cells positive for each of these markers
was observed in the central region of the dynamic group, as well as within both regions
of the static group.
Quantification of the TNF-α+DAPI+ and IL-10+DAPI+ cell populations in the central
(> 200 µm from scaffold edge) and peripheral (< 200 µm from scaffold edge) regions of
the scaffolds was performed. Similar expression patterns were observed for both TNF-α
(Figure 3.4B) and IL-10 (Figure 3.4C), with a significantly greater density of positive
cells in the peripheral region of the scaffolds in the dynamic group as compared to all
other regions. In addition, the TNF-α+DAPI+ and IL-10+DAPI+ cell densities were
significantly greater in the central region of the dynamic group as compared to the central
region of the static group. When expressed as a percentage of the total DAPI + cell
population, a higher percentage of cells were TNF-α+ in the peripheral region of the
scaffolds in the dynamic group versus the static group (Appendix Figure A.9A). In
contrast, no significant differences were observed in the percentage of IL-10+ cells in
either group (Appendix Figure A.9B).
Quantification also revealed that the Arg-1+TNF-α+IL-10+DAPI+ cell density was
significantly higher in the peripheral region of the dynamic group as compared to all
other regions (Figure 3.4D). Further, the percentage of TNF-α+IL-10+DAPI+ cells
(Appendix Figure A.9C) and Arg-1+TNF-α+IL-10+DAPI+ cells (Appendix Figure A.9D)
relative to the total DAPI+ cell population was significantly higher in the peripheral
regions of the DAT scaffolds in the dynamic group as compared to the static group,
suggesting that culturing in the perfusion bioreactor increased the relative number of
ASCs that were expressing both TNF-α and IL-10, and the majority of these cells were
also Arg-1+.
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Figure 3.4 Dynamic culture increased the density of TNF-α+ and IL-10+ human
ASCs in the peripheral region (< 200 µm from scaffold edge) of the DAT scaffolds
that were cultured in the perfusion bioreactor for 14 days. A) Representative
immunostaining showing Arg-1 (green), TNF-α (red) and IL-10 (cyan) expression with
DAPI counterstaining (blue) for the static and dynamic groups. Dashed lines indicate the
edge of the DAT scaffolds. Scale bars represent 100 µm. The B) TNF-α+DAPI+,
C) IL-10+DAPI+ and D) Arg-1+TNF-α+IL-10+DAPI+ cell density in the central and
peripheral regions of the DAT scaffolds in both the static and dynamic groups. Error bars
represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with different ASC
donors). * = significant difference between the peripheral region of the dynamic group
and all other regions, # = significant difference between the central region of the dynamic
and static groups (p<0.05).
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3.4.6

Dynamic culture of ASCs on the DAT enhanced CD31 +
endothelial cell recruitment into the scaffolds following
implantation in the nu/nu mouse model

Following the in vitro characterization, in vivo studies were performed to probe how
dynamic culture of the ASCs on the DAT modulated their capacity to stimulate the
recruitment of a range of host cell populations into the DAT scaffolds at 1, 4 and 8 weeks
post-implantation. Given the importance of angiogenesis in adipose tissue
regeneration328, the initial characterization focused on immunohistochemical staining to
assess the presence and distribution of CD31+ endothelial cells within the implants.
CD31+ vessels were observed within the implants at 1, 4 and 8 weeks in both the static
and dynamic groups. At the 8-week timepoint, there were qualitatively more CD31+ cells
within the DAT implants in the dynamic group as compared to the static culture group,
with some forming larger lumen structures (Figure 3.5A). Quantification of the staining
confirmed that the CD31+ cell density was significantly greater in the dynamic group as
compared to the static group at all timepoints (Figure 3.5B).
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Figure 3.5 Dynamic culture of ASCs on the DAT scaffolds enhanced CD31+ cell
recruitment following implantation in the nu/nu mouse model. A) Representative
immunostaining showing CD31 (red) with DAPI counterstaining within the DAT
implants for both the static and dynamic groups at 1, 4 and 8 weeks. Scale bars represent
100 µm. B) CD31+DAPI+ endothelial cell density in the implants. Error bars represent the
standard deviation (n=3 cross-sections/implant, N=6 implants/group). * = significant
difference relative to the static group at 1, 4 and 8 weeks, # = significant difference
relative to the static group at 1 and 8 weeks (*=p<0.05).
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3.4.7

Dynamic culture of ASCs on the DAT scaffolds enhanced
the recruitment of CD26+ host cells at 1 week
post-implantation in the nu/nu mouse model

Co-staining was performed for CD26 with human-specific Ku80 to probe host CD26+
cell infiltration into the implants at 1, 4 and 8 weeks, as a potential marker of multipotent
progenitor cells that can give rise to preadipocytes and adipocytes416. Qualitatively, the
staining results showed a high density of CD26+ cells in the dynamic group at 1 week
(Figure 3.6A). The Ku80+ human ASCs were distributed throughout the scaffolds in both
the static and dynamic groups at all three timepoints, with CD26+Ku80+ cells observed
(Figure 3.6A). Quantification of the CD26+Ku80-DAPI+ cell population indicated that
there was a significantly higher density of CD26+ host cells in the DAT implants within
the dynamic group as compared to the static group at 1 week (Figure 3.6B).
The Ku80+DAPI+ and CD26+Ku80+DAPI+ human ASC populations were also quantified
within the implants. Consistent with our previous work that demonstrated that dynamic
culture under 2% O2 within the perfusion bioreactor promoted human ASC expansion on
the DAT413, the Ku80+DAPI+ cell density was significantly higher in the dynamic group
relative to the static group at 1 week (Appendix Figure A.10A). However, the number of
human ASCs detected in the dynamic group was diminished at the later timepoints, with
no significant differences observed in the Ku80+DAPI+ cell density between the static
and dynamic groups at 4 or 8 weeks (Appendix Figure A.10A), similar to our previous
findings413. The percentage of the human ASCs within the DAT implants that expressed
CD26 also declined over time, with a significant decrease from 1 to 8 weeks, and no
significant differences observed between the static and dynamic groups at any of the
timepoints (Appendix Figure A.10B)
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Figure 3.6 Dynamic culture of human ASCs on the DAT scaffolds enhanced the
recruitment of CD26+ host cells at 1 week post-implantation in the nu/nu mouse
model. A) Representative immunostaining of CD26 (green) in combination with humanspecific Ku80 (red), with DAPI counterstaining (blue) at 1, 4 and 8 weeks. Scale bars
represent 50 µm. B) CD26+ host cell (CD26+Ku80-DAPI+) density within the DAT
implants at 1, 4 and 8 weeks. Error bars represent standard deviation (n=3
cross-sections/implant, N=6 implants/group). * = significant difference between the static
and dynamic groups at 1 week (p<0.05).
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3.4.8

Dynamic culture of ASCs on the DAT scaffolds did not alter
host macrophage recruitment following implantation in the
nu/nu mouse model

To probe host macrophage infiltration into the DAT implants over time, immunostaining
was performed for CD45 as a pan-leukocyte marker in combination with F4/80 as a
marker of mature murine macrophages and CD68 as a marker of phagocytic macrophages
(Figure 3.7A). Qualitatively, a high density of CD45+, F4/80+ and CD68+ cells was
observed within the DAT implants in both the static and dynamic groups at 1 week
(Figure 3.7A), 4 weeks (Appendix Figure A.11) and 8 weeks (Appendix Figure A.12)
post-implantation. Furthermore, CD45+, F4/80+ and CD68+ cells were also observed in
the fibrous capsules surrounding the implanted DAT at all three timepoints.
Quantification of the CD45+F4/80+CD68+DAPI+ cell density at 1, 4 and 8 weeks
indicated that there were no significant differences between the static and dynamic
groups at any of the timepoints (Figure 3.7B). However, a significant decline was
observed in the dynamic group from 1 week to 8 weeks. Analysis of the percentage of
CD45+ cells that co-expressed both F4/80 and CD68 within the total CD45+DAPI+ cell
population in the DAT implants indicated that the majority (>90%) of the CD45 + cells
were F4/80+CD68+ at 1 and 4 weeks, but a significant decline in this subpopulation was
observed for both groups at 8 weeks (Figure 3.7C).
Individual analysis of the CD45+F4/80+DAPI+ (Appendix Figure A.12A) and
CD45+CD68+DAPI+ (Appendix Figure A.12B) populations as a percentage of the total
CD45+DAPI+ population within the implants confirmed that a high percentage (>90%) of
the CD45+ population expressed these macrophage markers at 1 and 4 weeks. However a
significant decline in the relative expression of F4/80 was observed in the static group at
8 weeks as compared to both the dynamic and static groups at 1 and 4 weeks, and a
significant decline in the relative expression of CD68 was observed in both groups at 8
weeks as compared to both groups at the earlier timepoints (Appendix Figure A.12).
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Figure 3.7 The recruitment of CD45+F4/80+CD68+ macrophages was similar in both
the dynamic and static cultured ASC-seeded DAT scaffolds in the nu/nu mouse
model. A) Representative images showing CD45 (cyan), F4/80 (red) and CD68 (green)
expression with DAPI counterstaining (blue) at 1 week. Scale bars represent 100 µm.
B) CD45+F4/80+CD68+DAPI+ cell density in the static and dynamic groups. C) The
percentage of CD45+F4/80+CD68+DAPI+ cells relative to the total CD45+DAPI+ cell
population at 1, 4 and 8 weeks. Error bars represent the standard deviation (n=3
cross-sections/implant, N=4 implants/group). * = significant difference between the
dynamic group at 1 and 8 weeks, # = significant difference between the indicated group
and both the static and dynamic groups at 1 and 4 weeks (p<0.05).
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3.4.9

Dynamic culture of ASCs on the DAT scaffolds modulated
macrophage phenotype within the implants in the nu/nu
mouse model

To probe the macrophage phenotype within the implants, co-staining was performed for
the pan-leukocyte marker CD45 with the pro-regenerative macrophage marker CD163.
CD45+CD163+ cells were observed in the fibrous capsules at the periphery of the
implants at all three timepoints (Figure 3.8A). Interestingly, while CD45 + cells were
observed infiltrating the implants at 1, 4 and 8 weeks, very few CD45 +CD163+ cells were
visualized within the scaffolds, with the exception of the dynamic group at 8 weeks,
which showed a relatively high density of infiltrating CD45+CD163+ cells (Figure 3.8A).
The density of CD45+CD163+DAPI+ cells was quantified within the implanted scaffolds,
excluding the fibrous capsule. The analysis confirmed that there were significantly more
CD45+CD163+DAPI+ cells within the DAT implants in the dynamic group at 8 weeks as
compared to 1 and 4 weeks, as well as the static group at all three timepoints (Figure
3.8B). Additionally, the percentage of CD45+DAPI+ cells that were also CD163+ was
significantly greater in the dynamic group at 8 weeks (47.3 ± 6.5 %) as compared to all
other conditions, supporting that there was a shift in macrophage phenotype in this group
over time (Figure 3.8C).
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Figure 3.8 Dynamic culture of human ASCs on the DAT scaffolds enhanced the
expression of the pro-regenerative macrophage marker CD163 in the CD45+ host
cell population at 8 weeks post-implantation in the nu/nu mouse model.
A) Representative images showing CD45 (green), CD163 (red) and DAPI (blue). Scale
bars represent 100 µm. White arrowheads showing examples of CD45 +CD163+ cells.
Dashed lines indicate the border between the fibrous capsule (top) and the DAT implant
(bottom). B) CD45+CD163+DAPI+ cell density within the DAT implants. C) The
percentage of CD45+CD163+DAPI+ cells relative to the total CD45+DAPI+ population.
Error bars represent standard deviation (n=3 cross-section/implant, N=6 implants/group).
* = significant difference between the dynamic group at 8 weeks and all other conditions,
# = significant difference between the static group at 1 week and the static and dynamic
groups at both 4 and 8 weeks (p<0.05).
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3.5 Discussion
Culturing human ASCs on the DAT scaffolds within the perfusion bioreactor system
under 2% O2 over 14 days was previously shown to markedly enhance in vivo
angiogenesis and adipogenesis following subcutaneous implantation in the nu/nu mouse
model413. The enhanced regeneration of host-derived adipose tissue was likely attributed
in part to the fact that culturing within the bioreactor promoted the expansion of the
human ASCs on the DAT, resulting in an estimated 2.2-fold increase in the number of
ASCs delivered relative to the 2% O2 static culture group that was included in the current
study413. However, a growing body of evidence suggests that culturing under shear stress
can also induce functional and phenotypic changes in MSC populations that may
influence their capacity to stimulate regeneration289–291. As such, the focus of the current
study was on assessing whether there were differences in the phenotype and paracrine
function of the ASCs on the DAT following 14 days of culture under 2% O2 within the
bioreactor or under static conditions.
Flow cytometry analyses indicated that there were no significant differences in the
immunophenotype of the ASCs cultured on the DAT in the static and dynamic groups.
Interestingly, the expression levels of the markers analyzed were more similar to those
reported for P0 or P1 ASCs as compared to P3 ASCs expanded on 2-D TCPS417,
suggesting that culturing on the DAT may have modulated ASC surface marker
expression. In particular, while cell donor variability was observed, an average of ~40%
of the CD90+CD29+ cell population was CD34+, a marker that has been associated with
pro-angiogenic functionality in MSC populations418. Previous studies have shown that
CD34 is expressed on ~25% of the CD45- cells within the stromal vascular fraction
(SVF) of adipose tissue84, but that its expression rapidly diminishes following in vitro
culture such that <5% of P3 ASCs are CD34+417. Similarly, the CD146 expression levels
were more similar to those reported for P0 ASCs than the ~5% reported at passage 3417.
While CD146 is often regarded as a pericyte marker419, its expression within ASC
populations in humans has also been associated with enhanced pro-angiogenic
function420.

96

In addition, Arg-1 was found to be highly expressed in the ASCs cultured on the DAT
scaffolds in both groups. Arg-1 is an enzyme that is commonly used as a marker of proregenerative macrophage polarization421, which functions in breaking down L-arginine to
generate urea422. iNOS also utilizes L-arginine as a substrate to generate nitric oxide
(NO), and as such, Arg-1 can regulate iNOS activity422. In the present study, iNOS
expression was enhanced in the ASCs within the peripheral region of the DAT scaffolds
in the dynamic group. While the difference in the iNOS+ cell density can be attributed in
part to the overall higher density of ASCs in that region of the dynamic group 413, the fact
that a significantly higher fraction of the total cell population was iNOS +Arg-1+ suggests
that the shear stress stimulation may have altered the ASC phenotype in the dynamic
group. Interestingly, previous studies have shown that iNOS expression is critical for the
pro-regenerative immunomodulatory function of MSCs124,133,149.
As a first step in probing the effects of dynamic culture on ASC function, the qPCR array
identified 33 genes associated with angiogenesis that were differentially expressed
between the dynamic and static groups. Mechanical stimulation through intermittent fluid
flow has been previously reported to increase the production of pro-angiogenic factors
including VEGFA, HGF, follistatin and leptin in cultured human ASCs423. Further, shear
stress has been shown to enhance FGF2 gene expression in human umbilical vein
endothelial cells424, as well as downregulate VEGF expression in cultured human
umbilical veins425. In addition to activation of mechanotransduction pathways through
dynamic culture, other factors that may have influenced the alterations in the gene
expression patterns between the groups include the cell density, as well as a cascading
effect of altered levels of other growth factors or cytokines. For example, elevated levels
of TNF-α have been shown to induce the expression of chemokines including CXCL10 in
human endothelial and smooth muscle cells426,427. Likewise, the enhanced expression of
HGF was found to decrease IL-6 and increase IL-10 expression in lipopolysaccaride
(LPS)-induced macrophages in vitro and in interstitial macrophages in C57BL/6J mice428.
To further assess whether culturing within the bioreactor modulated the paracrine profile
of the ASCs on the DAT, a multiplex Luminex assay was performed to characterize the
expression levels of a subset of factors selected from the PCR array that are known to
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have the capacity to modulate various processes involved in soft tissue regeneration.
IL-10 expression, which has been shown to promote a more pro-regenerative macrophage
phenotype135,429 and downregulate the expression of pro-inflammatory cytokines in
immune cell populations140,430, was significantly enhanced in the dynamic group,
consistent with the gene expression results. In addition, the macrophage chemoattractant
CXCL-10431, as well as the pro-angiogenic factor HGF115, were also detected at
significantly higher levels in the lysates from the dynamic group. HGF can regulate
endothelial cell survival, proliferation and migration114, as well as endothelial tube
formation115. As such, the enhanced expression of this factor may have played a role in
the increased CD31+ cell recruitment observed in the in vivo model. Further, HGF has
also been shown to have immunomodulatory effects on monocytes and macrophages,
promoting a more pro-regenerative response432,433. Also consistent with the gene
expression results, the expression of IL-6, which is known to promote the proinflammatory polarization of monocytes143,144, was significantly down-regulated in the
dynamic group. In contrast to the gene array results, no significant differences were
observed in the protein expression levels of the pro-inflammatory factors CXCL-2 or
TNF-α within the lysates between the static and dynamic groups.
In contrast to the Luminex findings, the immunohistochemical analyses demonstrated
that a significantly higher fraction of the ASCs in the peripheral region of the DAT
scaffolds in the dynamic group expressed TNF-α relative to this same region in the static
group, suggesting that the shear stress stimulation may have promoted the localized
production of this factor. In addition, a significantly higher fraction of the ASCs in the
peripheral region of the DAT in the dynamic group co-expressed both pro-inflammatory
TNF-α and pro-regenerative IL-10, consistent with the mixed phenotype observed in the
analysis of Arg-1 and iNOS expression. Although TNF-α and other pro-inflammatory
factors are often regarded negatively for their association with chronic inflammation and
disease434,435, it is becoming increasingly recognized that inflammation plays an
important role in stimulating angiogenesis and tissue regeneration 131,436. As such, the
locally enhanced expression of TNF-α may have been a mediating factor in the markedly
increased host-derived adipose tissue regeneration in the dynamic group413.
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Building from the in vitro findings, in vivo studies were subsequently performed to
further investigate whether dynamic culture on the DAT altered the capacity of the
human ASCs to stimulate regeneration via paracrine-mediated mechanisms by assessing
the effects on host cell recruitment. While there was a significantly higher density of
human ASCs within the scaffolds in the dynamic group at 1 week post-implantation,
there was no difference in human cell retention between the groups at either 4 or 8 weeks,
consistent with our previous findings413. While the higher initial cell dose delivered in the
dynamic group may have influenced the response, the in vitro characterization studies
support that there were also differences in the phenotype and secretome of the ASCs
within the DAT that could have impacted regeneration.
As a measure of angiogenesis within the implants, CD31+ endothelial cell recruitment
was significantly enhanced in the dynamic group at 1, 4, and 8 weeks. These findings are
consistent with previous Masson’s trichrome staining results that showed a significant
increase in the density of erythrocyte-containing blood vessels in the DAT implants in the
dynamic group at 4 and 8 weeks413. However, it is also possible that other nonendothelial CD31+ cell populations, such as certain macrophage subsets437, could also be
present in the scaffolds and contributing to the higher density observed in the dynamic
group.
The infiltration of host-derived CD26+ cells was also probed. Recent studies have shown
that CD26, also known as dipeptidylpeptidase IV (DPPIV), can be associated with an
adipocyte precursor phenotype375,416. More specifically, a study by Merrick et al.
demonstrated that a CD26+ interstitial progenitor population within adipose tissue could
give rise to an intermediate population that was committed to the adipogenic lineage and
could differentiate into mature adipocytes in vivo416. Notably, CD26 expression was
down-regulated as the progenitor cells began to differentiate416. In the present study, the
higher density of host-derived CD26+ cells observed at 1 week post-implantation may
indicate that there was enhanced adipogenic progenitor cell recruitment in the dynamic
group, contributing to the previously-characterized increased presence of host-derived
adipocytes within this implant group at 8 weeks413. However, it is important to note that
CD26 can also be expressed by other cell populations. For example, CD26 has been
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associated with a more pro-fibrotic phenotype in fibroblast populations438. In addition,
CD26 can be expressed on immune cells including dendritic cells 439,440, macrophages440,
and natural killer cells441. As such, further studies are required to more fully characterize
the CD26+ cells and determine more conclusively whether there is a link between this
population and the enhanced adipogenesis observed in this group.
Macrophages have been indicated to play an important role in mediating both
angiogenesis and adipose tissue regeneration within ECM-derived bioscaffolds169,442,443.
As such, the effects of dynamic culture on host macrophage recruitment were probed
through co-staining for CD45, F4/80 and CD68, which showed no significant differences
in terms of cell densities between the groups at any of the timepoints. These findings are
similar to previous studies showing that seeding the DAT with allogeneic ASCs did not
significantly impact the CD68+ macrophage density within the implants in an
immunocompetent rat model over 12 weeks relative to unseeded controls 169. Further,
similar to the previous results169, a high density of macrophages was observed within the
DAT implants in both groups at all time points. Interestingly, within the CD45 + cell
population there was an increased percentage of cells that were F4/80 - and CD68- within
both implant groups at 8 weeks. These cells may be other macrophage subpopulations or
dendritic cells that do not express these markers444, or potentially natural killer cells445.
However, further analyses using additional markers would be required to more fully
characterize the CD45+F4/80-CD68- cell population and assess their potential effects
within the implants.
While there was no difference in total macrophage recruitment, analysis of CD163
expression in the CD45+ cell population suggested that there was a shift in macrophage
phenotype at 8 weeks in the dynamic group. CD163 is a hemoglobin scavenger receptor
found on macrophage subpopulations446 that is upregulated by IL-10 and suppressed by
pro-inflammatory mediators such as TNF-α447,448. The expression of CD163 in
macrophages has been associated with a more pro-regenerative phenotype that is
involved in both angiogenesis and ECM remodeling351. In the previous
immunocompetent rat model, seeding the DAT with allogeneic ASCs was shown to
enhance the fraction of CD163+ cells within the implants relative to unseeded controls at
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both 8 and 12 weeks, which also showed significantly greater remodeling into hostderived adipose tissue169. As such, the infiltrating CD163+ macrophages may have
contributed to the enhanced adipose tissue regeneration that was previously reported in
the DAT implants that were cultured for 14 days under 2% O2 prior to implantation413.

3.6 Conclusions
The findings of the current study support that in addition to promoting cell expansion,
dynamic culture of human ASCs on the DAT scaffolds within the perfusion bioreactor
under 2% O2 altered their phenotype and paracrine profile relative to controls cultured
under static conditions. Interestingly, a fraction of the ASCs within the peripheral region
of the DAT implants in the dynamic group were shown to exhibit both pro-inflammatory
and anti-inflammatory characteristics, co-expressing iNOS and Arg-1, as well as both
TNF- and IL-10. Moreover, shear stress stimulation was shown to modulate the
expression of a range of genes and proteins associated with the immunomodulatory and
pro-angiogenic paracrine functionality of MSCs. These findings suggest that culturing
within the perfusion bioreactor system may pre-condition the ASCs, altering their
capacity to stimulate regeneration via paracrine-mediated mechanisms. Analysis in the in
vivo model indicated that culturing within the bioreactor prior to implantation enhanced
the recruitment of CD31+ endothelial cells, as well as CD26+ host cells, into the implants,
which may have contributed to the enhanced angiogenesis and adipogenesis previously
observed in this group. While there was no significant difference in total macrophage
recruitment between the groups based on analysis of F4/80 and CD68 expression, greater
infiltration of CD163+ macrophages was observed in the dynamic group at 8 weeks,
indicative of a shift towards a more pro-regenerative macrophage response. Future
studies should focus on de-coupling the effects of increased initial cell density versus
altered cell function in modulating the host response. Overall, the findings support the
further investigation of shear stress stimulation as a means to pre-condition ASCs and
enhance their capacity to stimulate angiogenesis and tissue regeneration through indirect
mechanisms.
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Chapter 4

4

Development of a rocking bioreactor system for the
dynamic culture of adipose-derived stromal cells on
decellularized adipose tissue coatings

4.1 Abstract
The development of bioreactor systems for promoting the expansion of pro-regenerative
cell populations is of significant interest in the fields of tissue engineering and
regenerative medicine. The mechanical stimulation that can be induced by dynamic
culture can modulate cell phenotype and function, including paracrine factor secretion.
The focus of this work was on the preliminary exploration of a novel rocking bioreactor
system that incorporated coatings derived from tissue-specific extracellular matrix
(ECM) as a dynamic preconditioning strategy for human adipose-derived stromal cells
(ASCs). More specifically, the studies compared the response of ASCs seeded on fibrous
coatings fabricated from human decellularized adipose tissue (DAT) or uncoated controls
and cultured either dynamically on the rocking platform or statically for up to 7 days.
Analysis of the ASC immunophenotype through multi-colour flow cytometry showed
that dynamic culture on the DAT coatings significantly enhanced the expression of
CD146 in the CD90+CD29+ ASC population compared to all other conditions. Further,
pilot study results indicated that dynamic culture on the DAT coatings stimulated the
expression of inducible nitric oxide synthase (iNOS) and promoted cell alignment at 7
days, suggesting that there was a change in cell phenotype in this group. Analysis of the
expression of a range of pro-regenerative gene markers through a custom qPCR array
identified no significant differences between the groups, suggesting that the dynamic
culture conditions require further optimization. Collectively, these studies provide initial
support for the further exploration of this new rocking bioreactor system incorporating
the DAT coatings as a potential strategy to modulate the pro-regenerative capacity of
human ASCs through cell expansion under dynamic conditions.
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4.2 Introduction
The repair of damaged and deficient subcutaneous adipose tissue remains a significant
clinical challenge in the fields of plastic and reconstructive surgery, and there is a clear
need for new approaches that stimulate the regeneration of healthy host-derived adipose
tissue and support long-term volume augmentation18,377. Recent advances in adipose
tissue engineering have shown that combining tissue-specific bioscaffolds with
regenerative cell populations may be a promising strategy for this clinical
application169,170,255,258,259,449.
Research in the Flynn lab has focused on the development of a broad range of bioscaffold
formats derived from decellularized adipose tissue (DAT), including 3-D scaffolds253,
foams227, microcarriers257, coatings385 and hydrogels255. These unique adipose-derived
bioscaffolds have been shown to provide a highly supportive microenvironment for the
adipogenic differentiation of human adipose-derived stromal cells (ASCs) in culture253–
255,257,260,385

. Moreover, DAT scaffolds seeded with allogeneic ASCs stimulated host-

derived adipose tissue regeneration within the implants when delivered subcutaneously in
immunocompetent Wistar rats169,255.
Building from this work, a scaffold-based perfusion bioreactor system was developed
with the goal of promoting human ASC expansion and infiltration on the DAT
scaffolds413. Dynamic culture of the ASCs on the DAT scaffolds within the perfusion
bioreactor under 2% O2 for 14 days was shown to enhance ASC proliferation relative to
bioreactor culture under 20% O2 and static culture controls413. Further, when implanted
subcutaneously in an athymic mouse (nu/nu) model, angiogenesis and adipogenesis were
markedly enhanced in the ASC-seeded scaffolds that had been cultured within the
bioreactor for 14 days under 2% O2 prior to implantation413. Subsequent studies in
Chapter 3 of this thesis supported that in addition to promoting ASC expansion, dynamic
culture on the DAT scaffolds within the bioreactor modulated the ASC phenotype and
paracrine factor secretion profile.
While the pro-regenerative effects were promising, scaling up the perfusion bioreactor
system to be able to generate scaffolds of sizes suitable for clinical applications in
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humans would be a significant challenge. In particular, ASCs cultured within this system
were found in higher density along the periphery of the DAT scaffolds, suggesting that
there was limited medium perfusion into the central regions of the DAT scaffolds 413. In
these previous studies, an integrated approach was applied in which the ASCs were
expanded on the same DAT scaffolds on which they would be delivered. The findings
suggest that a better strategy may be to develop separate platforms for ASC expansion
and delivery that would be more readily scalable. Focusing on the ASC expansion
platform, rocking bioreactor systems are an interesting alternative, as they have been
successfully applied for the culture of embryonic stem cells (ESCs) 450, human bone
marrow-derived mesenchymal stromal cells (MSCs)451, dermal fibroblasts452 and
lymphocytes453. These systems leverage gravity to drive an oscillating fluid motion that
ensures thorough mixing of the media and applies shear stress to the cells in culture 451.
This shear stress stimulation has the potential to promote cell expansion 454 and modulate
cell phenotype including paracrine function451.
The focus of this study was to perform a preliminary assessment of a novel rocking
bioreactor system as a new approach for the dynamic preconditioning of human ASCs.
Recognizing the innate cell-instructive capacity of the extracellular matrix (ECM) 256,260,
the effects of incorporating fibrous DAT coatings (~150 m thick) as a substrate within
this system were explored. In contrast to conventional culture on tissue culture
polystyrene (TCPS), the DAT coatings have a complex ECM ultrastructure and
mechanical properties (Young’s modulus ~40 kPa) more similar to native tissues 385.
Further, culturing human ASCs on the DAT coatings was shown to significantly enhance
their expansion and adipogenic differentiation under static culture conditions relative to
similar collagen-based coatings and uncoated TCPS controls385. In the current study,
human ASCs were seeded onto the DAT coatings or uncoated controls and cultured for
up to 7 days either dynamically on the rocking platform or statically under 2% O 2,
selected based on the previous perfusion bioreactor studies413. Multi-colour flow
cytometry was performed to characterize the ASC immunophenotype after 7 days of
culture. Immunohistochemical analyses assessed the effects of dynamic culture on the
ASC morphology and expression of inducible nitric oxide synthase (iNOS), a marker
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associated with immunomodulatory function in MSCs124,133,415. Finally, gene expression
analyses were conducted using a custom-made qPCR array to probe for changes in the
expression levels of a range of markers associated with soft tissue regeneration between
the groups.

4.3 Methods
4.3.1

Materials

Unless otherwise stated, all materials were purchased from Sigma Aldrich Canada Ltd.
(Oakville, Canada), and all antibodies for immunostaining were purchased from Abcam
(Cambridge, USA).

4.3.2

Human ASC isolation and DAT coating fabrication

Human adipose tissue was processed to either isolate ASCs238 or decellularized253 using
published methods. In brief, surgically discarded adipose tissue was collected with
informed consent from the University Hospital and St. Joseph’s Hospital in London,
Canada and transported to the laboratory in sterile phosphate buffered saline (PBS) with
2% bovine serum albumin (BSA) on ice. The protocols for this study were reviewed and
approved by the Human Research Ethics Board at Western University (REB# 105426).
The ASCs were cultured (37°C, 5% CO2) in proliferation medium comprised of
DMEM:Ham’s F12 (Wisent, St. Bruno, Canada) supplemented with 10% fetal bovine
serum (FBS) (Wisent, St. Bruno, Canada) and 100 U/mL penicillin and 0.1 mg/mL
streptomycin (1% pen-strep) (ThermoFisher, Waltham, USA). The cells were frozen at
passage 1 (P1) until ready for use.
Decellularized tissues from multiple donors were pooled and fabricated into DAT
coatings based on published work385. Briefly, the DAT was finely minced and cryomilled prior to decontamination through rinsing in 70% ethanol overnight under constant
agitation at room temperature. The milled DAT was then rinsed in PBS (3 x 15 min) and
digested with α-amylase (3% w/v in 0.25 M NaH2PO4) at room temperature under
constant agitation at 300 RPM for 3 days. The digested samples were then washed in 5%
NaCl (w/v in deionized H2O) for 10 min, resuspended at a concentration of 25 mg
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DAT/mL in 0.2 M acetic acid, and homogenized (PowerGen Model 123 homogenizer,
Fisher Scientific, Ottawa, Canada) to generate a DAT suspension. The DAT suspension
was plated in 4-well rectangular plates (ThermoFisher) at a volume of 3 mL per well and
air dried at room temperature within a biological safety cabinet overnight. For
immunohistochemical characterization studies, rectangular glass coverslips were
positioned within the wells prior to the coating application.

4.3.3

ASC seeding

The DAT coatings were washed twice in sterile PBS immediately prior to seeding.
Passage 3 (P3) ASCs were seeded on the DAT coatings or uncoated control wells at a
density of 5,000 cells/cm2 in proliferation medium and incubated overnight (37°C, 5%
CO2, ~20% O2) to promote cell attachment. Subsequently, the seeded well plates were
transferred to the rocking platform (Thermo Scientific Compact Digital Rocker)
(Appendix Figure A.14) and cultured dynamically at a frequency of 30 RPM and a
rocking angle of 13° under 2% oxygen tension (2% O2/93% N2/5% CO2, 37°C)
controlled using a tri-gas incubator (ThermoFisher Forma Series II 3110) for up to 7
days. Static culture controls were also included in all assays, to generate a total of 4
experimental conditions: (i) static uncoated, (ii) static DAT-coated, (iii) dynamic
uncoated, and (iv) dynamic DAT-coated.

4.3.4

Multi-colour flow cytometry

To explore the effects of dynamic culture on the DAT coatings on the ASC
immunophenotype, multi-coloured flow cytometry analysis was performed to assess the
expression levels of the positive ASC markers CD90 and CD29, along with the variable
markers CD26, CD34 and CD146. Gating was performed to exclude any contaminating
CD31+ endothelial cells and CD45+ hematopoietic cells. After 7 days of culture under
static or dynamic conditions, the cells were trypsin-released through incubation in 0.25%
Trypsin/EDTA (325-043-CL, Wisent, St. Bruno, Canada) for 10 min at 37°C. The
suspended cells were filtered through a 100 µm nylon mesh and then stained with calcein
violet-AM (BioLegend) for 25 min. The stained cells were then centrifuged at 500 xg for
7 min at 4°C prior to antibody staining and flow analysis following the methods
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described in Section 3.3.4. For the analyses, duplicate wells were pooled per condition
(n=2 wells pooled) to obtain sufficient cell numbers and the studies were repeated with a
total of 3 different ASC donors (N=3).

4.3.5

Immunohistochemical analysis of ASC morphology and
iNOS expression

A pilot study was performed to probe the effects of dynamic culture on the DAT coatings
on the ASC morphology and expression of iNOS as a potential marker of phenotypic
changes in the ASCs133. Samples prepared with ASCs from one donor (N=1) were
collected after 1, 3 and 7 days of culture, fixed in 4% paraformaldehyde for 5 min, and
washed 3 times in PBS. The samples were then stained overnight with a rabbit anti-iNOS
antibody (ThermoFisher PA1-036, 1:200 dilution) diluted in PBS-T (0.1% Tween-20
supplemented with 1% BSA) at 4°C before being stained with a goat anti-rabbit antibody
conjugated with Alexa Fluor® 594 (1:200 dilution) diluted in PBS-T for 1 h at room
temperature. To visualize the cell morphology, staining with Alexa Fluor ® 680 Phalloidin
(Abcam AB176760) was performed in accordance with the manufacturer’s protocols.
Finally, the samples were counterstained with Hoechst 33258 (ThermoFisher) to
visualize the cell nuclei and mounted in Fluoroshield Mounting Medium. The samples
were visualized with an EVOS® FL Cell Imaging System under 20X magnification. The
number of iNOS+Hochest+ cells was quantified using ImageJ software in 15 randomly
selected non-adjacent fields of view per condition per timepoint.

4.3.6

PrimePCR™ array analysis of gene expression

To probe whether dynamic culture on the DAT coatings altered the gene expression
profile of the human ASCs, analysis was performed using a custom-made PrimePCR™
Array (BioRad) that included genes associated with (i) angiogenesis, (ii) inflammation,
(iii) ECM synthesis, and (iv) ECM remodeling. Appendix Table A.2 lists the specifics of
the 26 genes of interest included in the array. The total cellular RNA from duplicate
sample wells was extracted and pooled from all four conditions after 7 days of culture
using PureZol® RNA Isolation Reagent (BioRad) and the Aurum® Total RNA Mini kit
(BioRad). cDNA was synthesized from 2 µg of input RNA with an iScript ® cDNA
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synthesis kit (BioRad). The PrimePCR™ Array was performed in accordance with the
manufacturer’s protocols with duplicate samples (n=2) of 25 ng of cDNA per well, and
repeated with ASCs from a total of three different donors (N=3). The expression of all
genes of interest was normalized against the geometric mean of the reference genes UBC,
GAPDH and RSP18 using BioRad CFX Maestro® Software. Data was normalized against
the static uncoated group for comparative purposes.

4.3.7

Statistical analysis

All numerical values are represented as the mean ± standard deviation. Statistical
analyses were performed using GraphPad Prism® version 6 by one-way ANOVA and
followed with a Tukey’s post-hoc test. Differences were considered statistically
significant at p<0.05.

4.4 Results
4.4.1

Dynamic culture of ASCs on the DAT coatings enhanced the
expression of CD146 within the CD90+CD29+ human ASC
population

Multi-colour flow cytometry analysis was performed to assess the effects of dynamic
culture on the DAT coatings on the immunophenotype of the cultured human ASCs. For
all groups, CD31+CD45+ cells accounted for <2.5% of all viable cells, and >90% of the
viable CD31-CD45- population was CD90+CD29+, confirming their stromal origin (Table
4.1). The CD90+CD29+ human ASCs were also highly positive for CD26 and showed
donor-dependent variability in terms of CD34 expression, with no significant differences
between the four culture conditions for either of these markers (Table 4.1). Interestingly,
a significantly greater percentage of the CD90+CD29+ cell population was CD146+ in the
dynamic DAT-coated group as compared to all other conditions following 7 days of
culture (Table 4.1). Representative scatter plots for the CD26 and CD34 analyses are
shown in Appendix Figure A.15, and for CD146 are shown in Figure 4.1.
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Table 4.1 The percentage of live CD90+ CD29+CD31-CD45- cells that were positive
for CD26+, CD34+ and CD146+ (n=2 wells pooled, N=3 trials with different ASC
donors).
Static
Static
Dynamic
Dynamic
Uncoated
DAT-coated
Uncoated
DAT-coated
Viable Cells (calcein
94.7 ± 3.7 % 94.4 ± 1.5%
94.4 ± 4.8%
97.2 ± 1.0%
violet-AM+)
CD90+CD29+CD3189.5 ± 6.7% 89.8 ± 1.6%
82.7 ± 4.8%
87.6 ± 6.8%
CD45- (of viable cells)
CD90+CD29+CD3194.3 ± 5.4% 94.7 ± 6.3%
92.8 ± 4.9%
91.5 ± 7.1%
CD45-CD26+
CD90+CD29+ CD3118.8 ± 25.0% 13.0 ± 18.3% 11.9 ± 15.4% 10.2 ± 12.7%
CD45- CD34+
CD90+CD29+ CD313.1 ± 1.1%
6.9 ± 4.4%
2.1 ± 0.8%
13.9 ± 3.2%
CD45-CD146+

Figure 4.1 Dynamic culture of human ASCs on the DAT coatings for 7 days on the
rocking platform enhanced the expression of CD146 in the CD90+CD29+ cell
population. Representative scatter plots showing the fluorescence intensity of CD146
versus the forward scatter area (FSC-A).
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4.4.2

Dynamic culture of ASCs on the DAT coatings promoted cell
alignment and upregulated iNOS expression

Immunohistochemical analysis was performed to probe the morphology and iNOS
expression patterns in the human ASCs that were cultured dynamically or statically on
the DAT coatings or uncoated controls for 1, 3 and 7 days. Notably, there was a
qualitative reduction in the number of cells visualized in the dynamic DAT-coated group
from 1 to 3 days, suggesting that the shear stress stimulation may have caused initial cell
detachment in this group, but higher densities were observed at day 7 (Figure 4.3A). At
both 3 and 7 days, the ASCs were observed to have a more spindle-like morphology
when cultured on the DAT coatings, with less cell spreading as compared to the uncoated
controls. Interestingly, the ASCs in the dynamic DAT-coated group appeared to align
perpendicular to the direction of the fluid flow at day 7 (Appendix Figure A.17). iNOS+
cells were observed in the dynamic DAT-coated group at both 3 and 7 days.
Quantification of the iNOS+Hoechst+ cell population indicated that there was a marked
increase in the iNOS+ cell density in the dynamic DAT-coated group as compared to all
other groups at 7 days in this pilot study (Figure 4.3B).
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Figure 4.2 Dynamic culture of human ASCs on the DAT coatings promoted iNOS
expression at 7 days in vitro. A) Representative images showing iNOS (red), F-actin
(green) and nuclei (blue) at 1, 3 and 7 days of culture. ASCs cultured on the DAT
coatings showed a more spindle-like morphology at 3 and 7 days, with alignment
perpendicular to the direction of the fluid flow in the dynamic group at 7 days. Scale bars
represent 100 µm. B) Quantification of iNOS+Hoechst+ cell density at 1, 3 and 7 days
(N=1 trial with one ASC donor). A total of 15 non-overlapping images were analyzed in
each sample. Values represent the mean ± standard deviation.
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4.4.3

Dynamic culture of the human ASCs on the DAT coatings
did not significantly alter the gene expression patterns of a
range of pro-regenerative markers

The expression of 26 selected genes associated with (i) angiogenesis, (ii) inflammation,
(iii) ECM synthesis and (iv) ECM remodeling was assessed through a custom-made PCR
array to probe the effects of the rocking bioreactor strategy on the expression levels of a
range of markers associated with soft tissue regeneration (Appendix Table A.2).
Amplification was observed for all genes with the exception of IL4, which was excluded
from the analysis. There was donor variability in the response, and no significant
differences were observed between the various culture conditions for any of the genes
(Figure 4.3). To aid in visualization of the trends, Appendix Figure A.16 shows the data
alternatively plotted as a heat map. While not significant, many of the genes associated
with angiogenesis and inflammation appeared to be down-regulated in the ASCs cultured
statically or dynamically on the DAT coatings or dynamically on the uncoated controls
relative to the static uncoated group. Notably while a number of the ECM synthesis
markers (i.e. COL3A1, COL4A1, CTGF) were downregulated in the ASCs cultured
dynamically on the DAT coatings relative to the static uncoated controls, the ECM
remodeling markers TGFB1, MMP1, and MMP2 were all upregulated, while TIMP1 was
downregulated (Figure 4.3D).
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A)

B)

C)

D)

Figure 4.3 Analysis of the effects of the varying culture conditions on the expression
levels of a range of gene markers associated with soft tissue regeneration in the
ASCs after 7 days of culture. Relative expression levels normalized to the static
uncoated group for gene markers associated with A) angiogenesis, B) inflammation, C)
ECM synthesis and D) ECM remodeling. The data is plotted on a log2 scale and the error
bars represent the standard deviation (n=2 technical replicate samples/trial, N=3 trials
with different ASC donors).
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4.5 Discussion
Many recent studies have emphasized that ASCs can be harnessed to stimulate
regeneration within engineered bioscaffolds for a broad range of cell therapy
applications, including adipose tissue engineering40,449,455–459. From a translational
perspective, there is a need for improved cell expansion strategies that can be applied to
obtain large populations of cells with predictable pro-regenerative functionality from
relatively small tissue biopsies. While adipose tissue is regarded as a rich source of
MSCs, typical yields of 1 x 105 - 4 x 105 ASCs can be extracted per gram of human
adipose tissue70,71, while it is estimated that cell doses in the range of 107 - 1010 cells/mL
would be required for many clinical applications in humans460.
Although conventional culture on 2-D TCPS remains the standard approach, prolonged
culture on these rigid substrates is associated with a loss of regenerative potential in
ASCs257,393, including their capacity to proliferate and differentiate, which may impact
the overall effectiveness of adipose tissue regeneration strategies applying these cell
populations. To address this limitation, 3-D culture systems have been explored as an
alternative expansion strategy257,305,308,325,381,389–391,413. In the context of adipose tissue
engineering, a perfusion bioreactor system was previously applied to expand human
ASCs on 3-D DAT scaffolds that could also be used as a cell delivery platform 413. In
addition to promoting ASC expansion, culturing the ASCs on the DAT scaffolds within
the perfusion bioreactor under 2% O2 for 14 days enhanced their capacity to stimulate in
vivo adipose tissue regeneration413. However, scaling up this bioreactor system for
clinical implementation in humans would be technically challenging. As such, an
alternative, more scalable rocking bioreactor platform was explored in this pilot study.
Relative to 3-D perfusion bioreactor systems, the rocking bioreactor offers advantages in
that it can both support cell expansion and act as a preconditioning platform, while
remain highly scalable, as these systems can easily be stacked to enable mass culturing.
Fundamentally, a rocking bioreactor platform leverages a back-and-forth rocking motion
to drive an oscillating fluid flow, which can deliver fluid shear stress and promote the
efficient distribution of nutrients to the cultured cell populations. Within the system
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developed in the current study, all of the cells would be subjected to shear stress
stimulation induced by the flow of the media. In contrast, previous evidence suggested
that there was limited media perfusion into the central regions of the DAT scaffolds
cultured within the perfusion bioreactor system, which resulted in heterogeneity in the
cellular response in terms of both proliferation and phenotype 413.
Recognizing the importance of both the complex ECM composition and mechanical
properties in directing cell function461, DAT coatings were incorporated as a substrate
within the new dynamic culture system385. Human DAT was selected as a tissue-specific
substrate, as it has been shown to support ASC proliferation and adipogenesis 255,257,260,385.
For example, the favorable properties of DAT-based biomaterials in terms of ASC
proliferation were demonstrated in a study where DAT-derived microcarriers were shown
to better support the proliferation of human ASCs as compared to commercially-available
Cultispher-S microcarriers, which are gelatin-based257. More recently, human ASC
proliferation under static conditions was shown to be enhanced on DAT coatings similar
to those used in the current study relative to both collagen-derived coatings and uncoated
TCPS385.
In addition to supporting cell expansion, there is evidence that culturing on DAT-derived
biomaterials may be favorable for enhancing the secretion of pro-regenerative paracrine
factors. More specifically, a recent comparison of human fibroblasts cultured on
structurally and biomechanically similar DAT-derived and collagen-derived foams
demonstrated that pro-angiogenic growth factor production was significantly increased in
the cells cultured on the DAT foams, including hepatocyte growth factor (HGF) and
vascular endothelial growth factor A (VEGFA)462.
The findings in Chapter 3 of this thesis support that fluid shear stress stimulation can be
applied to modulate the phenotype of the human ASCs and potentially enhance their proregenerative paracrine functionality. In the current study, the flow cytometry analyses
support that fluid shearing can alter the ASC phenotype, with a significantly higher
percentage of the CD90+CD29+ population expressing CD146 in the ASCs cultured on
the DAT coatings on the rocking platform. Although CD146 is commonly regarded as a
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surface marker for pericytes419,420, its expression in ASCs has been associated with an
increased capacity for proliferation, clonogenicity and trilineage differentiation87.
Additionally, this surface marker is also strongly associated with an increased capacity to
support endothelial tube formation, suggesting that this specific subpopulation is more
pro-angiogenic86,463. While ASCs are known to express CD146, it is typically expressed
in a small fraction of the overall population at early passages when cultured on TCPS
(<10%)464,465. The marked enrichment of the CD146+ population in the dynamic DAT
coated group relative to the more conventional static uncoated group may be a positive
indicator in terms of the pro-regenerative potential of the cells expanded on the new
platform, which should be explored further in future work.
Preliminary evidence also suggests that the shearing forces from the rocking bioreactor
system also induced iNOS expression in the ASCs that were cultured on the DAT
coatings, consistent with the findings from the perfusion bioreactor study in Chapter 3.
These observations are also similar to a study by Bassaneze et al. which demonstrated
that subjecting ASCs to a shearing stress of 10 dyn/cm2 for 96 h was sufficient to
upregulate iNOS expression and promote nitric oxide (NO) production 289,466. Since iNOS
expression has been associated with an increase in the pro-regenerative capacity of
MSCs124,133,415, the pilot data from this study supports the further investigation and
development of the new rocking bioreactor platform, including confirming the response
in multiple ASC donors.
While the immunophenotype and IHC studies were a promising indication that culturing
the ASCs on the DAT coatings under dynamic conditions on the rocking platform
modulated the ASC response, the gene expression findings suggest that further
optimization of the system is required. While no significant differences were observed
between the groups, the trend towards the reduced levels of expression of a range of proangiogenic and immunomodulatory factors under dynamic conditions relative to the static
uncoated controls is an indicator that the selected conditions were not favorable for
stimulating paracrine factor expression in the cultured ASCs. Further, the qualitative
reduction in the number of cells observed on the DAT coatings in the dynamic group
from 1 to 3 days suggests that excessive shear forces may have been applied that were
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disruptive to the cells and potentially the coatings. This interpretation may be supported
by the qPCR array results that showed a shift towards higher expression of genes
associated with matrix degradation, combined with reduced expression of a number of
ECM components, suggestive of a more catabolic response that may be detrimental for
regeneration467. Within the rocking bioreactor system, a broad range of parameters could
be refined, including the rocking speed, rotation angle, media volume, and culture
duration, with the goal of promoting a more desirable response. In addition, the gene
expression results should be further validated at the protein level in a larger number of
ASC donors.

4.6 Conclusions
The present study provided initial evidence to support the further investigation of this
new scalable rocking bioreactor system integrating tissue-specific ECM-derived coatings
to dynamically culture and precondition human ASCs, towards the long-term goal of
promoting cell expansion and enhancing the pro-regenerative functionality of the cells
through shear stress stimulation. The system is cost-effective and simple to use and
appears to stimulate a more homogeneous response across the cultured ASC population
relative to what was observed in the previous perfusion bioreactor strategy. Another
advantage to this new approach is that the cells can easily be extracted from the DAT
coatings through enzymatic digestion, for subsequent incorporation into a range of cell
delivery platforms. The preliminary findings supported that dynamic culture on the DAT
coatings modulated the ASC phenotype, enhancing the expression of CD146 and iNOS,
which may be positive indicators in terms of their pro-angiogenic and
immunomodulatory functionality. However, the gene expression results suggest that
optimization is required to assess whether this dynamic culture strategy can be harnessed
to stimulate ASC paracrine factor production. In addition, further studies are required to
characterize ASC proliferation over time and the capacity of the expanded cells to
support in vivo angiogenesis and adipose tissue regeneration.
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Chapter 5

5

General discussion and future work

5.1 General discussion
To address the clinical need in plastic and reconstructive surgery for a therapeutic
strategy with the capacity to promote the stable regeneration of subcutaneous soft tissues,
the Flynn lab pioneered the development of decellularized adipose tissue (DAT) as an
off-the-shelf adipose tissue substitute253. Over the past 10 years since its initial
development, the DAT has been fabricated into an array of bioscaffolds that have been
shown to have adipo-inductive properties229,255,257,385,462. Moreover, the DAT can be
combined with adipose-derived stromal cells (ASCs), which was previously shown to
significantly enhance angiogenesis and constructive remodeling of the scaffolds into
host-derived adipose tissue in an immunocompetent rat model169. This work was crucial
in highlighting the important role that ASCs can play in mediating key processes
involved in adipose tissue regeneration. Recognizing both the capacity of the ASCs to
stimulate regeneration and of the DAT to provide a supportive microenvironment for
adipogenesis, a perfusion bioreactor strategy was developed with the goals of promoting
(i) ASC expansion and infiltration on the DAT and (ii) enhancing the pro-regenerative
function of the ASC-seeded DAT.
The capacity of the perfusion bioreactor system to support ASC expansion on the DAT
addressed the limitations that were associated with the static seeding methods that had
previously been applied, which can lead to low attachment and a heterogeneous
distribution of ASCs primarily on the surface of the DAT. While it may be possible to
expand a large number of ASCs on 2-D tissue culture polystyrene (TCPS) before seeding
on the DAT, prolonged proliferation under these conditions is often associated with a
decreased potential for the ASCs to promote regeneration257,393. As such, 3-D culture
systems represent a promising approach to circumvent this challenge by enabling the
cells to be directly expanded on a bioscaffold that more closely mimics the biochemical,
biomechanical, and structural properties of the native cellular microenvironment, which
play important roles in directing cell function247,256,260. In terms of 3-D culture systems, a
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diverse range of bioreactors257,305,308,325,381,389–391,413, including spinner flasks254,308,388,392
and rotating wall vessels88,306,307,309 have been explored. However, these bioreactor
systems are typically designed such that the expanded cells are enzymatically released
from their 3-D expansion platforms for downstream tissue engineering applications303,394.
In contrast, the perfusion bioreactor system was designed with the goal of promoting cell
expansion and in vivo delivery on the same scaffold system.
While perfusion bioreactor systems have primarily been explored for generating highly
cellularized bone tissue grafts310,312,314,316,317,319, the studies outlined in Chapter 2 provide
a strong case for their use in adipose tissue engineering applications. In particular, the
increased density of ASCs that was found along the periphery of the DAT scaffolds that
were cultured in the perfusion bioreactor under hypoxic conditions (2% O2) is consistent
with previous studies316,319. For example, Xie et al. demonstrated that sheep bone
marrow-derived mesenchymal stromal cells (MSCs) seeded on porous β-tricalcium
phosphate ceramic bioscaffolds and cultured in a perfusion bioreactor were significantly
more proliferative than controls cultured under static conditions over 28 days317.
Furthermore, the perfused regions of the ceramic scaffolds contained a high density of
MSCs with a homogeneous distribution317. While similar cell expansion effects were
observed in the present study, the cell distribution patterns also suggest that the central
regions of the DAT bioscaffolds may have been poorly perfused. The greater density of
ASCs along the periphery of the scaffold may have been caused by an increased delivery
of nutrients from the culture medium397,398, which could have also driven the migration of
cells from the central region to the periphery, in addition to promoting the proliferation of
cells around the scaffold border. These observations provided a case for developing an
alternative system where the cells could be in contact with the DAT but receive more
uniform exposure to the media and shear stress stimulation, which served as the rationale
for the development of the rocking bioreactor ASC expansion platform incorporating the
DAT coatings outlined in Chapter 4.
Increasing the density of the ASCs on the DAT was likely a mechanism through which
dynamic culturing in the perfusion bioreactor enhanced the capacity of the ASC-seeded
DAT to promote blood vessel formation and constructive adipose tissue remodeling
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following implantation in the subcutaneous thymic nude (nu/nu) mouse model in Chapter
2413. However, shear stress has also been shown to affect the function of MSC
populations290,291,313,326. For example, Yuan et al. showed that subjecting human bone
marrow-derived MSCs to 2 Pa of shear could increase vascular endothelial growth factor
A (VEGFA) expression compared to static controls290. In a more recent study, Bravo et
al. demonstrated that intermittent fluid flow upregulated the expression of VEGFA,
hepatocyte growth factor (HGF) and follistatin in human ASCs in vitro423. These studies
support that shear stress stimulation can be applied as a strategy to precondition MSCs to
enhance their capacity to stimulate in vivo regeneration. Their findings contributed to the
motivation to probe potential changes in the ASC phenotype and paracrine function
following culture on the DAT within the perfusion bioreactor under 2% O2 in Chapter 3.
Previous studies have shown that human ASCs that were subjected to 10 dyn/cm 2 of
shear stress upregulated the expression of nitric oxide (NO) through inducible nitric oxide
synthase (iNOS)289. As such, the increased iNOS expression in the ASCs within the
peripheral regions of the DAT that were dynamically cultured in the perfusion system not
only supports that those cells were experiencing fluid shear, but may be phenotypically
altered. To further compare the ASCs that were cultured dynamically or statically on the
DAT, the expression of key angiogenic factors and cytokines that were identified to be
altered in the PCR array was analyzed with a multiplex Luminex Assay. An increase in
interleukin 10 (IL-10) and C-X-C motif chemokine (CXCL-10) expression in the
dynamically cultured ASCs suggests that there may be differences in the
immunomodulatory function of the cells, as these factors have been associated with
promoting an anti-inflammatory/pro-regenerative macrophage phenotype and
macrophage recruitment, respectively135,429. Additionally, the increased expression of
HGF in the dynamically cultured ASCs could correlate with an increased capacity to both
promote angiogenesis114,115,118 and a more anti-inflammatory/pro-regenerative
macrophage response433. Further, the down-regulation of interleukin 6 (IL-6) in the
dynamically cultured ASCs would suggest a decreased capacity to induce a proinflammatory macrophage response143. Together, the in vitro studies from Chapter 3
suggest that dynamic culturing may enhance the capacity of the ASCs to promote both a
pro-angiogenic and a pro-regenerative macrophage response. These findings not only
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align with the results of the in vivo studies, but also provide a strong rationale for
applying the perfusion bioreactor strategy as a preconditioning system to increase the
pro-regenerative paracrine capacity of human ASCs through shear stress stimulation.
ASCs are recognized for their capacity to promote angiogenesis via the secretion of proangiogenic paracrine factors101,265,468,469, which has been leveraged for an array of tissue
engineering and regenerative applications101,170,470–472. For example, a study by Matsuda
et al. demonstrated that culturing human ASCs on decellularized cardiac tissue matrix
(cardiogel) can lead to an increased expression of interleukin 8 (IL-8), basic fibroblast
growth factor (bFGF) and stromal cell-derived factor 1 (SDF-1) than controls on
plastic170. Furthermore, these ASCs were shown to better support blood vessel formation
than cardiogel only control when delivered into the inguinal region of nude rats for 7
days170. Moreover, a study by Suga et al. demonstrated that the transplantation of
allogeneic ASCs into the inguinal fat pad in mice promoted blood vessel formation in the
target tissue at 14 days and this was achieved through the ASC-mediated secretion of
HGF and VEGF101. In Chapter 3 of this thesis, the qPCR array identified a variety of proangiogenic factors that were up-regulated in the ASCs that were dynamically cultured on
the DAT, including HGF, TNF, FGF13, AGGF1, and PLG. Follow-up studies to assess
changes at the protein level confirmed upregulation of HGF using the Luminex ® Assay,
as well as the locally enhanced expression of tumour necrosis factor alpha (TNF-α) in the
ASCs in the periphery of the DAT scaffolds within the dynamic culture group via
immunostaining. The increased levels of these pro-angiogenic paracrine factors may have
contributed to the increased CD31+ endothelial cell recruitment observed starting at 1
week and the increased density of erythrocyte-containing blood vessels at both 4 and
weeks in the DAT implants from the 2% O2 dynamic culture group413.
Previous studies have demonstrated that ASCs can also secrete a wide array of cytokines,
which can modulate the immune response, including promoting a more pro-regenerative
macrophage response124,473,474. For example, a study by Anderson et al. demonstrated that
human ASCs could stimulate the anti-inflammatory polarization of mouse macrophages
in vitro through the secretion of IL-10475. In a more recent study, human ASCs that were
seeded on Integra Matrix, a commercially-available wound dressing, were shown to
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promote macrophage infiltration and a decreased pro-inflammatory macrophage
response, which led to increased wound closure at 21 days in C57BL/6 mice 476.
Consistent with these studies, the Flynn lab has previously shown that delivering
allogeneic ASCs on the DAT subcutaneously into Wistar rats promoted a more proregenerative macrophage response associated with enhanced expression of CD163, as
well as increased blood vessel formation and adipose tissue remodeling of the DAT
bioscaffolds as compared to unseeded controls169. As previously discussed, the studies in
the current thesis demonstrated that human ASCs that were dynamically cultured on the
DAT expressed increased levels of IL-10 in vitro. When delivered in vivo into athymic
nude mice, a more pro-regenerative macrophage response was observed, with enhanced
infiltration of CD163+ macrophages into the implants in the dynamic group, coupled with
an increased angiogenic response and adipose tissue remodeling 413. Collectively, the in
vivo studies in Chapter 3 provided further support that ASCs could modulate the
macrophage phenotype, which have been an important factor in mediating both
angiogenesis353 and extracellular matrix remodeling351,447 within the implants.
In Chapter 2 of this thesis, significantly increased remodeling of the DAT into hostderived adipose tissue was observed at 8 weeks in the scaffolds that were cultured
dynamically within the perfusion bioreactor under 2% O2 for 14 days prior to
implantation, as compared to all other groups. The timeframe in which adipose tissue
formation was observed in this study was consistent with the previous rat study from the
Flynn lab, where seeding the DAT with allogeneic ASCs was found to better promote
adipose tissue remodeling as compared to the DAT scaffold alone at both 8 and 12
weeks169. Given the highly vascularized nature of mature adipose tissue, it is likely that a
well-established vasculature and the infiltration of pro-regenerative macrophages with the
capacity to remodel the DAT would be required before adipose tissue formation could
occur259,443,477. This interpretation would be consistent with the timing of adipose tissue
remodeling observed in the in vivo studies from Chapter 2, as well as the reduced
adipogenic response in the other groups, where there were significantly fewer blood
vessels infiltrating the implants.
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Adipogenesis in the context of adipose tissue engineering is an understudied process, and
little is known about the cell populations that can give rise to mature adipocytes within
engineered bioscaffolds. However, a study by Rodeheffer et al. identified an adipocyte
precursor population (CD29+CD34+CD24+stem cell antigen 1+ (SCA-1)) in the stromal
vascular fraction (SVF) of adipose tissue that could differentiate into adipocytes in
vivo374. In a more recent study, a large percentage of this adipocyte precursor cell
population was also identified as being CD26+375. In Chapter 3 of this thesis, a greater
host-derived CD26+ cell population was found in the implants in the dynamic group at 1
week, which could suggest there was enhanced infiltration of adipogenic progenitor cells
in this group. While CD26 is also expressed on non-adipocyte precursor cells including
fibroblasts and immune cell populations439–441, the CD26+ cell population may have
contributed to the increased perilipin+ adipocytes observed at 8 weeks in the implants
from the 2% O2 dynamic culture group, as shown in Chapter 2.

5.2 Future directions
The studies highlighted in this thesis provided important insights into how dynamic
culture systems could be applied to both expand and precondition ASCs to promote their
capacity to stimulate adipose tissue regeneration within DAT scaffolds. Based on insights
acquired from these studies, future work should focus on i) further exploring the effects
of dynamic culture within the perfusion bioreactor system on modulating ASC function,
ii) further investigating the mechanisms behind adipose tissue regeneration in vivo and
iii) further development and optimization of the rocking bioreactor system.
The perfusion bioreactor was set at a flow rate of 0.5 mL/min in the studies in Chapter 2
and Chapter 3. While this parameter supported ASC expansion and promoted the
expression of several key paracrine factors, it is possible that a different flow rate could
impact the proliferative and secretory behaviour of these cells. For example, a previous
study has shown that the proliferation capacity of bovine aortic endothelial cells was
inversely correlated with shear force478. For the perfusion bioreactor used in this study, it
is possible that the flow rate could be refined to further accelerate ASC expansion on the
DAT. Moreover, shear stress could also affect the paracrine secretion of the ASCs, as
shown in Chapter 3 and by Bassazene et al.289. While decreasing the flow rate could be
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conducive for ASC expansion, it could also attenuate pro-regenerative paracrine factor
secretion. Future studies should aim to test a range of flow rates that are both faster and
slower than the current parameter (e.g. 0.25 mL/min to 1 mL/min). The in vitro studies in
Chapter 2 could be used as a benchmark to assess proliferation, and the techniques
developed in Chapter 3 could be adopted as a framework to guide the analysis of
paracrine factor secretion. Upon in vitro refinement, additional in vivo studies using the
subcutaneous implantation model in athymic nude mice could be performed for up to 12
weeks to determine the long-term effects of altering the dynamic culture parameters on
angiogenesis and adipogenesis within the DAT.
The in vivo studies highlighted in Chapter 3 indicated that while dynamic culturing of
ASCs on the DAT did not significantly impact the recruitment of macrophages in the
nu/nu mouse model, it did result in a more pro-regenerative polarization within the DAT
implants, with enhanced infiltration of CD163+ macrophages. Given the dynamic nature
of the immune system, it is possible that the bioreactor cultured implants could have also
affected the phenotype of macrophages at earlier time points (e.g. 1, 2, 4 and 6 weeks).
Additionally, dynamic culture was shown to up-regulate IL-10 expression in the human
ASCs, which can promote a pro-regenerative macrophage phenotype and inhibit proinflammatory macrophage polarization. As such, it is possible that culturing the ASCs on
the DAT scaffolds under dynamic conditions may have also inhibited the proinflammatory polarization of macrophages at earlier timepoints in vivo. Future studies
could be performed to further examine the phenotype of macrophages at 1, 2, 4, 6 and 8
weeks. Potential markers of interest could include CD80, iNOS and Ly6c for proinflammatory macrophage polarization, as well as interleukin 4 (IL4), CD206, CD163
and Arg-1 for pro-regenerative macrophage polarization. In addition to the
immunostaining analyses performed in Chapter 3, scaffolds could be digested to isolate
the infiltrating cells for multi-colour flow cytometry analysis to identify specific
macrophage populations with distinct functions that may be relevant for regeneration. An
in-depth understanding of the immune response would provide important insights into the
role of macrophages in mediating adipose tissue regeneration.

124

The selection of in vivo analyses in both Chapter 2 and Chapter 3 examined the effects of
dynamic culturing of the ASCs on the DAT prior to implantation on the host response,
with a particular focus on angiogenesis and the macrophage response. While increased
angiogenesis and a more pro-regenerative macrophage phenotype are strongly correlated
with constructive adipose tissue remodeling169,259, how ASCs and/or the DAT promote
the formation of new host-derived adipose tissue remains poorly understood. Chapter 3 of
this thesis highlighted the increased infiltration of host-derived CD26+ cells, which may
have the potential to give rise to adipocytes, within the implants in the dynamic group at
1 week. However, it remains unclear whether this population contributed to adipogenesis.
Therefore, further investigation of this cell population could provide greater insight into
the potential mechanisms behind the observed adipose tissue regeneration within the
DAT implants. More specifically, implanted DAT scaffolds could be extracted, and
enzymatically digested to generate cell suspensions that could be analyzed using multicolour flow cytometry for the adipocyte precursor markers CD26, CD24, CD34, CD29
and SCA-1374. Understanding if these cells are present and the role these cells may play
in mediating adipogenesis would allow for the design of more targeted and efficient
therapeutic strategies to support adipose tissue regeneration.
The preliminary development of the rocking bioreactor system described in Chapter 4
demonstrated initial promise as a dynamic culturing system that could harness the cellinstructive capacity of the DAT and shear stress stimulation to modulate the proregenerative potential of the ASCs. The PCR Array performed did not indicate significant
differences in the gene expression levels of a range of pro-regenerative markers, which
suggests that the parameters used for the rocking system require further refinement. More
specifically, a combination of different rocking angles, frequencies and medium volumes
should be tested to first identify the amount of shear (dyn/cm2) the cells are experiencing
before moving forward to determine parameters that could both promote ASC expansion
as well as upregulate pro-angiogenic and immunomodulatory gene and protein
expression. Given the initial cell attachment issues observed in the dynamic DAT-coated
group, reducing the amount of shear by lowering the frequency from 30 RPM to 15 RPM,
decreasing the rocking angle from 13° to 10° and increasing the media volume from 3
mL/well to 4 mL/well could be initially tested. In addition to immunophenotypic
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analyses, further probing for angiogenic gene expression with qPCR and protein
expression with Luminex® Assays would help to determine a range of parameters to
move forward with in vivo assessments.
For in vivo analysis, the ASCs could be enzymatically released from the DAT coating
and encapsulated within a previously-developed DAT-methacrylated chondroitin sulfate
(MCS) composite hydrogel system255. The macrophage, angiogenic and adipogenic
responses could subsequently be evaluated at 1, 4, 8, 12 and 24 weeks to evaluate both
the short- and long-term potential of the system to promote angiogenesis and
adipogenesis, following the methods described in Chapter 3. Overall, the in vitro
optimization studies and subsequent in vivo validation would be an important next step to
assess the feasibility of the approach and potential benefits of ASC pre-conditioning
towards future clinical application.

5.3 Summary and significance
The body of work described in this thesis demonstrated that the perfusion bioreactor
system can be used as both an expansion and preconditioning platform for the human
ASCs on the DAT. Through dynamic culturing in the perfusion bioreactor system, the
ASC-seeded DAT scaffolds promoted a more pro-regenerative in vivo response, resulting
in an increased capacity to support angiogenesis, pro-regenerative macrophage
polarization and adipogenesis. To the best of my knowledge, this is the first study to
explore the application of a scaffold-based perfusion bioreactor system for adipose tissue
engineering.
The perfusion bioreactor was initially developed as a dynamic culturing platform to
support ASC expansion on the DAT. The in vivo study clearly demonstrated that the
ASCs that were cultured on the DAT within this system under 2% O2 exhibited an
increased capacity to promote both angiogenesis and adipogenesis in
immunocompromised animals in vivo. Beyond acting as a 3-D expansion platform, the
perfusion bioreactor altered the ASC phenotype and increased the expression of key
paracrine factors, which may have contributed to the enhanced infiltration of host-derived
cell populations and the polarization of host macrophages towards a more
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pro-regenerative phenotype within the implants. It is postulated that these cell
populations played an important role in the substantial remodeling of the implants into
host-derived adipose tissue that was observed in this group at 8 weeks.
Building on this work, pilot studies were performed to explore an alternative rocking
bioreactor strategy as a more scalable system that allows for the 3-D culturing of ASCs.
The preliminary studies performed demonstrated that the rocking bioreactor system
incorporating the DAT coatings has the potential to alter the ASC phenotype. Overall,
this work contributes to an emerging body of evidence that dynamic culture under shear
stress can be applied to modulate the pro-regenerative capacity of MSCs during cell
expansion.
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Appendix A: Supplemental Figures and Tables

Figure A.1 Schematic of the perfusion bioreactor system. A) Culture media is pumped
unidirectionally via the peristaltic pump through the sample chamber before being
recycled back into the media reservoir. B-C) The components of the sample chamber (B)
and culture inserts (C).
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Figure A.2 Representative Ki-67 staining in the central regions of the ASC-seeded
DAT scaffolds cultured under static or dynamic conditions within the bioreactor for
14 days. Ki-67 expression is shown in red and DAPI counterstaining in blue. Scale bars
represent 100 µm.
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Figure A.3 Representative HIF-1α staining in the central regions of the ASC-seeded
DAT scaffolds cultured under static or dynamic conditions within the bioreactor for
14 days. HIF-1α+ cells are shown in green and DAPI counterstaining in blue. Scale bars
represent 100 µm.

180

Figure A.4 The average erythrocyte-containing blood vessel A) diameter and B)
depth of infiltration in the DAT scaffolds following subcutaneous implantation in
the nu/nu mouse model for 4 and 8 weeks. Error bars represent standard deviation (n=3
cross-sections/implant, N=6 implants/group). *=significant difference in the 2% O2
dynamic group as compared to the unseeded, freshly-seeded and 2% O2 static groups at 8
weeks (p<0.05).
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Figure A.5 Representative images showing perilipin staining (brown) in the DAT
scaffolds implanted subcutaneously in the nu/nu mouse model for 4 weeks. Scale
bars represent 100 µm.
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Figure A.6 Representative immunostaining showing Ku80+ (red) human ASCs
counterstained with DAPI (blue) in the DAT scaffolds that implanted
subcutaneously in the nu/nu mouse model for 4 weeks. Scale bars represent 100 µm.
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Figure A.7 Representative scatter plots showing that dynamic culture did not
significantly alter the immunophenotype of the ASCs on the DAT scaffolds. The
ASCs were enzymatically-released from the DAT for flow analysis. A) Representative
scatter plots for one ASC donor showing the percentage of CD90+CD29+ cells in the
calcein violet-AM+CD31-CD45- subset. Representative scatter plots showing the
percentage of this population that also expressed B) CD26, C) CD34 or D) CD146.
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Figure A.8 Analysis of iNOS and Arg-1 expression in the ASC-seeded DAT scaffolds
cultured in vitro statically or dynamically for 14 days. A) The density of iNOS+DAPI+
cells and B) iNOS+DAPI+ cells as a percentage of the total DAPI+ cell population, and
C) the density of Arg-1+DAPI+ cells and D) Arg-1+DAPI+ cells as a percentage of the
total DAPI+ cell population in both the central (> 200 µm from scaffold border) and
peripheral (< 200 µm from scaffold border) regions of the DAT scaffolds. Error bars
represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with different ASC
donors). * = significant difference between the peripheral region of the dynamic group
and all other groups, # = significant difference between the peripheral region of the
dynamic group and the central region of the static group (p<0.05).

he
ra
l
Pe
rip

en
tr
al
C

Arg-1+ TNF

+

IL10+ DAPI+ /DAPI+ (% )

IL-10+ DAPI+ /DAPI+ (% )

185

Figure A.9 Analysis of TNF-α and IL-10 expression in the ASCs cultured statically
or dynamically on the DAT for 14 days. The percentage of the total DAPI+ human ASC
population that was A) TNF-α+DAPI+, B) IL-10+DAPI+, C) TNF-α+IL-10+DAPI+ and D)
Arg-1+TNF-α+IL-10+ DAPI+ in both the central (> 200 µm from scaffold border) and
peripheral (< 200 µm from scaffold border) regions of the DAT scaffolds. Error bars
represent standard deviation (n=3 cross-sections/scaffold, N=3 trials with different ASC
donors). * = significant difference between indicated groups (p<0.05).
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Figure A.10 The A) density of Ku80+DAPI+ human ASCs within the DAT implants
and B) the CD26+ human ASCs as a percentage of the total Ku80+DAPI+ human
ASC population in the DAT implants at 1, 4 and 8 weeks. Error bars represent
standard deviation (n=3 cross-sections/implant, N=6 implants/group). * = significant
difference between the dynamic group at 1 week and all other groups, # = significant
difference between the indicated group and both the static and dynamic groups at 1 week,
as well as the dynamic group at 4 weeks (p<0.05).
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Figure A.11 Representative immunostaining for CD45 (cyan), F4/80 (red) and CD68
(green) with DAPI counterstaining (blue) in the static and dynamic implants at 4
weeks. Scale bars represent 100 µm.
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Figure A.12 Representative immunostaining for CD45 (cyan), F4/80 (red) and CD68
(green) with DAPI counterstaining (blue) in the static and dynamic implants at 8
weeks. Scale bars represent 100 µm.
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Figure A.13 The percentage of A) CD45+F4/80+DAPI+ cells and
B) CD45+CD68+DAPI+ relative to the total CD45+DAPI+ cell population in the DAT
implants at 1, 4 and 8 weeks. Error bars represent standard deviation (n=3 crosssections/implant, N=4 implants/group). * = significant difference between the indicated
group and both the static and dynamic groups at 1 and 4 weeks (p<0.05).
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Figure A.14. Images of the rocking bioreactor platform.
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Figure A.15 Representative scatter plots showing the fluorescence intensity of CD90
versus CD29 in the calcein violet+CD31-CD45- cell population, and the fluorescence
intensity of CD26 or CD34 versus FSC-A in the viable CD90+CD29+ subpopulation
following 7 days of culture.
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Figure A.16. Heatmap showing the relative expression levels for each gene of
interest in the various culture conditions after 7 days of culture. Data shown was
normalized against the geometric mean of the housekeeping genes in each respective
sample. Genes with low average expression are indicated in blue and high expression in
red on a log2 scale.

Figure A.17 ASCs appeared to align perpendicular to the direction of the fluid flow
in the dynamic DAT-coated group at 7 days. Representative images taken from various
regions on the DAT coating showing iNOS (red), F-actin (green) and nuclei (blue). Scale
bars represent 100 µm.
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Table A.1 A list of genes assessed in the Human Angiogenic Growth Factor PCR
Array
Gene Symbol Gene Name
AGGF1
Angiogenic factor with G patch and FHA domains 1
AMOT
Angiomotin
ANG
Angiogenin, ribonuclease, RNase A family, 5
ANGPT1
Angiopoietin 1
ANGPT2
Angiopoietin 2
ANGPTL1
Angiopoietin-like 1
ADGRB1
Brain-specific angiogenesis inhibitor 1
BMP2
Bone morphogenetic protein 2
BTG1
B-cell translocation gene 1, anti-proliferative
CCL15
Chemokine (C-C motif) ligand 15
CCL2
Chemokine (C-C motif) ligand 2
CD55 molecule, decay accelerating factor for complement (Cromer
CD55
blood group)
CD59
CD59 molecule, complement regulatory protein
CHGA
Chromogranin A (parathyroid secretory protein 1)
COL18A1
Collagen, type XVIII, alpha 1
COL4A3
Collagen, type IV, alpha 3 (Goodpasture antigen)
CSF3
Colony stimulating factor 3 (granulocyte)
CXCL10
Chemokine (C-X-C motif) ligand 10
CXCL11
Chemokine (C-X-C motif) ligand 11
CXCL12
Chemokine (C-X-C motif) ligand 12
CXCL13
Chemokine (C-X-C motif) ligand 13
CXCL14
Chemokine (C-X-C motif) ligand 14
CXCL2
Chemokine (C-X-C motif) ligand 2
CXCL3
Chemokine (C-X-C motif) ligand 3
CXCL5
Chemokine (C-X-C motif) ligand 5
Chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein
CXCL6
2)
CXCL9
Chemokine (C-X-C motif) ligand 9
EDIL3
EGF-like repeats and discoidin I-like domains 3
EREG
Epiregulin
FGF1
Fibroblast growth factor 1 (acidic)
FGF13
Fibroblast growth factor 13
FGF2
Fibroblast growth factor 2 (basic)
FGFBP1
Fibroblast growth factor binding protein 1
FIGF
C-fos induced growth factor (vascular endothelial growth factor D)
FN1
Fibronectin 1
FOXO4
Forkhead box O4
FST
Follistatin
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GRN
GRP
HGF
IFNA1
IFNB1
IFNG
IL10
IL12A
IL12B
IL17F
IL6
CXCL8
KITLG
KLK3
LEP
MDK
NPPB
NPR1
PDGFB
PDGFD
PF4
PGF
PLG
PPBP
PRL
PROK1
PTN
RHOB
RNH1
RUNX1
SERPINC1
SERPINE1
SERPINF1
SPINK5
STAB1
TGFA
TGFB1

Granulin
Gastrin-releasing peptide
Hepatocyte growth factor (hepapoietin A; scatter factor)
Interferon, alpha 1
Interferon, beta 1, fibroblast
Interferon, gamma
Interleukin 10
Interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic
lymphocyte maturation factor 1, p35)
Interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic
lymphocyte maturation factor 2, p40)
Interleukin 17F
Interleukin 6 (interferon, beta 2)
Interleukin 8
KIT ligand
Kallikrein-related peptidase 3
Leptin
Midkine (neurite growth-promoting factor 2)
Natriuretic peptide B
Natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic
peptide receptor A)
Platelet-derived growth factor beta polypeptide
Platelet derived growth factor D
Platelet factor 4
Placental growth factor
Plasminogen
Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
Prolactin
Prokineticin 1
Pleiotrophin
Ras homolog gene family, member B
Ribonuclease/angiogenin inhibitor 1
Runt-related transcription factor 1
Serpin peptidase inhibitor, clade C (antithrombin), member 1
Serpin peptidase inhibitor, clade E (nexin, plasminogen activator
inhibitor type 1), member 1
Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment
epithelium derived factor), member 1
Serine peptidase inhibitor, Kazal type 5
Stabilin 1
Transforming growth factor, alpha
Transforming growth factor, beta 1
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THBS1
TIE1
TIMP1
TIMP2
TIMP3
TNF
TNNI2
TNNI3
TYMP
VEGFA

Thrombospondin 1
Tyrosine kinase with immunoglobulin-like and EGF-like domains 1
TIMP metallopeptidase inhibitor 1
TIMP metallopeptidase inhibitor 2
TIMP metallopeptidase inhibitor 3
Tumor necrosis factor
Troponin I type 2 (skeletal, fast)
Troponin I type 3 (cardiac)
Thymidine phosphorylase
Vascular endothelial growth factor A
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Table A.2 List of genes included in the PrimePCRTM array analysis.
Gene Symbol
ANGPT1
FGF2
HGF
IGF1
SERPINE1
VEGFA
Gene Symbol
CCL2
CSF2
IL1B
IL4
IL10
TNF
CXCL10
Gene Symbol
ACAN
ACTA2
BGN
COL1A1
COL3A1
COL4A1
CTGF
DCN
VCAN
Gene Symbol
MMP1
MMP2
TGFB1
TIMP1
Gene Symbol
GAPDH
RPS18
UBC

Angiogenesis
Gene Name
Angiopoietin-1
Basic fibroblast growth factor
Hepatocyte growth factor
Insulin like growth factor-1
Serpin family E member-1
Vascular endothelial growth factor A
Inflammation
Gene Name
C-C motif chemokine ligand 2
Colony stimulating factor 2
Interleukin-1 beta
Interleukin-4
Interleukin-10
Tumor necrosis factor
C-X-C motif chemokine ligand-10
ECM synthesis
Gene Name
Aggrecan
Smooth muscle actin alpha 2
Biglycan
Collagen type 1 alpha 1 chain
Collagen type III alpha 1 chain
Collagen type IV alpha 1 chain
Connective tissue growth factor
Decorin
Versican
ECM remodeling
Gene Name
Matrix metalloproteinase-1
Matrix metalloproteinase-2
Transforming growth factor-beta 1
Tissue inhibitor of metalloproteinases-1
Housekeeping
Gene Name
Glyceraldehyde 3-phosphate dehydrogenase
Ribosomal protein S18
Ubiquitin C
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